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Abstract 
Ingestion of nitrate (NO3
-) from natural sources can improve indices of cardiovascular 
health and exercise tolerance. The aim of this thesis was to determine the impact of 
dietary NO3
- as a therapeutic aid when consumed amongst factors that might affect its 
efficacy such as antibacterial mouthwash, blood donation, different food forms and co-
ingestion with alcoholic beverages. Young, healthy, normotensive individuals 
volunteered to participate in each experiment and undergo an array of physiological 
assessments. Chapter 4: Mouth rinsing with chlorhexidine and non-chlorhexidine 
mouthwash prior to consumption of concentrated NO3
--rich beetroot juice (BR), over 6 
days, blunted the rise in plasma nitrite concentration ([NO2
-]) by 53 % and 29 % 
respectively, compared with control. Chlorhexidine mouthwash also elevated systolic 
(SBP) and mean arterial (MAP) blood pressure (BP) during treadmill walking. Chapter 
5: Short-term BR ingestion lowered the oxygen (O2) cost of moderate-intensity exercise 
(by ~ 4 %), better preserved muscle oxygenation and attenuated the decline in 
incremental exercise tolerance (by 5 %) following whole blood donation. Chapter 6: 
An array of different NO3
--rich vehicles, including BR, beetroot flapjack (BF), non-
concentrated beetroot juice (BL) and beetroot crystals (BC), elevated salivary, plasma 
and urinary NO3
- concentration ([NO3
-]) and [NO2
-] when compared with baseline and 
control, with the largest increases in plasma [NO2
-] occurring in BF and BR. BR also 
reduced SBP (~5 mmHg) and MAP (~ 3-4 mmHg), and BF reduced diastolic BP (DBP; 
~ 4 mmHg). Chapter 7: A high NO3
-
 salad, accompanied by polyphenol-rich (NIT-
RW) and -low (NIT-A) alcoholic beverages and a water control (NIT-CON) elevated 
salivary, plasma and urinary [NO3
-] and [NO2
-] compared with control (CON). SBP was 
reduced 2 h post consumption of NIT-RW (-4 mmHg), NIT-A (-3 mmHg) and NIT-
CON (-2 mmHg) compared with CON. DBP and MAP were also lower in NIT-A, and 
more so in NIT-RW, compared with NIT-CON. 
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Overall, the findings in this thesis demonstrate the efficacy of naturally derived NO3
- on 
NO metabolites, BP and exercise tolerance. The potential for such benefits to arise may 
be maximised if antibacterial mouthwash is avoided during supplementation and if NO3
- 
is consumed as BR, BF or as a green leafy salad with or without an alcoholic beverage. 
It may also be suggested that NO3
- ingestion can offset decrements in exercise tolerance 
following blood donation. 
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 Chapter 1: Introduction 
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Chapter 1: Introduction 
Recently, there has been a surge in the use of dietary nitrate (NO3
-) as an ergogenic and 
therapeutic aid. The scientific and medical communities have led many investigations 
into the physiological effects of dietary NO3
- ingestion in sport and exercise and on 
indices of cardiovascular health and well-being. The emerging evidence base (see 
Chapter 2) has resulted in the promotion of NO3
-, in many different forms, as a tool for 
improving athletic performance and the vasculature.  
One of the first reports of NO3
- supplementation on human physiological functioning 
was by Larsen et al. (2006) who showed that ingestion of sodium NO3
- (NaNO3) for 3 
days reduced resting blood pressure (BP) in healthy, normotensive persons. This finding 
has since been replicated, with different doses of NO3
- salt (Bahra et al., 2012; Kapil et 
al., 2010). The same group later reported that NO3
- salts were also capable of lowering 
the oxygen (O2) cost of cycling exercise (Larsen et al., 2007), a phenomenon previously 
considered to be unaffected by exercise training or breathing hyperoxic gas. These 
remarkable findings provoked many others to explore the impact of NO3
-, particularly in 
its more natural forms, such as beetroot juice and vegetables, on BP, health and 
performance. In 2009, Bailey and colleagues found that 500 mL of beetroot juice, 
consumed every day, for 6 days, reduced systolic BP (SBP) and the O2 cost of 
submaximal cycle exercise and improved tolerance to high intensity exercise. Further 
research reported that NO3
- ingestion reduced systemic BP (Webb et al., 2008) and the 
O2 cost of exercise in a number of other exercise modalities (Bailey et al., 2010; 
Lansley et al., 2011; Muggeridge et al., 2013) and improved time-trial (Cermak, Gibala 
& van Loon, 2012; Lansley 2011a), intermittent exercise (Thompson et al., 2016) and 
cognitive performance (Thompson et al., 2015).  
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However, NO3
- ingestion has not always resulted in reductions in BP (Gilchrist et al., 
2013; Wilkerson et al., 2012) or improvements in exercise performance and cognitive 
parameters (Kelly et al., 2013), and this may be due to a number of factors influencing 
the effectiveness of the supplement, such as the population under investigation or the 
type and dose of NO3
- administered (James et al., 2015).   
Whilst most research studies carefully control experimental conditions when 
investigating the efficacy of NO3
- supplementation on physiological parameters, the 
influence of certain factors, particularly those which relate to ‘normal’ lifestyle routines, 
in combination with NO3
- ingestion, remain unknown. It is evident that some choices, 
such as the source of NO3
- ingested (Jonvik et al., 2016), training status (Wilkerson et 
al., 2012) and smoking (Bailey et al., 2016) can influence the efficacy of the 
physiological response to dietary NO3
-. It has also been reported that chlorhexidine-
containing mouthwash can attenuate the rise in NO3
- derivatives, like nitrite (NO2
-) and 
the vasodilator, nitric oxide (NO; Govoni et al., 2008) and the BP reducing effect (Kapil 
et al., 2010; Petersson et al., 2009) of NO3
- salt ingestion. However, further research is 
required to determine the impact of the prolonged use of chlorhexidine and weaker 
antiseptic agents on exercise BP when a NO3
--rich vegetable source is ingested. 
Although many studies now support a therapeutic and ergogenic role for NO3
-, 
particularly in hypoxic (Kelly et al., 2014; Masschelein et al., 2012) and ischaemic 
conditions (Hendgen-Cotta et al., 2012), which may occur during exercise and in 
disease states (Kenjale et al., 2011), it is not known whether NO3
- supplementation can 
counteract the reduction in O2-carrying capacity and subsequent decrements in exercise 
performance which occur after voluntary blood donation and this is an avenue for future 
work. 
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The acute and chronic physiological effects of beetroot juice have been compared 
(Vanhatalo et al., 2010; Wylie et al., 2016). Whilst the pharmacokinetic and dose-
response relationship to NO3
--rich salts and beetroot juice have been determined (Kapil 
et al., 2010; Wylie et al., 2013), the optimal NO3
- vehicle (from the many commercially 
available products that exist) needed to maximise supplementation regimens remains 
unknown.  
Mediterranean and Japanese diets have often been endorsed for their positive influence 
on cardiovascular health, mainly due to the high NO3
- content of the vegetables (Hu, 
2003; Sobko et al., 2010). In addition, polyphenols, particularly those found in red wine, 
have been reported to promote NO formation in the stomach after a NaNO3 bolus (Gago 
et al., 2007). Similarly, the combined ingestion of NO3
- and alcohol has also been 
shown to increase ethyl NO2
-, a vasodilator (Rocha et al., 2015). However, the 
pharmacokinetic response to the combination of a typical vegetable based NO3
--rich 
meal and accompanying alcoholic beverage, whether high or low in polyphenols, is not 
known and warrants further investigation. 
The purpose of this thesis was to determine the impact of a number of factors, some of 
which are typical daily choices, on the physiological and therapeutic response to dietary 
NO3
- supplementation. Specifically, the following literature review develops a rationale 
for the investigation of the physiological response to NO3
- ingestion in different forms, 
alongside chronic antibacterial mouthwash use, after blood donation, and in conjunction 
with polyphenol-rich and -low alcoholic beverages. 
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Chapter 2: Literature Review 
Nitric Oxide 
NO, a clear, odourless gas, was discovered in the late 1700’s by Joseph Priestley and 
was predominantly known as an atmospheric pollutant. In the 1980’s, Furchgott, 
Ignarro and Murad identified that the molecule produced in the body that was 
responsible for vasodilation, known at the time as endothelium derived relaxing factor 
(EDRF), was, in fact, NO. Nowadays, NO is known as a key and widespread 
mammalian signalling molecule that can regulate both physiological and 
pathophysiological processes (Nathan, 1992). It is one of the most researched molecules 
in physiology and medicine today due to its influence on BP (Rees, Palmer & Moncada, 
1989; Webb et al., 2008), blood flow (Shen et al., 1994), immunity (Coleman, 2001; 
Kilbourn, 1991; Tripathi, 2007), blood clotting (Radomski, Palmer & Moncada, 1990), 
skeletal muscle glucose uptake (Merry, Lynch & McConell, 2010), calcium handling 
and skeletal muscle contractility (Hart & Dulhunty, 2000; Viner et al., 2000), skeletal 
muscle fatigue (Percival et al., 2010), mitochondrial efficiency (Larsen et al., 2011) and 
neurotransmission (Garthwaite, 2008). NO has a short half-life in vivo (~ 0.1 s; Kelm & 
Schrader, 1990) and a reduction in its bioavailability has been associated with both 
cardiovascular (Förstermann, 2010) and metabolic (Huang, 2009) disease. Therefore, it 
may be suggested that maintaining continual NO production, via either of the two 
known pathways, the NO synthase (NOS)-dependent pathway and the NOS-
independent NO3
--NO2
--NO pathway, is critical for normal biological functioning.  
 
Endogenous, NOS-dependent NO production  
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It is well established that NO can be produced at a number of sites in the body by a 
family of NOS enzymes, including the endothelial (eNOS), neuronal (nNOS) and 
inducible (iNOS) isoforms (Moncada et al., 1989; Stamler & Meissner, 2001; 
Villanueva & Giulivi, 2010). These enzymes catalyse the complex oxidation of one of 
the guanidine nitrogen groups on the amino acid, L-arginine, to yield NO and L-
citrulline (Stamler & Meissener, 2001; Stuehr et al., 1991). However, this reaction is 
only possible in the presence of molecular O2 and several essential co-factors, such as 
nicotinamide adenine dinucleotide phosphate (NADPH, acting as an electron donor), 
tetrahydrobiopterin (BH4), haem, calmodulin, calcium, flavin mononucleotide (FMN) 
and flavin adenine dinucleotide (FAD; Alderton et al., 2001; Machha & Schechter; 
Stuehr et al., 2004; White & Marletta, 1992). A reduction in the bioavailability of one or 
more of these co-factors can hinder the production of NO via the NOS pathway 
(Crabtree et al., 2009). In fact, NOS can become uncoupled under particular conditions 
and cannot catalyse the conversion of L-Arginine to L- citrulline, yielding NO, instead, 
superoxide (O2
-) is formed via the donation of an electron from NADPH to molecular 
O2 (Roe and Ren, 2012). The causes of uncoupling are not fully understood at present 
but the oxidation of BH4 by O2
- and alterations in NOS phosphorylation or 
destabilisation of the functional NOS dimer have all been considered to play a role (Alp 
and Channon, 2004). 
Increasing age (Lyons et al., 1997) and cardiovascular (Försterman, 2010) and 
metabolic morbidities (Huang, 2009; Wu et al., 2009) have been associated with a 
decline in endogenously formed NO and can also result in impaired exercise capacity 
(Lauer et al., 2008). It is therefore evident that NO availability plays a crucial role in the 
preservation of normal endothelial function and tolerance to exercise.  
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It is important to note that NO formation is very sensitive to alterations in the 
physiological milieu, and conditions such as hypoxia or acidosis can limit NO 
production via the NOS pathway (Griffith and Stuehr, 1995). This may be due to the 
reduced availability of O2 per se, decreased expression of eNOS (Ho et al., 2012; 
McQuillan et al., 1994; Torporsian et al., 2000) or even the favouring of NO production 
via an alternative route (i.e. by the reduction of NO2
- through the NOS independent 
pathway, which suggests an existence of a crosstalk between the two pathways; 
Carlstrӧm et al., 2015). Recently, an additional O2 independent pathway for NO 
generation has been identified, in which the products of the reaction, NO3
- and NO2
-, are 
progressively reduced to create NO (Benjamin et al., 1994). This means of NO 
production is a way of maintaining NO availability when the oxidation of L-arginine to 
form NO is compromised, by, for example, areas of low O2 concentration (Bryan et al., 
2008; Carlstrӧm et al., 2010; Lundberg et al., 2008) or in individuals with NOS 
dysfunction (Lauer et al., 2008).  
 
NO3--NO2--NO pathway 
NO3
- and NO2
- were originally viewed as biologically inert oxidation products of 
endogenously derived NO (Moncada & Higgs, 1993). Specifically, NO3
- can be 
produced via the reaction of NO2
- or NO with oxyhaemoglobin (Cooper, 1999), and 
NO2
- can be formed by the reaction of NO with O2 (Ignarro et al., 1993), ceruloplasmin 
(Shiva et al., 2006) or with the active copper site in cytochrome c oxidase (Cooper et al., 
1997). 
However, nowadays, there is a wealth of evidence to suggest that NO3
- and NO2
- can be 
serially reduced in vivo to form NO, particularly in hypoxic and acidic environments,  
 Chapter 2: Literature Review 
7 
 
 
which may manifest during exercise and disease (Van Faassen et al., 2009). NO can 
also be stimulated by the consumption and serial reduction of NO3
- from dietary sources 
(Bryan & Hord, 2010) and this is a focus of the current thesis (See Figure 1.1). 
NO3
- can be ingested as a salt or as part of a natural nutritional regimen. Typically, 60-
80 % of daily NO3
- intake in a Western diet is derived from vegetables (Ysart et al., 
1999). It is important to note, however, that ingested NO3
- and NO2
- results in a similar 
amount of NO production compared to that derived from endogenous vascular (~ 70 % 
of systemic NO is derived via eNOS in the endothelium) or gastrointestinal (e.g. 
through the reduction of recycled NO2
- in the acidic environment of the stomach, in the 
absence of dietary NO3
- ingestion; Weitzberg and Lundberg, 1998) sources, assuming 
most of the endogenously derived NO is oxidised to NO3
- and NO2
- (Hord, Tang & 
Bryan, 2009). 
Once ingested, 100 % of dietary NO3
- is rapidly absorbed from the upper 
gastrointestinal tract and enters the systemic circulation within ~ 60 min (Lundberg & 
Weitzberg, 2009), where it merges with endogenously derived NO3
- (Florin et al., 1990; 
van Velzen et al., 2008). Plasma NO3
- concentration ([NO3
-]) remains elevated for up to 
~ 5 h (Wagner et al., 1983), although more recent research by Wylie et al. (2013) 
suggests that NO3
- may remain above baseline values until 24 h post ingestion of the 
NO3
- source. Although ~ 60-70 % of NO3
- is ultimately excreted in the urine 
(Bartholemew & Hill, 1984; Lundberg & Weitzber, 2009), approximately 25 % is taken 
up by the salivary glands, with the aid of the transporter protein sialin (Qin et al., 2012), 
and concentrated in the saliva by ~ 20 fold (Lundberg & Govoni, 2004; McKnight et al., 
1997). 
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A number of species of facultative and strict anaerobic bacteria (including Veillonella, 
Rothia and Neisseria; Burleigh et al., 2018; Doel et al., 2005; Hyde et al., 2014; 
Vanhatalo et al., 2018), located on the dorsal surface of the tongue, facilitate the 
reduction of ~ 20 % of salivary NO3
- (~ 5 % overall dietary NO3
- intake) to NO2
- 
(Duncan et al., 1995).  
After ingestion of a NO3
- source, salivary NO2
- concentration ([NO2
-]) has been reported 
to rise up to 2 mM, and, once swallowed, some of this NO2
- is reduced to NO in the 
acidic environment of the stomach (e.g. NO2
- + H+  HNO2, 2HNO2  2N2O3 + H2O, 
N2O3  NO + NO2; Benjamin et al., 1994; Lundberg & Govoni, 2004). The reduction 
of NO2
- to NO can be enhanced by the presence of vitamin C (e.g. 2HNO2 + Asc  
2NO + dehydrogAsc + 2H2O) and polyphenols (e.g. Ph-OH + HNO2  Ph-O• + •NO + 
H2O; Weitzberg and Lundberg 1998; Gago et al., 2007). Gastric NO, produced 
enzymatically by activated leukocytes (Malawista et al., 1992; Salvemini et al., 1989), 
or when acting as an effector molecule for macrophages (Brunet, 2001; Cenci et al., 
1993), can play a role in host defence by destroying or inhibiting swallowed pathogens 
(Benjamin et al., 1994; McKnight et al., 1997). Despite this, some NO2
- enters the 
systemic circulation, increasing plasma [NO2
-] (Dejam, Hunter, Schechter & Gladwin, 
2004; Lundberg & Govoni, 2004). The time to peak plasma [NO3
-] and [NO2
-] has 
typically been reported to occur at ~ 1-2 and 2-3 h, after an acute dose of NO3
-, 
respectively (Webb et al., 2008; Wylie et al., 2013). It is noteworthy that antibacterial 
mouthwash (Govoni et al., 2008) and failure to swallow saliva (Webb et al., 2008) have 
been shown to blunt the increase in plasma [NO2
-] following NO3
- ingestion. This 
suggests that the reduction of NO3
- to NO2
- is highly dependent on the presence of the 
NO3
- reducing bacteria found in the oral cavity. 
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NO synthesis from NO2
- 
The final step in the NO3
--NO2
--NO pathway is the one electron reduction of NO2
- to 
NO via both enzymatic and non-enzymatic means (Lundberg et al., 2008; van Faassen 
et al., 2009). This pathway is facilitated by several catalysts including 
deoxyhaemoglobin (Cosby et al., 2003), deoxymyoglobin (Shiva et al., 2007), 
cytochrome P-450 (Kozlov et al., 2003) aldehyde oxidase (Li et al., 2008), xanthine 
oxidase (Zhang et al., 1998), NOS (Vanin et al., 2007), components of the 
mitochondrial electron transport chain (Kozlov, Staniek & Nohl, 1999), ascorbate 
(Carlsson et al., 2001) and polyphenols (Gago et al., 2007; Peri et al., 2005). Unlike the 
O2-dependent NOS route, acidic (Modin et al., 2001) and hypoxic (Castello et al., 2006) 
physiological environments can enhance the production of NO via the NO3
--NO2
--NO 
pathway (van Faassen et al., 2009). In fact, Ferguson and colleagues (2016) recently 
found that in rats, NO2
- infusion, alongside NO blockade, restores skeletal muscle 
vascular control during exercise to levels reported in healthy rats with normal NOS 
function. Overall, it may be suggested that dietary NO3
- supplementation can provide an 
alternative means for elevating NO2
- and NO concentrations when the NOS pathway of 
generating NO is comprised, by, for example, hypoxic or acidic conditions which may 
occur during exercise (Richardson et al., 1999), oxidative stress and disease (Van 
Faassen et al., 2009; Williams et al., 2002).  
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Figure 2.1 The nitrate (NO3
-) -nitrite (NO2
-) -nitric oxide (NO) pathway in the human 
body  
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Typical dietary NO3- and NO2- intake 
NO3
- is usually ingested as part of a natural diet, with the main source being vegetables, 
which can contain up to ~ 400 mg of NO3
- per 100 g of fresh produce (Wang, Wei & Li, 
2000). Sixty to 80 % of daily NO3
- intake in a Western diet is derived from leafy greens, 
such as spinach, rocket, lettuce and red beetroot (Beta vulgaris rubra; Ysart et al., 
1999). However, NO3
- is also present in drinking water and cured meats where it is used 
as a preservative (Hord et al., 2009). It has been estimated that NO3
- intake in humans 
can range from 31-350 mg per day (Hord et al., 2009; Pennington, 1998). This variation 
in NO3
- consumption may be due to a number of factors, including the type and portion 
size of vegetable ingested, fertiliser use and the growth, storage and transport conditions 
of the NO3
- source (Hord et al., 2009; Pennington, 1998). 
The average daily intake of NO2
- by humans ranges from 0 to 20 mg per day in U.K 
(Knight et al., 1987; Walters, 1980) and U.S (Fassett, 1973) diets, with the main source 
in the diet being from processed meats, where it is used to enhance taste and prevent 
bacterial growth (Pennington, 1998). NO2
- is also found in vegetables but at much lower 
concentrations than NO3
-, ranging from 10-100 mg per kg (Hord et al., 2009; 
Pennington, 1998; Santamaria, 2006; Sušin et al., 2006). 
 
Health concerns relating to NO3- consumption 
The consumption of NO3
- has traditionally been considered harmful to health due to 
links with infantile methaemoglobinaemia (Comly et al., 1945), increased nitrosamine 
production (Mirvish, 1975) and carcinogenesis (Newberne et al., 1979). The NO3
- anion 
is relatively inert, with any harmful effects being related to its conversion to the more 
reactive ion, NO2
-. As a result, the World Health Organisation (WHO) have declared the  
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acceptable daily intake (ADI) of NO3
- as 3.7 mg per kg of body mass (e.g. ~ 4.5 mmol 
of NO3
- for a 75 kg person; WHO, 2002). Despite these guidelines, vegetarians and 
those who follow initiatives such as the Dietary Approaches to Stop Hypertension 
(DASH) diet tend to exceed the ADI considerably, often by consuming up to 20 mmol 
of NO3
- per day (Appel et al., 1997; Sacks et al., 1995). 
Methaemoglobin is formed when one of the iron atoms in the haem group of 
oxyhaemoglobin is oxidised (by NO2
-), converting ferrous (Fe2+) iron into the ferric 
state (Fe3+; Stryer, 1988). This prevents the haemoglobin molecule from binding with 
O2 and therefore can result in cell hypoxia (Fan & Steinberg, 1996; McKnight et al., 
1999). The initial concern with regard to NO3
- and methaemoglobinaemia (‘blue baby 
syndrome’) arose in 1945 and was associated with infants that had been ingesting NO3- 
containing well water (Comly et al., 1945). This remains the basis for the regulation of 
NO3
- in drinking water today, despite suggestions that the development of 
methaemoglobinaemia is unlikely to occur in the absence of bacterial contamination 
(Avery, 1999) and the lack of subsequent reports of methaemoglobinaemia following 
both NO3
- and NO2
- consumption across a number of countries (Cornblath & Hartmann, 
1948; Dejam et al., 2007; Kortboyer et al., 1997). However, infant NO3
- poisoning still 
remains a problem in the U.S., particularly in rural areas where milk formula may be 
prepared with contaminated well water (Johnson & Kross, 1990; Knobeloch & Proctor, 
2001; Kross, Ayebo & Fuortes, 1992). 
It has been reported in rodents that nitrosamines (a potential carcinogen) can be formed 
endogenously after the ingestion of NO2
- (Mirvish, 1975). In fact, a few incidences of 
lymphoma were reported in rats after chronic NO2
- exposure. However, it must be noted 
that the dose administered in this study was supra-physiological and unlikely to occur in  
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humans (Newberne et al., 1979). NO3
- and NO2
- are often used as preservatives in 
processed meats and a high consumption of such foods has been associated with an 
increased risk of gastric cancer due to the formation of carcinogenic N-nitroso 
compounds, by, for example, the nitrosation of amines or amides by NO2
- in the 
stomach (Larsson, Orsini & Wolk, 2006; Song, Wu & Guan, 2015). A recent meta-
analysis has revealed, however, that NO3
- intake is linked with a reduced risk of gastric 
cancer (Song et al., 2015) and many other studies have also failed to provide evidence 
that dietary NO3
- consumption is linked to an increased risk of cancer in humans 
(Beresford, 1985; Forman et al., 1985; Gangolli et al., 1994; WHO, 2010). Actually, 
high NO3
- foods, particularly vegetables and beetroot products, are a rich source of 
antioxidants and polyphenols (Kavalcovά et al., 2015; Khanam et al., 2012; Shepherd et 
al., 2015), which are known to inhibit the formation of carcinogenic N-nitroso 
compounds (Mirvish et al., 1998; Wootton-Beard & Ryan, 2012). 
There is an expanding body of evidence to suggest that dietary NO3
- consumption may 
be both cardio-protective and ergogenic. These findings have resulted in an increase in 
research exploring the use of NO3
- as a therapeutic and performance enhancing aid, but 
the influence of a number of factors, particularly daily choices, and their role in the 
effectiveness of NO3
- ingestion has yet to be determined. 
 
Salivary, plasma and urinary [NO3-] and [NO2-]  
NO can be produced endogenously or formed from the serial reduction of ingested 
dietary NO3
-. However, due to its high reactivity and short half-life in vivo it is 
extremely difficult to measure in biological fluids (Kelm & Schrader, 1990). NO reacts  
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rapidly with, for example, O2 or haemoglobin, and therefore, it is likely that its free 
transport is limited, particularly in the blood (Hakim et al., 1996). Many NO storage and 
transport forms exist, including S-nitrosothiols, S-nitrosohaemoglobin (Doctor & 
Stamler, 2011; Pinheiro et al., 2015), NO3
-, and NO2
-, with the latter two forms being 
the predominant, stable and easily detectable pools found in the human body (Cosby et 
al., 2003; Silver, 2011). Measuring the concentration of NO3
- and NO2
- in the saliva, 
plasma and urine will allow further insight into the metabolism of NO in vivo, 
particularly after dietary NO3
- supplementation. In addition, determination of the area 
under the curve, peak concentrations and the time taken to achieve peak and return to 
baseline concentrations of the stated NO metabolites, across a range of biological fluids, 
will provide crucial information for supplementation regimes where the aim is to 
improve indices of cardiovascular health. More specifically, knowledge of the kinetic 
pattern, including the magnitude and duration of exposure to these NO metabolites, will 
allow individuals to tailor supplementation of NO3
- to maximise and prolong the 
expected physiological responses, such as improvements in BP or exercise performance.  
Resting [NO3
-] and [NO2
-] in plasma (15-60 µM; 50-1000 nM), saliva (200-600 µM; 
30-210 µM) and urine (250-2000 µM; < 1 µM) are susceptible to variation, depending 
on the individual’s age, nutritional intake and health status (Bescós et al., 2012; Green 
et al., 1982; Lundberg & Govoni, 2004; Pannala et al., 2002). The measurement 
techniques employed, such as ozone based chemiluminescence, high performance liquid 
chromatography, electrophoresis and colorimetric assays, may also impact the [NO3
-] 
and [NO2
-] reported in biological fluids (Moorcroft, Davis & Compton, 2001; Tsikas, 
2005). It is important to note here that chemiluminescence is the gold standard  
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technique for determining [NO3
-] and [NO2
-] due to its high sensitivity and therefore 
ability to detect concentrations in the nM range (Tsikas, 2005).  
Typically, endothelial dysfunction results in lower levels of systemic NO3
- and NO2
- 
(Kleinbongard et al., 2006), whilst exercise (Green et al., 2004) and inflammatory 
disease (Crawford et al., 2004) can increase baseline circulating concentrations of NO3
-. 
Exercise has also been found to increase plasma [NO2
-] (Allen et al., 2010; Gladwin et 
al., 2000), but more frequently it has been shown, particularly at high intensities, to 
reduce plasma [NO2
-], suggesting that circulating NO2
-, after NO3
- intake, may be 
reduced to NO during exercise in both normoxia and hypoxia (Bescós et al., 2011; 
Dreissigacker et al., 2010; Kelly et al., 2014; Larsen et al., 2010; Wylie et al., 2013a). 
Dietary NO3
-, in the form of salts and vegetables, has consistently been shown to 
increase plasma (Kapil et al., 2010; Webb et al., 2008), salivary (Kapil et al., 2015; 
Lundberg & Govoni, 2004; Woessner et al., 2016) and urinary (Pannala et al., 2002) 
[NO3
-] and [NO2
-].  
Time to peak salivary [NO3
-] and [NO2
-] usually occurs between 1-3 h post ingestion of 
NO3
- (Pannala et al., 2002; Woessner et al., 2016). Although a direct relationship has 
been noted between NO3
- intake and salivary [NO3
-] and [NO2
-], a number of factors, 
such as salivary flow-rate, oral pH and the activity of the NO3
- reducing bacteria can be 
altered by daily choices (like using mouthwash or the type and dose of the NO3
- source 
ingested) and subsequently influence the concentration of NO metabolites in the mouth 
(Djekoun-Bensoltane et a., 2007). 
A dose-dependent increase in markers of NO bioavailability, such as plasma [NO3
-] and 
[NO2
-], has been reported after beetroot juice and potassium NO3
- (KNO3) ingestion 
(Kapil et al., 2010), with baseline levels evident by 24 h after ingestion of lower NO3
-  
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doses (Wylie et al., 2013). Increases in plasma [NO3
-] and [NO2
-] after KNO3 have been 
associated with reductions in SBP and diastolic BP (DBP), albeit a little later (6 and 3 h,  
respectively) than those detected following beetroot juice ingestion (Kapil et al., 2010). 
Time to peak plasma [NO3
-] and [NO2
-] typically occur within 2-4 h (Wylie et al., 
2013). However, it seems that the kinetic response and time to maximum elevation in 
NO bioavailability, namely plasma [NO3
-] and [NO2
-], may differ depending on the 
NO3
- vehicle ingested (Fleuck et al., 2016; Jonvik et al., 2016; Muggeridge et al., 2014; 
van Velzen et al., 2008). For example, Muggeridge et al. (2014) reported a faster time to 
peak plasma [NO3
-] and [NO2
-] (60 and 90 min) following ingestion of Swiss chard and 
rhubarb extract gels, respectively.  
Approximately 60-75 % of both endogenously and exogenously derived NO3
- is 
excreted in the urine (Hobbs et al., 2013; Pannala et al., 2002; Wagner et al., 1983) and 
this can be shown by increases in urinary [NO3
-] and [NO2
-] or total NO3
- and NO2
- 
output (Oldreive et al., 2001), which peak approximately 4-6 h post ingestion 
(Bartholomew et al., 1984; Cortas et al., 1991; Hobbs et al., 2012; Pannala et al., 2002).  
Many NO3
--rich products are commercially available, but the pharmacokinetic response 
to different food forms (e.g. solid or liquid) has not been determined and warrants 
investigation. This information would help to optimise supplementation regimens where 
the aim is to increase plasma [NO2
-] and lower BP after ingestion of various types of 
NO3
- containing foodstuffs or products.   
 
Beneficial effects of dietary NO3- ingestion 
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The remainder of this review will summarise the established physiological effects of 
dietary NO3
- supplementation and highlight particular factors that may alter these 
responses. 
 
Blood pressure 
The beneficial effect of a diet rich in fruit and vegetables on cardiovascular health 
(Gilchrist et al., 2010) and life expectancy (Visioli et al., 2005) is well established. The 
consumption of plant foods, such as green leafy vegetables and beetroot, has been 
estimated to lower the risk of cardiovascular morbidity and mortality (Hord, Tang & 
Bryan, 2009). These effects have been partly attributed to the high NO3
- content of such 
vegetables (Santamaria, 2006) and the vasodilatory effects of its derivatives, NO2
- 
(Classen, Stein-Hammer & Thöni, 1990) and NO (Ignarro et al., 1987). 
Vascular changes and risk for cardiovascular events and disease can be monitored and 
predicted using a variety of different techniques, such as ankle-brachial index, pulse 
wave velocity, electrocardiograms, laser-Doppler, pulse pressure and standard BP 
measurements, amongst many others. Typically, BP measurements performed using a 
single arm are utilised in everyday general practice and in research studies as it is a 
simple, non-invasive and effective method of predicting cardiovascular events and total 
mortality (Lewington et al., 2002; Psaty et al., 2001) and therefore this technique has 
been employed throughout this thesis. 
There is now a plethora of evidence to suggest that the consumption of NO3
-, in the 
form of beetroot juice, leafy vegetables or NO3
- salts, can reduce resting BP in healthy 
individuals (Ashworth et al., 2015; Bailey et al., 2010; Jonvik et al., 2016; Larsen et al., 
2006; Webb et al., 2008) and in those with chronic obstructive pulmonary disease  
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(COPD; Berry et al., 2015; Curtis et al., 2015) and peripheral arterial disease (PAD; 
Kenjale et al., 2011). Indeed, short term (Kapil et al., 2010; Webb et al., 2008; Wylie et 
al., 2013) NO3
- supplementation has been found to positively influence BP and these 
effects have been known to last up to four weeks in healthy (Thompson et al., 2016a; 
Wylie et al., 2016) and hypertensive (Kapil et al., 2015) persons. More specifically, 
Webb et al., (2008) reported a reduction in SBP (~ 10 mmHg), DBP (~ 8 mmHg) and 
mean arterial pressure (MAP; ~ 8 mmHg) approximately 2.5-3 h post 500 mL of 
beetroot juice (~ 22.5 mmol of NO3
-) consumption. These reductions are similar to 
those observed after anti-hypertensive medication and are likely important as it has been 
suggested that a decrease of just 5 mmHg in SBP could lower the risk of stroke- and 
heart disease- related mortality by 14 and 9 %, respectively (Stamler et al., 1991). Even 
a 2 mmHg reduction in SBP, if sustained, has been suggested to lower stroke mortality 
by 10 % and cardiovascular disease mortality by 7 % (Lewington et al., 2002). 
Both Wylie et al. (2013) and Kapil et al. (2010) reported a dose-dependent increase in 
plasma [NO2
-] and reduction in BP after different quantities of NO3
- were ingested. 
Alterations in BP have typically been reported to have returned to pre-supplementation 
baseline values by 24 h (Webb et al., 2008; Kapil et al., 2010), but this has not always 
been the case (Wylie et al., 2013).  
A meta-regression by Siervo and colleagues (2013) indicated that greater reductions in 
SBP were associated with a higher daily dose of dietary NO3
- (in the form of both salts 
and beetroot juice), but not increased study duration or plasma [NO2
-]. However, a more 
recent systematic review reported reductions in SBP and DBP following beetroot juice 
ingestion, with larger changes in SBP noted following interventions with higher doses 
of NO3
- and when supplementation was continued for more than 14 days (Bahadoran et  
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al., 2017). Another review by Jackson et al. (2018) showed that KNO3, beetroot juice 
and adoption of a high NO3
- diet (e.g. ingestion of green leafy vegetables) was 
associated with reductions in BP, with more pronounced effects noted in healthy 
individuals compared with patient participants. In addition, BP reduction was greater 
following acute supplementation (< 24 h) compared with longer interventions (> 24 h) 
and higher doses of NO3
- were associated with larger reductions in SBP but not DBP. 
Overall, further work is required to confirm the effects of inorganic NO3
- on BP. 
The reduction of NO3
- to NO is suggested to be accountable for the reduction in BP 
following NO3
- supplementation (Ignarro et al., 1987), although it must be noted that 
NO2
- itself may also produce direct vasodilatory effects on the vasculature (Alzawahra 
et al., 2008; Demoncheaux et al., 2002; Pinder et al., 2009), but such findings remain 
equivocal and further work is required to confirm the role of NO2
- as a direct vasodilator 
in humans (Lauer et al., 2001). An elevated level of intracellular NO is known to 
encourage the binding of NO with guanylate cyclase (Ignarro et al., 1986), which, in 
turn, stimulates the release of cyclic guanosine monophosphate (cGMP). An increase in 
cGMP activates a number of protein kinases to phosphorylate substrate proteins, which, 
subsequently, reduces intracellular calcium concentration ([Ca2+]) and leads to smooth 
muscle relaxation, lowering BP (Lohmann et al., 1997). Therefore, it may be suggested 
that dietary NO3
- ingestion has the potential to treat and/or prevent hypertension and 
associated vascular diseases.  
However, it must be stated that NO3
- supplementation does not always lower BP 
(Beijers et al., 2017; Cermak, Gibala & van Loon, 2012; Larsen et al., 2010; Wilkerson 
et al., 2012). A number of factors other than health status, and in particular, lifestyle 
choices, such as the type of food and drink one might ingest during a typical day, may  
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influence the BP response to dietary NO3
- consumption. Kapil et al. (2010) reported a 
negative correlation between baseline BP and the BP response to NO3
- supplementation 
i.e. the lower the baseline BP, the smaller the peak BP reduction achieved. It has also 
been reported that the frequent use of a chlorhexidine-containing mouthwash can 
abolish the beneficial effects on BP afforded by NO3
- ingestion (Kapil et al., 2013; 
Petersson et al., 2009; Woessner et al., 2016). The presence of dietary components, such 
as polyphenols and vitamin C, which are found in fruit and vegetables, are likely to 
promote the production of NO from NO2
- in the stomach (Gago et al., 2007; Lundberg 
et al., 2010) and the consumption of alcohol may also increase NO storage pools (Rocha 
et al., 2015) and subsequently lead to vasodilation (Gago et al., 2008). Nowadays, a 
number of different NO3
--rich products are on the market but the impact of such 
products on resting BP has not been determined. Future studies that characterise the BP 
response and metabolism of NO3
- and NO2
- following dietary NO3
- ingestion alongside 
factors (for example, mouthwash use, alcohol consumption and the type of NO3
- food 
form ingested) that might impact its effectiveness on these parameters, will provide 
important information for the regular use of NO3
- as a potentially therapeutic aid 
amongst habitual practices. 
 
Oxygen cost of submaximal exercise 
In recent years, dietary NO3
- supplementation has been found to positively affect the 
physiological response to exercise (Bailey et al., 2009; Lansley et al., 2011; Larsen et 
al., 2007). Larsen and colleagues (2007) were the first to report a reduction (~ 5 %) in 
the O2 cost of submaximal exercise in well trained athletes after 3 days of NaNO3 
ingestion (0.1 mmol∙kg-1∙d-1). This decrease in O2 consumption (V̇O2) was evident in  
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the presence of an increase in plasma [NO2
-] (by ~ 82 %) and in the absence of 
detectable changes in ventilation, blood lactate concentration and respiratory exchange 
ratio (RER), suggesting an improvement in muscle oxidative metabolic efficiency rather 
than alterations in the O2 cost of cardiopulmonary processes, substrate utilization or 
increases in energy supply from non-oxidative sources (Larsen et al., 2007).  
In 2009, Bailey et al. also found a reduction in V̇O2 (~ 5 %) during moderate-intensity 
constant work rate (CWR) cycling after 4-6 days of supplementation with a natural 
NO3
- source, beetroot juice (0.5 L∙d-1, containing 5.5 mmol·d-1 of NO3-). Many studies 
have since reported similar reductions in the O2 cost of exercise in various modalities 
following up to six days of NO3
- supplementation (Bailey et al., 2010; Cermak et al., 
2012; Lansley et al., 2011; Muggeridge et al., 2013; Whitfield et al., 2016; Wylie et al., 
2016). Decreases in V̇O2 during moderate-intensity exercise have been reported to be 
dose-dependent (Wylie et al., 2013) and can occur just 1-3 h after acute bolus 
consumption of NO3
- salts (~ 0.033 mmol.kg-1 of body mass; Larsen et al., 2010) and 
beetroot juice (~5-8 mmol; Vanhatalo et al., 2010; Muggeridge et al., 2013; 2014; 
Thompson et al., 2014) and these effects may still be evident if daily supplementation 
with concentrated beetroot juice (BR) is continued for four weeks (~13 mmol.d-1; 
Thompson et al., 2016a). Acute (Masschelein et al., 2012) and chronic (Kelly et al., 
2014; Muggeridge et al., 2014) beetroot juice ingestion has also been found to decrease 
steady state V̇O2 in hypoxia. However, it is unknown whether similar effects are present 
when O2-carrying capacity is limited, such as after whole blood withdrawal.  
Lowering the O2 cost of exercise may improve functional capacity and the quality of life 
of older persons and those with cardiovascular, respiratory or metabolic disease. 
Vanhatalo and colleagues (2016) recently reported that 10 days of beetroot juice  
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ingestion reduced the O2 cost of treadmill walking in healthy older persons (70-80 years 
of age). In addition, a lowered V̇O2 during submaximal cycling has also been found in 
individuals with COPD (Curtis et al., 2015) and during a cardiopulmonary treadmill test 
in patients with PAD (Kenjale et al., 2011). A number of studies, however, have not 
found any influence of beetroot juice ingestion on the O2 cost of exercise (Breese et al., 
2013; Kelly et al., 2013; Thompson et al., 2015), particularly in highly trained cohorts 
(Bescós et al., 2011; Christensen et al., 2013; Peacock et al., 2012; Boorsma et al., 
2014; Sandbakk et al., 2015) and in persons with type 2 diabetes (Shepherd et al., 
2015), COPD (Berry et al., 2015; Shepherd et al., 2015) and in those with heart failure 
with reduced (Coggan et al., 2018; Hirai et al., 2017) or preserved (Zamani et al., 2015) 
ejection fraction. A recent systematic review reported that dietary NO3
- can indeed 
reduce the O2 cost of moderate- and even heavy- intensity exercise in healthy subjects, 
but such effects were not evident in individuals with chronic disease (Pawlak-Chaouch 
et al., 2016). The reason for such disparity in findings is not known but the timing of 
NO3
- ingestion, type of supplement used and the training/health status and habitual 
actions or daily lifestyle choices (e.g. mouthwash use and diet) of the subjects under 
investigation may account for these discrepancies.  
The mechanistic bases for a lower O2 cost of submaximal exercise following NO3
- 
supplementation may include a reduction in the adenosine triphosphate (ATP) cost of 
muscle force production (Bailey et al., 2010), a reduction in the O2 cost of 
mitochondrial resynthesis (Larsen et al., 2011) and/or alterations in redox signalling 
(Whitfield et al., 2016), but further work is required to confirm such mechanisms.  
 
Exercise tolerance and performance 
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NO3
- supplementation and the subsequent rise in plasma [NO2
-] has been correlated 
with exercise tolerance and/or improvements in performance in healthy (Dreissigacker 
et al., 2010; Rassaf et al., 2007) and trained (Lansley et al., 2011a) individuals. More 
specifically, tolerance to severe-intensity [70 % Δ; 70 % of the difference between the 
power output at the gas exchange threshold (GET) and V̇O2peak (peak O2 uptake)] CWR 
cycling improved by 16 % after 6 days of beetroot juice supplementation (5.5 mmol of 
NO3
- per day; Bailey et al., 2009). Many authors have since investigated the influence of 
dietary NO3
- (5-10 mmol per day for 5-11 days) on exercise tolerance and 
improvements in time to exhaustion (TTE) achieved during two-legged knee extensor 
exercise (25 %; Bailey et al., 2010), treadmill running (15 %; Lansley et al., 2011) and 
severe-intensity cycling (12-21 %; Breese et al., 2013; Kelly et al., 2013; Thompson et 
al., 2014) have been reported.  
Beetroot juice ingestion has been found to improve incremental exercise tolerance 
during single-legged knee-extensor exercise (Lansley et al., 2011) and cycling 
(Vanhatalo et al., 2010) in normoxia, hypoxia (+ 5 %; Masschelein et al., 2012) and in 
those with PAD (+ 17 %; Kenjale et al., 2011). Muggeridge et al. (2014) have also 
reported that a single dose of BR, ingested 3 h prior to exercise at a simulated altitude of 
2500 m, resulted in improvements in 16.1 km cycling time trial performance. 
Suggested mechanisms for improvements in exercise performance and tolerance to 
high-intensity exercise following dietary NO3
- supplementation may include reductions 
in muscle metabolic perturbation (Bailey et al., 2010; Vanhatalo et al., 2011) and 
increases in skeletal muscle Ca2+ handling proteins (Hernández et al., 2012) and blood 
flow particularly in type II fibres (Ferguson et al., 2013; 2015). 
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A number of studies have, however, reported no improvement in long duration running 
or cycling performance after acute beetroot juice ingestion, particularly in those who are 
well trained (Cermak et al., 2012a; Peacock et al., 2012; Wilkerson et al., 2012). This 
may be due to higher baseline plasma [NO2
-] due to increased NOS activity (Wilkerson 
et al., 2012) and an increased capillary density (achieved via training) which is likely to 
reduce the development of a hypoxic environment in the working skeletal muscle 
(Jensen, Bangsbo & Hellsten, 2004). There is also evidence to suggest that plasma 
[NO2
-] may be reduced during exercise and therefore, the potential for beetroot 
supplementation to enhance performance reduces as the event continues (Wylie et al., 
2013a; Thompson et al., 2015). In addition, NO3
- supplementation has been found to 
enhance muscle blood flow, particularly to type II muscle fibres (Ferguson et al., 2013; 
Hernández et al., 2012) and therefore the effectiveness of NO3
- ingestion may be 
attenuated in persons with a lower proportion of these ‘fast-twitch’ fibres, i.e. endurance 
trained athletes. 
A systematic review reported that inorganic dietary NO3
- ingestion is likely to elicit 
improvements in exercise tolerance when measured as time to exhaustion achieved 
during an exercise capacity test, but less likely when measured as performance in a time 
trial in healthy adults (McMahon et al., 2017). Other reviews have also reported 
improvements in time to exhaustion following NO3
- supplementation in older adults 
(Stanaway et al., 2017) and in athletes (Domínguez et al., 2017). 
Differences in supplementation regimes (dose, duration and type of supplement 
administered), exercise duration and modality and the subject population (recreationally 
active versus highly trained) may all be factors contributing to intra-study variations and  
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therefore must be considered when investigating the efficacy of dietary NO3
- ingestion 
on exercise performance. 
The improvements in exercise tolerance following beetroot juice ingestion are more 
pronounced in hypoxia than normoxia (Kelly et al., 2014). The amelioration of the 
negative effects of a reduced O2 availability on O2 transport and exercise performance 
after NO3
- ingestion is important as it may reflect the cardiovascular insufficiency that 
can be present in conditions, such as PAD, that limit skeletal muscle oxygenation, 
particularly during exercise (Kenjale et al., 2011). However, the influence of dietary 
NO3
- on incremental exercise performance when normal O2 carrying capacity is reduced, 
such as in anaemia or after blood donation, has not yet been determined and warrants 
further investigation.  
 
Factors influencing the effects of dietary NO3- supplementation 
It is evident that dietary NO3
- ingestion can elevate markers of NO and elicit favourable 
effects on cardiovascular health and exercise performance. However, the impact of 
some daily lifestyle choices and habitual practices can play an important role on the 
effectiveness of the physiological response to NO3
- supplementation. Specifically, a 
paucity of data exist regarding the influence of mouthwash use, blood donation, 
different NO3
- food forms and alcohol consumption (particularly red wine) on the 
ability of dietary NO3
- to induce cardiovascular benefits.  
 
Mouthwash use 
 
 Chapter 2: Literature Review 
26 
 
 
Dietary NO3
- can elevate precursors of NO, such as NO2
-, in biological fluids, which is 
often associated with reductions in systemic BP. It is important to note that circulating 
NO2
-, a major storage pool of NO (Cosby et al., 2003), is dependent on the presence and 
activity of NO3
- reducing oral bacteria. Therefore, a disturbance in the oral flora may 
reduce the availability of plasma [NO2
-] and the possibility of beneficial effects on the 
vasculature occurring. 
Recently, it has been shown that the use of a chlorhexidine-containing mouthwash, 
which may be considered as part of a daily routine by some persons, can reduce the 
number of bacteria on the tongue and NO gas produced in the stomach and also 
attenuate the rise in both salivary and plasma [NO2
-] after an acute dose (10 mg.kg-1 in 
humans; Govoni et al., 2008) or more prolonged ingestion (140 mg.kg-1 per day, for 5 
days, in rats; Petersson et al., 2009) of NaNO3. It is also important to note that the 
decrease in MAP and DBP recorded after 5 days of NO3
- ingestion in rats, was 
abolished after the oral cavity was sprayed twice daily with antibacterial mouthwash 
(Petersson et al., 2009). 
In 2013, Kapil and colleagues showed in healthy volunteers that mouth-rinsing twice 
daily for 7 days with chlorhexidine-containing mouthwash alongside a low-NO3
- diet 
reduced salivary and plasma [NO2
-] by 90 and 25 %, respectively. The attenuation in 
these NO metabolites was accompanied by an elevation in seated and ambulatory SBP 
and DBP. However, the influence of different strength antibacterial mouthwashes on 
resting and exercise BP, following prolonged natural NO3
- ingestion has not yet been 
determined. This information may raise awareness of the influence of commercially 
available mouthwashes on the ability of NO3
- supplementation to alter parameters of 
vascular health, such as BP. 
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Blood donation 
Supplementing the diet with different NO3
--rich products or increasing the consumption 
of green leafy vegetables can increase NO bioavailability via the NO3
--NO2
--NO 
pathway. This means of enhancing NO storage pools may be particularly important 
when NOS activity is compromised (Lundberg et al., 2008) and O2 availability is 
reduced (Castello et al., 2006). It is well known that when O2 transport is limited, by, 
for example, disease, blood donation or challenging atmospheric conditions, tissue 
hypoxia may occur (Linarsson et al., 1974) and exercise tolerance is likely to deteriorate 
(Hogan et al., 1999; Kelly et al., 2014). However, there is evidence to suggest that NO3
- 
supplementation can offset performance decrements due to compromised O2 availability 
via increases in skeletal muscle blood flow (Casey et al., 2010). In fact, NO3
--rich 
beetroot juice has been found to improve muscle oxygenation during incremental 
exercise (Masschelein et al., 2012) and offset reductions in tolerance to CWR high-
intensity knee extensor exercise in hypoxia (Vanhatalo et al., 2011). However, it is 
unknown whether beetroot juice ingestion can alter the haemodynamic and 
physiological response to exercise in those persons who choose to donate whole blood 
and subsequently reduce their O2 carrying capacity. The results of such research may 
have important implications for persons with anaemia, those recovering from blood loss 
and for recreationally active individuals wishing to donate blood. 
 
Food forms 
Athletes, coaches and medical professionals are interested in new ways to improve 
performance and/or cardiovascular health. In addition to seeking out new training and 
recovery regimens, nutritional interventions are widely utilised among elite and  
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recreationally active individuals. Dietary NO3
- ingestion, in the form of beetroot juice 
and NO3
- salts, has become one of the most popular ergogenic aids in recent times, and 
there are now a number of different commercially available NO3
--rich supplements.  
However, a number of questions remain unanswered with regard to the NO3
- food form 
which may optimise vascular health and performance. Additional research is necessary 
to allow the development of supplementation guidelines for the use of NO3
- as a 
therapeutic and ergogenic aid. 
To date, a number of studies have investigated the impact of dietary NO3
- in various 
forms, including salts, vegetable juices, gels and bread, on NO bioavailability and BP 
(Hobbs et al., 2012; Jonvik et al., 2016; Kapil et al., 2010; Muggeridge et al., 2014; 
Vanhatalo et al., 2010). Whilst NO3
- supplementation in general may elevate NO 
bioavailability and often elicit favourable physiological effects, it is evident that the 
NO3
- food form (e.g. NaNO3 or beetroot juice) ingested can influence such responses 
(Flueck et al., 2016; Jonvik et al., 2016; van Velzen et al., 2008). At present, there is no 
study that has determined the pharmacodynamic pattern of salivary, plasma and urinary 
[NO3
-] and [NO2
-] and BP response to an equimolar dose of NO3
- administered in 
different food forms in the same subject cohort over a 24 h period. Further work is 
necessary to establish the relationship between different NO3
- vehicles and NO 
bioavailability in bodily fluids. Establishing the time to peak plasma [NO2
-] and area 
under the curve after each NO3
- source may allow for supplementation regimens to be 
optimized, particularly when the aim is to sustain a lowered BP over time. 
 
Simultaneous ingestion of salad and alcohol 
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The beneficial effects on vascular health afforded by the consumption of beetroot juice 
and/or the adoption of a Mediterranean diet have been chiefly attributed to the high 
NO3
- content of the vegetables consumed. It is well established that exogenous NO3
- is 
reduced to NO2
- by bacteria in the oral cavity and once swallowed, this salivary NO2
- 
can re-enter the circulation, increasing plasma [NO2
-]. NO2
- can also be reduced to NO 
and other nitrogen oxides, particularly in acidic environments, like the stomach 
(Benjamin et al., 1994; McKnight et al., 1997), and in the presence of a number of 
different enzymes and polyphenols (Rocha et al., 2009). NO3
--rich vegetables and red 
wine are rich in polyphenols and the acute consumption of both, in isolation (Gago et 
al., 2007; Webb et al., 2008) and in combination (Rocha et al., 2015), have been 
reported to promote NO formation. In addition, NO2
- and alcohol have also been 
reported to generate ethyl-NO2
- a potent vasodilator and storage pool of NO. However, 
the bioavailability of NO in different biological fluids and the BP response to the 
combination of a vegetable based NO3
--rich meal and polyphenol-rich red wine and 
polyphenol-low alcoholic beverage is not known, nor is the magnitude of or time to 
peak salivary, plasma and urinary [NO3
-] and [NO2
-]. This warrants investigation as the 
consumption of a green leafy salad may serve as a practical and low cost way of acutely 
improving indices of vascular health. It is also important to determine if there is an 
additive effect of alcohol, particularly red wine, if consumed in moderation, as part of a 
typical Mediterranean meal on BP. 
 
Summary 
Acute and chronic NO3
- supplementation has been shown to increase markers of NO 
bioavailability, lower BP, reduce the O2 cost of moderate-intensity exercise and  
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improve tolerance to high-intensity exercise. However, it is evident that some factors 
must be considered carefully when the overall aim is to elicit cardiovascular and 
exercise-related benefits from NO3
- consumption. Therefore, elucidating the optimal 
NO3
- supplementation regimen for vascular and performance benefits would require 
determination of the influence of factors, such as: 1) the use of different strength 
mouthwashes; 2) blood donation; 3) NO3
- food forms; and 4) polyphenol-rich (red 
wine) and a low polyphenol alcoholic beverage in combination with a typical 
Mediterranean salad. 
 
Aims and hypotheses 
The aim of this thesis is to provide novel insight into the use of dietary NO3
- 
supplementation as a potential therapeutic aid in the face of factors that might influence 
its effectiveness. The experimental chapters will address the following research 
questions in young, healthy and normotensive persons:  
 
1) What are the effects of prolonged use of different strength antibacterial 
mouthwashes, in combination with NO3
- supplementation, on NO metabolites 
and resting and exercise BP? 
- Hypothesis: NO3
--rich concentrated beetroot juice supplementation 
preceded by chlorhexidine-containing mouthwash will significantly 
attenuate the rise in plasma [NO2
-] and the expected reductions in BP at rest 
and during exercise compared with non-chlorhexidine-containing 
mouthwash and a water control mouthwash. It is also expected that the non-
chlorhexidine-containing mouthwash will not significantly alter the variables 
under investigation when compared with control. 
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2) What are the effects of short-term NO3- ingestion on moderate-intensity and 
ramp incremental exercise performance following voluntary blood donation? 
- Hypothesis: NO3
--rich concentrated beetroot juice will significantly lower 
the O2 cost of moderate-intensity exercise, improve muscle oxygenation 
status and attenuate the expected reduction in exercise tolerance during ramp 
incremental exercise following whole blood donation. 
 
3) What are the pharmacokinetic responses of salivary, plasma and urinary [NO3-] 
and [NO2
-] and BP following consumption of different NO3
- food forms? 
- Hypothesis: Relative to baseline and the control condition, concentrated 
beetroot juice, non-concentrated beetroot juice, beetroot flapjack and 
beetroot crystals will all significantly elevate salivary, plasma and urinary 
[NO3
-] and [NO2
-] and reduce BP, but such changes may vary in magnitude 
and time to peak between the different food forms. 
 
4) What are the pharmacokinetic responses of salivary, plasma and urinary [NO3-] 
and [NO2
-] and BP following polyphenol-rich and -low alcoholic beverages in 
combination with a NO3
--rich meal? 
- Hypothesis: Relative to baseline and a low NO3
- meal with a water control 
drink, a high NO3
- meal in combination with red wine, vodka and lemonade 
or water, will significantly increase salivary, plasma and urinary [NO3
-] and 
[NO2
-] and reduce BP. It was also hypothesised that the NO3
- and red wine 
condition will significantly lower BP when compared to the other high NO3
- 
conditions due to the increased polyphenol content. 
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Chapter 3: General Methods 
The four experimental chapters (Chapters 4-7) in this thesis required 286 visits to the 
laboratory by the subjects under investigation, all of which were conducted by the chief 
researcher (Sinead McDonagh). A further 175 laboratory visits were undertaken by the 
chief researcher for the determination of salivary, plasma and urinary [NO3
-] and [NO2
-
]. All of the tests in Chapters 4, 5, 6 and 7 were conducted in an air conditioned 
physiology laboratory at sea level and at an ambient temperature (between 18-22 ◦C). 
Prior to the commencement of data collection, all experimental procedures employed 
during each experimental chapter were approved by the University of Exeter Ethics 
Committee. 
 
Health and Safety 
The University of Exeter School of Sport and Health Sciences health and safety 
guidelines were followed during all experimental testing. Specifically, care was taken to 
ensure that all preparation and data collection areas were clean and safe and provided a 
suitable environment for the assessment of human subjects. This was achieved by 
regularly cleaning work surfaces, ergometers, blood pressure cuffs and floors using a 
dilute Virkon disinfectant. All respiratory apparatus were disinfected after each use in 
line with the manufacturers’ guidelines. During blood sampling and analysis, disposable 
nitrile gloves were worn by the experimenter and all biohazard material and sharps were 
disposed into appropriate bins and incinerated at a later date. 
 
Informed Consent 
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Prior to participation in a study, subjects were given an information sheet to read which 
included a comprehensive outline of the experimental procedures and the requirements 
of the tasks to be undertaken. Potential risks and benefits of participation were 
explained and subjects were informed that whilst their anonymity would be preserved, 
the results from the study may be published in academic journals and presented at 
conferences. All participants were free to ask any questions regarding the study 
procedures and were ensured that they had the right to withdraw from the study at any 
time, with no disadvantage to themselves. After a minimum of 24 h and when 
participants were content that they had read and understood the requirements of the 
study, written informed consent to participate in the study was provided. 
 
Participants 
All volunteers for each of the four experiments were recruited from the staff and student 
population at the University of Exeter. Subjects were healthy, non-smokers, free from 
disease and did not habitually use antibacterial mouthwash during data collection 
periods. In Chapter 5, subjects were recreationally active individuals who participated in 
structured exercise and/or competitive sport regularly. In Chapters 6 and 7, all subjects 
were instructed to arrive at the laboratory in a fasted and well-hydrated state. 
Participation in strenuous exercise and alcohol intake were avoided during each 
experimental period (unless instructed by the researcher) and in the 24 h preceding each 
visit to the laboratory. Subjects were also asked to refrain from consuming caffeine in 
the 3 h period prior to each testing session. All tests were conducted at the same time of 
day (± 2 h) to minimise the effects of diurnal variation on the physiological variables 
under investigation.  
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Supplementation 
NO3
- supplementation was administered in many different forms across the 
Experimental Chapters. The [NO3
-] and [NO2
-] of all supplements were determined via 
chemiluminescence prior to commencement of each study.  
 
Preparation of food sources for determination of NO3
- and NO2
- content 
Neat 50 µL samples of NO3
--rich concentrated beetroot juice shots (Chapters 4, 5 and 
6), NO3
--depleted concentrated beetroot juice shots (Chapter 5), non-concentrated 
beetroot juice, beetroot crystals (Chapter 6), deionised water (Chapters 6 and 7), red 
wine, lemonade and vodka (Chapter 7 only) were injected into the purge vessel for 
determination of NO3
- and NO2
- content via chemiluminescence (as described in detail 
later in this chapter). In addition, in Chapters 6 and 7, prior to analysis of the NO3
- and 
NO2
- content of each food form, a 1.5 mL aliquot of each homogenised vegetable 
(rocket, spinach, green beans and cucumber), fruit (cherry tomatoes) or flapjack was 
transferred to a heat-resistant microcentrifuge tube. Samples were then heated to 130 °C 
for 60 min using a heat plate (Grant QBD2, Cambridge, UK) to disintegrate the cell 
membranes for release of intracellular NO3
-. Subsequently, samples were centrifuged at 
12 000 g and 4 °C for 8 min and the supernatant was removed for analysis via 
chemiluminescence and diluted with deionised water, where appropriate.  
A brief description of each supplementation regimen is provided below. 
 
Supplementation regimens 
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In Chapters 4 and 5, inorganic NO3
- was consumed in the form of a concentrated 
beetroot juice containing ~ 6.2 mmol of NO3
- (BR; Beet It Sport Stamina Shot, James 
White Drinks, Ltd., Ipswich, UK). In Chapter 4, subjects were assigned in a double 
blind, randomised crossover design to mouth-rinse with 3 different strength 
mouthwashes prior to consuming a 70 mL shot of BR, twice per day, for 6 days. More 
specifically, subjects were instructed to consume 70 mL of BR in the morning and 70 
mL in the evening for 5 days. On day 6, subjects consumed 2 x 70 mL of BR, 2 h before 
returning to the laboratory for post intervention measures. A minimum of a 10 day 
washout period separated each of the 3 supplementation periods in this study.  
In Chapter 5, after blood donation, subjects were randomly assigned in a double-blind, 
independent groups, placebo-controlled fashion to consume 7 x 70 mL shots of NO3
--
rich BR or NO3
--depleted beetroot juice (PL; containing ~0.04 mmol of NO3
-) over ~ 48 
h. During both supplementation periods, subjects were asked to consume 2 x 70 mL of 
the assigned beverage in the evening 2 days prior to testing, 1 x 70 mL in the morning 
and again in the evening 1 day prior to testing and a further 2 x 70 mL 2 h prior to 
testing. On arrival at the laboratory, subjects also consumed a final 70 mL beverage. 
Each supplementation period was separated by a minimum of 8 days. It is important to 
note here that the PL drink was similar in appearance, taste and smell and was created 
by passing the juice, before pasteurisation, through a column containing Purolite A520E 
ion exchange resin, which selectively removes NO3
- ions. 
Single-blind (personnel performing the physiological measurements were blind), 
randomised, controlled trials were undertaken in Chapters 6 and 7 with a minimum of 
48 h separating each experimental period. In Chapter 6, an acute dose of ~ 5.76 mmol of 
NO3
-, in the form of a concentrated beetroot drink (BR; 55 mL of Beet It Sport Stamina  
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Shot, James White Drinks, Ltd., Ipswich, UK), a non-concentrated beetroot drink (BL; 
456 mL of Beet It Organic Beetroot Juice, James White Drinks, Ltd., Ipswich, UK) and 
a beetroot flapjack (BF; 60g of Beet It Pro Elite Sport Flapjack, James White Drinks, 
Ltd., Ipswich, UK) were ingested. Subjects also consumed (5g dissolved in 4 oz./114 
mL of water; 1.40 mmol of NO3
-) Concentrated Organic Beetroot Crystals (BC; 
SuperBeets Canister; Neogenis, now known as HumanN, Texas, US) and a control 
drink (CON; 70 mL deionised water) which contained negligible NO3
- and NO2
- 
content.  
In Chapter 7, subjects were instructed to consume an acute dose of ~ 6.05 mmol of 
dietary NO3
- in the form of a green leafy salad (50 g rocket, 88 g spinach and 160 g 
cucumber) in combination with either a polyphenol-rich red wine [NIT-RW; 
Montepulciano d’Abruzzo, Tesco Stores Ltd, Welwyn Garden City, U. K; 12.5 % 
alcohol by volume (ABV)], a low polyphenol alcoholic beverage (NIT-A; 58 mL Red 
Label Smirnoff  Vodka, The Smirnoff Co., London, U.K; 117 mL Tesco Sparkling 
Lemonade, Tesco Stores Ltd, Welwyn Garden City, U. K;  12.5 % ABV) or a control 
drink (NIT-CON; 175 mL deionised water). Subjects were also asked to consume a low 
NO3
- salad (55 g cucumber, 68 g green beans and 200 g cherry tomatoes; 0.69 mmol 
NO3
-) with a control drink (CON; 175 mL deionised water).  
In Chapters 4-6, subjects were advised that ingestion of the BR (and BL in Chapter 6) 
supplement might result in the temporary appearance of red urine (beeturia) and stools. 
All supplementation regimens used in Chapters 4-7 were well tolerated by all subjects 
with no adverse effects reported. 
 
Measurement Procedures 
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Prior to any supplementation or exercise testing, subjects’ height, mass and age were 
recorded.  
 
Blood Pressure 
In Experimental Chapters 4, 5, 6 and 7, BP of the brachial artery was measured using an 
automated sphygmomanometer (Dinamap Pro; GE Medical Systems, Tampa, FL) after 
a period of rest. Specifically, subjects were seated in a quiet room, and after 10 minutes 
of solitary rest, five BP measurements were recorded and the mean of the final four 
measurements were used for data analysis. In Chapter 4, BP was also measured after 10 
minutes of supine rest using the automated device, and a manual sphygmomanometer 
(Accoson, Blood Pressure Cuff, Essex, England) and stethoscope (Spirit Dual Head 
Stethoscope CK-605T, Spirit Medical Co. Ltd., New Taipei City, Taiwan) were used to 
determine BP during treadmill walking (during 4-6 and 8-10 minutes of exercise). 
The reliability of measuring SBP was determined by repeating BP assessments of the 
brachial artery, in 10 subjects, on five separate days. Subjects arrived at the laboratory 
on each day in a fasted state and were asked to rest, in a seated position, in a quiet room 
for 10 minutes. BP was measured five times and the mean of the final four SBP 
measurements was calculated and recorded. The coefficient of variation for the intra-test 
(using BP measurements taken on the same day) was 1.4 %. The inter-test (using BP 
measurements taken on different days) coefficient of variation was 1.1 %.   
 
Heart rate 
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In each experimental chapter, after 10 minutes of rest in a seated (or supine; Chapter 4 
only) position, heart rate (HR) was recorded using an automated device. In addition, in 
Chapter 5, HR was recorded every 5 s during moderate-intensity and incremental 
exercise using short-range telemetry (Polar RS400, Polar Electro Oy, Kempele, 
Finland). 
 
Blood sampling 
In Chapters 4, 5 and 6 (at 24 h post ingestion of each supplement), blood samples were 
obtained from the antecubital fossa via venepuncture only. In Chapters 6 and 7, a 
cannula (Insyte-WTM, Becton-Dickinson, Madrid, Spain) was inserted into the 
antecubital vein of each subject to allow regular blood sampling during each 
experimental period. The cannula was infused with 0.9 % saline at 10 mL/h to ensure 
patency. All samples were drawn into 7.5 mL lithium-heparin tubes (Vacutainer, 
Becton-Dickinson, NJ, USA) and centrifuged for 10 minutes at 3000 g and 4 ºC within 
2 minutes of collection. The plasma was then extracted, aliquoted into 3 Eppendorf 
tubes and stored at -80 ºC for later determination of [NO3
-] and [NO2
-]. 
 
Saliva and urine sampling 
In Chapters 4, 6 and 7, saliva samples were collected by expectoration, without 
stimulation, over a period of 5 minutes, prior to and after NO3
- supplementation. The 
saliva samples were subsequently aliquoted into 1.5 mL Eppendorf tubes. In Chapters 6 
and 7, midstream urine samples were also collected at baseline and at a number of time 
points after NO3
- ingestion. Each sample was aliquoted into 3 x 1.5 mL Eppendorf 
tubes.  
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Both the saliva and urine samples were frozen immediately at -80 ºC for later 
determination of [NO3
-] and [NO2
-] via chemiluminescence. 
 
NO3
- and NO2
- concentration 
Plasma (Chapters 4-7), saliva (Chapters 4, 6 and 7) and urine (Chapters 6 and 7) 
samples were analysed for [NO3
-] and [NO2
-] using gas-phase chemiluminescence. This 
process is dependent on the reduction of NO3
- and NO2
- to NO gas. Prior to and during 
analyses, all glassware, utensils and surfaces were regularly rinsed with deionized water 
to remove residual NO2
-. 
Before the determination of plasma [NO3
-], the neat plasma was first deproteinized. In 
Chapters 4-6, 400 μL of zinc sulphate (ZnSO4; 10 % w/v) and 400 μL of sodium 
hydroxide (NaOH; 0.5 M) were added to 200 μL of plasma and vortexed for 30 s and 
then left to stand at room temperature for 15 minutes. Subsequently, the plasma samples 
were centrifuged for 5 minutes at 4000 rpm and the supernatant was removed for 
analysis of NO3
-. In Chapter 7, plasma samples were deproteinized for both [NO3
-] and 
[NO2
-] (to prevent protein deposit build up and damage to the NO analyser) using a cold 
ethanol precipitation technique. Specifically, 1000 µL of ethanol (at 0 ºC) were added to 
500 µL of plasma and vortexed for 30 s before being left to stand on ice for 30 minutes. 
Subsequently, samples were centrifuged at 18 600 g for 5 minutes. The supernatant was 
removed and used for analysis. For [NO3
-], the supernatant was injected into a gas 
sealed purge vessel containing vanadium trichloride (VCl3; 0.8 % w/v) in hydrochloric 
acid (HCl; 1M) at 95 ºC. An additional gas bubbler containing NaOH (1 M) was 
installed to prevent damage to the nitric oxide analyser from acid vapour. 
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For NO2
- reduction, untreated (Chapters 4-6) and deproteinized (Chapter 7) plasma was 
injected into the glass purge vessel, which contained 5 mL glacial acetic acid and 1 mL 
sodium iodide (NaI; 4 % w/v) at 35 ºC. 
In Chapters 4, 6 and 7, saliva and urine samples were centrifuged for 10 minutes at 18 
600 g prior to analysis. The supernatants from all saliva samples were diluted with 
deionised water by a factor of 100 prior to determination of [NO3
-] and [NO2
-]. Urine 
samples were also diluted using deionised water, by a factor of 100 (Chapter 6: [NO3
-] 
only; Chapter 7: [NO2
-] only) and 1000 (Chapter 7: [NO3
-] only). The same analysis 
technique as stated for plasma (above) was employed for saliva and urine samples. 
The NO produced from the reduction of NO3
- and NO2
- was measured using a NO 
analyser (Sievers NOA 280i, Analytix Ltd, Durham, UK). The reaction of NO with 
ozone in the chemiluminescent chamber yielded nitrogen dioxide, which on production, 
emits a light at the infra-red region on the electromagnetic spectrum. This light was 
detected by a red-sensitive photomultiplier tube, housed in the NO analyser, and was 
amplified to produce an analogue mV output signal. [NO3
-] and [NO2
-] were determined 
by plotting the signal area against a calibration plot of 25 nM to 1 μM sodium NO2- 
(NaNO2) and 100 nM to 10 uM NaNO3, respectively. The coefficients of variation for 
duplicate samples for [NO3
-] and [NO2
-] after a NO3
- dose and using the above 
techniques were 0.49 and 3.87 % for plasma, 0.33 and 0.66 % for saliva and 0.00 and 
0.23 % for urine, respectively.  
 
Exercise testing procedures  
Chapter 5 includes a detailed description of the exercise tests undertaken in this thesis. 
In addition, the reliability of pulmonary gas exchange measurements was established  
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using bouts of moderate-intensity exercise performed on two separate days in 11 
participants.  
On each visit, participants completed a constant work step test, consisting of a 3 minute 
baseline cycling period at 20 W, followed by a sudden transition to a work rate eliciting 
80 % of the work-rate associated with the GET for 5 minutes, with each bout separated 
by 10 minutes of passive rest. Participants were asked to cycle at the same preferred 
cadence (~ 80 rpm) on each visit. The coefficient of variation for steady state V̇O2 was 
1.3 % at an absolute power output of 90 W. 
 
Statistical analyses 
All statistical analyses were performed using the Statistical Package for Social Sciences 
(SPSS). More specific details of the statistical procedures performed in each experiment 
are outlined in the ‘Statistical Analyses’ section of Chapters 4-7. Data are presented as 
mean ± SD unless otherwise stated. Statistical significance was accepted at P < 0.05. 
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Abstract 
 
Chlorhexidine containing mouthwash (STRONG), which disturbs oral microflora, has 
been shown to diminish the rise in plasma nitrite concentration ([NO2
-]) and attenuate 
the reduction in resting blood pressure (BP) typically seen after acute nitrate (NO3
-) 
ingestion. We aimed to determine whether STRONG and weaker antiseptic agents 
attenuate the physiological effects of chronic NO3
- supplementation using beetroot juice 
(BR). Twelve healthy volunteers mouth rinsed with STRONG, non-chlorhexidine 
mouthwash (WEAK) and deionised water (CON) three times a day, and ingested 70 mL 
BR (6.2 mmol NO3
-), twice a day, for 6 days. BP (at rest and during 10 min of treadmill 
walking) and plasma and salivary [NO3
-] and [NO2
-] were measured prior to and on day 
6 of supplementation. The change in salivary [NO3
-] 4 h post final ingestion was higher 
(P < 0.05) in STRONG (8.7 ± 3.0 mM) compared to CON (6.3 ± 0.9 mM) and WEAK 
(6.0 ± 3.0 mM). In addition, the rise in plasma [NO2
-] at 2 h was lower in STRONG 
compared with WEAK (by 89 ± 112 nM) and CON (by 200 ± 174 nM) and in WEAK 
compared with CON (all P < 0.05). Changes in resting BP were not different between 
conditions (P > 0.05). However, during treadmill walking, the increase in systolic and 
mean arterial BP was higher 4 h after the final NO3
- bolus in STRONG compared with 
CON (P < 0.05) but not WEAK. The results indicate that both strong and weak 
antibacterial agents suppress the rise in plasma [NO2
-] observed following the 
consumption of a high NO3
- diet and the former can influence the BP response during 
low-intensity exercise. 
 
Key words: beetroot juice; nitrate; antibacterial mouthwash; blood pressure; nitric 
oxide; exercise 
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Introduction 
There is now an abundance of evidence that a diet rich in vegetables, particularly those 
with a high concentration of inorganic nitrate (NO3
-), is favourable to cardiovascular 
health and is associated with longevity [12, 19, 44]. NO3
-
, a relatively inert molecule, 
can be reduced in vivo to nitrite (NO2
-) and the potent vasodilator and blood flow 
regulator, nitric oxide (NO) [20, 21, 39]. Dietary supplementation with NO3
--rich 
beetroot juice (BR) can significantly increase plasma [45, 47] and salivary NO2
- 
concentrations ([NO2
-]) [17] and lead to reductions in systolic (SBP) and diastolic 
(DBP) blood pressure (BP) [30, 40, 45]. 
Ingested dietary NO3
- is rapidly absorbed in the upper gastrointestinal tract with 
approximately 25% of this circulating NO3
- being taken up and concentrated by the 
salivary glands [39]. Mammalian cells lack NO3
- reductase activity, and the 
fundamental step in reducing NO3
- to NO2
- is facilitated within the saliva by facultative 
anaerobic bacteria residing on the dorsal surface of the tongue (14, 17]. Once 
swallowed, some NO2
- is further reduced to NO in the acidic environment of the 
stomach [5, 34] but the remainder enters the systemic circulation, increasing plasma 
[NO2
-] [33, 45]. The reduction of NO2
- to NO is promoted by a number of different 
enzymes and proteins including deoxyhaemoglobin [10] and nitric oxide synthase 
(NOS) [42]. This NO3
--NO2
--NO pathway is believed to be an important alternative to 
the classic oxygen (O2)-dependent NOS-linked production of NO, particularly in acidic 
and hypoxic environments when NO production via the NOS pathway may be 
compromised [35].  
If the oral microflora is disturbed by the use of antibacterial mouthwash, the expected 
increase in plasma [NO2
-] and decrease in resting BP following the consumption of 
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NO3
- may not manifest [17, 24, 38]. An attenuation in NO2
- formation was observed in 
rats that were treated twice daily with a chlorhexidine containing mouthwash, despite 
consuming NO3
- supplemented drinking water for one week [38]. Consequently, the 
lowering of BP expected with NO3
- ingestion was absent [38]. In healthy humans, the 
expected rise in salivary [NO2
-] after the consumption of an acute bolus of dietary NO3
- 
was absent and the elevation in plasma [NO2
-] was reduced by ~ 75 %, following 
mouthwash administration when compared with the control condition [17]. Also in 
healthy individuals, mouth rinsing twice daily for 7 days with a commercially available 
chlorhexidine containing mouthwash resulted in a reduction in salivary and plasma 
[NO2
-] of ~ 90 % and ~ 25 %, respectively [24]. This was accompanied by an increase 
in seated and ambulatory SBP and DBP after only one day’s use of the chlorhexidine 
containing mouthwash, compared with baseline values [24]. More recently, Bondonno 
and colleagues [9] reported an increase in salivary [NO3
-], a reduction in salivary [NO2
-] 
and an elevation in SBP in treated hypertensive persons after 3 days of rinsing with an 
antibacterial wash. Surprisingly, plasma [NO2
-] was unaffected by the chronic use of an 
antimicrobial rinse in this population.  
Individuals often consume a diet rich in fruit and vegetables, particularly those 
foodstuffs high in NO3
-, to protect against cardiovascular [22, 23] and gastrointestinal 
[15] complications. In addition, NO3
- is often ingested prior to exercise as it has been 
reported to improve muscle efficiency [3, 30] and continuous [3, 27] and intermittent 
[48] exercise performance. However, the effect of prolonged chlorhexidine containing 
mouthwash alongside ‘natural’ NO3- ingestion (i.e., via BR), on BP during low-intensity 
exercise in a healthy cohort has not been evaluated.  
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It is important to establish whether regular use of chlorhexidine or weaker antiseptic 
agents (such as those mouth rinses that do not contain chlorhexidine as the principal 
antibacterial agent) might attenuate the beneficial effects of NO3
- achieved via the 
consumption of BR or other naturally occurring foodstuffs on BP during rest and 
exercise when NO3
- supplementation is continued over several days. Therefore, the 
purpose of this study was to determine the plasma and salivary [NO3
-] and [NO2
-] and 
the haemodynamic response to different types of mouth rinses prior to BR ingestion 
over 6 days in a healthy population. Specifically, the effects of mouthwashes containing 
strong (chlorhexidine; STRONG), minimal (no chlorhexidine; WEAK) and no (water; 
CON) antibacterial properties on indirect measures of oral NO3
- reductase effectiveness 
and parameters of vascular health were investigated. It was hypothesised that relative to 
CON and WEAK, BR supplementation preceded by STRONG mouthwash, would 
attenuate the rise in plasma [NO2
-] and the associated reductions in BP at rest and 
during exercise. It was also hypothesised that, relative to CON, WEAK would not alter 
the aforementioned variables.  
 
Methods 
 
Subjects 
Twelve healthy, recreationally active participants (males, n = 6; females, n = 6), 
volunteered to participate in this study (mean ± SD; females: age 22 ± 2 years, body 
mass 69 ± 8 kg, height 1.74 ± 0.55 m; males: age 24 ± 2 years, body mass 80 ± 7 kg, 
height 1.82 ± 0.89 m), none of whom habitually smoked tobacco, consumed dietary 
supplements or used mouthwash. The study was approved by the Institutional Research 
Ethics Committee. 
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Prior to testing, and after the requirements of the study, associated risks and potential 
benefits of participation were explained, written informed consent was obtained. In 
addition, this study was performed in accordance with the International Journal of 
Sports Medicine’s ethical standards [18]. 
Subjects were instructed to arrive at the laboratory in a fully rested and hydrated state, at 
least 3 h postprandial, and to avoid strenuous exercise in the 24 h preceding each testing 
session. In addition, subjects were asked to avoid alcohol consumption and chewing 
gum throughout each supplementation period and to refrain from caffeine intake in the 3 
h preceding each laboratory visit. All subjects were also asked not to use antibacterial 
mouthwash, unless instructed by the researcher, for the duration of the study. Each 
subject recorded habitual diet and exercise undertaken during the first supplementation 
period and were asked to replicate these during the second and third supplementation 
periods. All subjects were fully familiar with laboratory testing procedures having 
participated previously in similar studies within our laboratory. Exclusion criteria were 
the presence of known cardiovascular disease and hypertension and the use of 
antihypertensive medication and antibiotics. 
 
Experimental Overview 
Subjects were asked to report to the laboratory on six occasions, over an eight week 
period. The first visit included baseline measurements of BP (during seated and supine 
rest and during treadmill walking), heart rate (HR), arterial stiffness, and plasma and 
salivary [NO3
-] and [NO2
-]. Each subject was then randomly assigned, in a double-blind, 
crossover fashion to mouth rinse three times daily with either a strong, chlorhexidine 
containing mouthwash (STRONG; Corsodyl®, GlaxoSmithKline, Brentford, England), 
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a weak, non-chlorhexidine containing antibacterial mouthwash (WEAK; Vademecum 
med®, Schwarzkopf & Henkel, Düsseldorf, Germany), or deionised water (CON). 
Specifically, subjects were asked to mouth rinse 15 min prior to BR ingestion (as 
previously described by Govoni et al. [17]), twice a day, and before consuming a lunch 
time meal, each day, for six days. Subsequent measurements were performed prior to 
each supplementation period and on day six of each supplementation period. All tests 
were conducted at the same time of day (± 2 h) to minimise the effects of diurnal 
variation on the physiological variables under investigation.  
 
Experimental Protocol  
During each visit to the laboratory, following 10 min of solitary seated rest in a quiet 
room, BP of the brachial artery was measured using an automated sphygmomanometer 
(Dinamap Pro; GE Medical Systems, Tampa, FL, USA). Five measurements were 
recorded and the mean of the final four measurements was used for data analysis. Five 
further BP measurements were recorded after 10 min of supine rest. Arterial stiffness 
was measured three times, using a non-invasive automated pulse-wave velocity (PWV) 
device (Complior SP; Alam Medical, Vincennes, Paris, France) and the mean of the 
three values was reported at each time point. Electrodes were placed on the carotid, 
femoral, and radial arteries, and the pulse transit time was calculated and recorded. The 
position of each electrode was measured in relation to the nearest bony landmark to 
allow for precise reproduction of the position of the electrodes in subsequent tests. A 
resting venous blood sample (~ 4 mL) was then drawn from an antecubital vein into 
lithium-heparin tubes (Vacutainer, Becton-Dickinson, NJ, USA). The samples were 
centrifuged for 10 min at 3000 g and 4 ˚C, within 2 min of collection, and the plasma 
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was then extracted. A saliva sample (~ 1 mL) was collected by expectoration, without 
stimulation, over a period of 5 min. Plasma and saliva samples were frozen at -80 ˚C for 
later determination of [NO3
-] and [NO2
-] using a modified chemiluminescence technique 
as previously described [47]. Immediately prior to analysis, saliva samples were 
centrifuged for 10 min at 18 600 g. The supernatants were then removed and diluted by 
a factor of 100 with deionised water. 
A BP and walking protocol was completed 2 h and 4 h post ingestion of the final bolus 
of dietary NO3
- which was preceded by 2 min of mouth rinsing with either STRONG, 
WEAK or CON. Subjects completed 10 min of treadmill walking at 4 km·h-1 
(Woodway PPS 55 Sport slat-belt treadmill, Woodway GmbH, Weil am Rhein, 
Germany). BP of the brachial artery was measured during treadmill walking (during 4-6 
and 8-10 min) using a manual sphygmomanometer (Accoson, Blood Pressure Cuff, 
Essex, England) and stethoscope (Spirit Dual Head Stethoscope CK-605T, Spirit 
Medical Co. Ltd., New Taipei City, Taiwan). HR was measured using short-range 
radiotelemetry (Polar S610, Polar Electro Oy, Kempele, Finland).  
The duration of each phase of the protocol, during each visit to the laboratory, was ~1 h, 
with each measurement occurring approximately every 10 min. Therefore, on day 6 of 
each supplementation period, seated and supine BP and arterial stiffness were measured 
2 h 15 min, 2 h 30 min and 2 h 35 min after the final nitrate bolus, respectively. Blood 
and saliva samples were collected at 2 h 40 min and 2 h 45 min respectively, and 
exercising BP was measured, at two time points, from 2 h 50 to 3 h post final nitrate 
ingestion. The same data collection timing protocol was repeated from 4 h post 
supplementation of nitrate and during each baseline visit to the laboratory. 
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Supplementation 
All 12 subjects completed STRONG, WEAK and CON conditions, with each 6 day 
supplementation period separated by a minimum of 10 days wash-out. After the initial 
visit, all subjects were assigned in a double-blind, randomised, crossover design to 
mouth rinse with a strong antibacterial mouthwash (STRONG; Corsodyl®, containing 
0.2 % chlorhexidine digluconate), a weak antibacterial mouthwash [WEAK; 
Vademecum med®, containing ~ 2.5 mL of Vademecum med® concentrate in 500 mL 
deionised water (which includes peppermint oil, clove oil, sodium benzoate, chamomile 
oil, sage, menthol and alcohol)], and a mouthwash containing no antibacterial agents 
(CON; deionised water), prior to consuming a 70 mL shot of BR (BR; beetroot juice 
containing ~ 6.2 mmol of NO3
-, “Beet It Sport Stamina Shot”; James White Drinks Ltd., 
Ipswich, UK), twice a day, for six days. Subjects were also asked to mouth rinse 15 min 
prior to consuming a lunch time meal. On the day following pre-supplementation 
measures (visits 1, 3 and 5), subjects were instructed to consume 70 mL of BR in the 
morning (~ 10 a.m) and 70 mL in the evening (~ 7 p.m) each day, for five days. On day 
six (visits 2, 4 and 6), subjects consumed 2 x 70 mL of BR, 2 h prior to returning to the 
laboratory. Two 10 mL volumes of STRONG, WEAK and CON were each gargled for 
1 min (2 min of mouth rinsing overall), 15 min prior to each BR ingestion and the lunch 
time meal throughout the supplementation period. 
 
Statistical Analyses  
Differences in BP, HR, pulse-wave velocity, and plasma and salivary [NO3
-] and [NO2
-
], were assessed using a two-way (condition x time) repeated-measures ANOVA. 
Significant main and interaction effects were further explored using simple contrasts via 
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Fisher’s LSD. Statistical analyses were performed using SPSS version 19.0 (Chicago, 
IL, USA). Data are presented as mean ± SD, unless otherwise stated. Statistical 
significance was accepted at P < 0.05. A statistical trend was defined as P < 0.10. 
 
Results 
Subjects’ self-reported adherence to the BR supplementation protocol, mouth rinsing 
regimen and avoidance of potential confounding factors (such as the consumption of 
alcohol) was 100 % for each of three supplementation periods. All subjects reported that 
their physical activity and dietary patterns were similar throughout each 
supplementation period. The ingestion of BR was well tolerated with no negative side 
effects. Subjects did, however, report beeturia (red urine) and red stools.  
 
Plasma [NO3
-] and [NO2
-] 
The effects of BR supplementation and different mouth rinses on plasma [NO3
-] and 
[NO2
-] are presented (as the change relative to baseline) in Fig. 1. There was a 
significant main effect by time on plasma [NO3
-] (Fig. 1A; P < 0.01), and a significant 
main effect by condition and time and an interaction effect on plasma [NO2
-] (Fig. 1C; 
all P < 0.01). 
At baseline, before any mouth rinsing or ingestion of BR, plasma [NO3
-] was not 
different between conditions (CON: 17 ± 5; WEAK: 18 ± 10; STRONG: 18 ± 7 µM; P 
> 0.05). Following BR supplementation, plasma [NO3
-] was elevated above baseline at 
2 and 4 h in CON (2 h: 301 ± 56 and 4 h: 250 ± 53 µM), WEAK (2 h: 298 ± 69 and 4 h: 
246 ± 50 µM) and STRONG (2 h: 301 ± 102 and 4 h: 243 ± 79 µM) (Fig. 1A; all P < 
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0.05). The increase in plasma [NO3
-] above baseline was not significantly different 
between CON, WEAK and STRONG at 2 or 4 h post final BR ingestion (Fig. 1A; all P 
> 0.05).   
At baseline, before any mouth rinsing or ingestion of BR, plasma [NO2
-] was not 
significantly different between conditions (CON: 70 ± 24; WEAK: 76 ± 31; STRONG: 
80 ± 37 nM; P > 0.05). Following BR supplementation, plasma [NO2
-] was significantly 
increased from baseline at 2 and 4 h in CON (2 h: 380 ± 219 and 4 h: 323 ± 205 nM), 
WEAK (2 h: 269 ± 186 and 4 h: 278 ± 250 nM) and STRONG (2 h: 180 ± 141 and 4 h: 
114 ± 112 nM) (all P < 0.05). Follow up tests revealed that at 2 h, the elevation in 
plasma [NO2
-] was lower in STRONG compared to CON (by 200 ± 174 nM) and 
WEAK (by 89 ± 112 nM) (Fig. 1C; both P < 0.05). Similarly, the change in plasma 
[NO2
-] was lower (by 110 ± 157 nM) in WEAK compared to CON at 2 h (Fig. 1C; P < 
0.05). At 4 h, plasma [NO2
-] was higher in CON and WEAK, compared to STRONG 
(Fig. 1C; P < 0.01).  
 
Salivary [NO3
-] and [NO2
-] 
The effects of BR supplementation and different mouth rinses on salivary [NO3
-] and 
[NO2
-] are presented (as the change relative to baseline) in Fig. 1. There were significant 
main effects by condition and time for both salivary [NO3
-] (Fig. 1B; all P < 0.05) and 
[NO2
-] (Fig. 1D; all P < 0.05) and an interaction effect on salivary [NO2
-]. At resting 
baseline, before any mouth rinsing or supplementation of BR, salivary [NO3
-] was not 
significantly different between conditions (CON: 0.3 ± 0.2; WEAK: 0.2 ± 0.3; 
STRONG: 0.3 ± 0.3 mM; all P > 0.05). Following BR supplementation, salivary [NO3
-] 
was significantly elevated above baseline at 2 and 4 h in CON (2 h: 7.8 ± 1.9 mM and 4 
 Chapter 4: The effects of chronic nitrate supplementation and the use of strong and 
weak antibacterial agents on plasma nitrite concentration and exercise blood pressure 
 
53 
 
h: 6.3 ± 0.9 mM; both P < 0.05), WEAK (2 h; 7.4 ± 4.0 and 4 h: 6.0 ± 3.0 mM; both P < 
0.05) and STRONG (2 h: 10.6 ± 3.6 and 4 h: 8.7 ± 3.0 mM; both P < 0.05). At 2 h, the 
increase in salivary [NO3
-] relative to baseline, was greater in STRONG compared to 
CON (P < 0.05) but not WEAK (P > 0.05). Similarly, at 4 h, the increase in salivary 
[NO3
-] relative to baseline, was significantly larger in STRONG compared to CON and 
WEAK (Fig. 1B; both P < 0.05).  
At baseline, before any mouth rinsing or supplementation, salivary [NO2
-] was not 
significantly different between conditions (CON: 0.2 ± 0.1; WEAK: 0.1 ± 0.1; 
STRONG: 0.1 ± 0.1 mM; all P > 0.05). Following BR supplementation, salivary [NO2
-] 
was significantly elevated (Fig. 1D; all P < 0.05) above baseline at 2 and 4 h in CON (2 
h: 1.4 ± 1.1 and 4 h: 1.3 ± 0.9 mM), WEAK (2 h: 1.2 ± 0.8 and 4 h: 0.9 ± 0.6 mM) and 
STRONG (2 h: 0.2 ± 0.6 and 4 h: 0.4 ± 1.0 mM). The increase in salivary [NO2
-] 
compared to baseline was significantly lower at 2 h in STRONG compared to CON (P < 
0.05). At 4 h, salivary [NO2
-] was lower after STRONG compared to CON and WEAK 
(Fig. 1D; all P < 0.05).   
 
Pulse Wave Velocity and Heart Rate 
There were no significant main effects by condition or time, and no interaction effect 
for carotid-femoral and carotid-radial PWV (Table 1; P > 0.05). The mean change in 
HR relative to presupplementation baseline during rest and low-intensity exercise 
following chronic nitrate supplementation and prior mouth rinsing with STRONG, 
WEAK and CON are reported in Table 1. There was a main effect by time on HR 
during 10 min of treadmill walking (P < 0.05). Further analyses showed that HR 
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increased significantly from baseline to 4 h in STRONG (P < 0.05), but was not altered 
in WEAK or CON (both P < 0.05).  
 
Blood Pressure  
Supine BP. The effects of BR supplementation and different mouth rinses on supine 
SBP, DBP and MAP are presented in Fig. 2. At baseline, the mean supine SBP, DBP 
and MAP across all conditions was 111 ± 8, 59 ± 5 and 76 ± 6 mmHg, respectively. 
There was a significant main effect by time (P < 0.05) on SBP (Fig. 2A) and MAP (Fig. 
2C), but no main effect by condition or interaction effect (P > 0.05). Supine SBP tended 
to increase (by 4 ± 7 mmHg) from 2 h to 4 h in STRONG (Fig. 2A; P = 0.07). Supine 
MAP increased significantly from 2 to 4 h in CON (by 2 ± 3 mmHg) and in STRONG 
(by 2 ± 4 mmHg), (P < 0.05). No significant main effects by condition or time, or an 
interaction effect were present for supine DBP (all P > 0.05).  
Seated BP. The effect of BR supplementation and different mouth rinses on seated SBP, 
DBP and MAP are presented in Fig. 2. At baseline, the mean seated SBP, DBP and 
MAP across all conditions was 113 ± 8, 62 ± 5 and 79 ± 6 mmHg, respectively. There 
were no significant main effects by condition or time, and no interaction effect for SBP 
(all P > 0.05). There was, however, a significant main effect by time on seated DBP 
(Fig. 2E) and MAP (Fig 2F; P < 0.05). In the CON condition seated DBP was higher, 
relative to baseline, at 4 h (by 3 ± 4 mmHg) compared to 2 h (Fig. 2E; P < 0.05). Seated 
DBP in WEAK was significantly reduced (by 2 ± 3 mmHg) at 2 h compared to baseline 
(Fig. 2E; P < 0.05). In addition, the reduction in seated DBP in WEAK was 
significantly different from a small rise (by 1 ± 5 mmHg) in seated DBP in the 
STRONG condition (Fig. 2E; P < 0.05). Follow-up analyses also showed that the slight 
 Chapter 4: The effects of chronic nitrate supplementation and the use of strong and 
weak antibacterial agents on plasma nitrite concentration and exercise blood pressure 
 
55 
 
reduction in MAP at 2 h was different from the rise in MAP at 4 h in CON (Fig. 2F; P < 
0.05). 
Exercising BP. The effect of BR supplementation and different mouth rinses on 
exercising SBP, DBP and MAP recorded at 4-6 min and 8-10 min during walking are 
presented in Fig 3. At baseline, the mean exercising SBP, DBP and MAP across all 
conditions was 121 ± 10, 66 ± 6 and 84 ± 6 mmHg and 121 ± 10, 64 ± 5 and 84 ± 6 
mmHg, at 4-6 and 8-10 min of treadmill walking, respectively. There was a significant 
main effect by condition on SBP recorded at 4-6 min and 8-10 min during treadmill 
walking (Fig 3; all P < 0.05). Post hoc analyses revealed that exercising SBP at 4-6 min 
was significantly elevated (by 6 ± 10 mmHg) compared to baseline in STRONG at 4 h 
(P < 0.05). This increase in exercising SBP in STRONG was significantly different 
from the change in exercising SBP between baseline and 4 h in CON (-1 ± 8 mmHg; P 
< 0.05). Follow up tests also showed a trend for exercising SBP at 8-10 min to increase 
(by 6 ± 10 mmHg; P = 0.08) at 4 h (from baseline) in STRONG. This increase in 
exercising SBP was, however, significantly different from the change in exercising SBP 
between baseline and 4 h in CON (Fig. 3D; P < 0.05). At 4 h in the STRONG condition 
there was a trend for exercising MAP to be elevated at 4-6 min (3 ± 6 mmHg; P = 0.10) 
and there was a significant increase in MAP at 8-10 min (3 ± 6 mmHg; P < 0.05). At 4 
h, the increase in exercising MAP at 8-10 min in STRONG was significantly different 
from the exercising MAP in CON at 8-10 min (Fig. 3F; P < 0.05).  
 
Discussion 
The principal finding of this study, consistent with our hypothesis, was that 
supplementation with BR alongside regular rinsing with STRONG over a 6 day period 
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significantly attenuated the rise in plasma and salivary [NO2
-] when compared with 
WEAK and CON. Contrary to our hypothesis, however, the increase in plasma [NO2
-] 
was also significantly blunted in the WEAK condition compared with CON. Nitrate 
supplementation was largely ineffective in reducing BP in the current study; however, 
during treadmill walking, BP tended to be higher after rinsing with STRONG 
mouthwash. Specifically, an original finding of this study was that SBP and MAP were 
significantly increased during walking at 4 h after the final BR ingestion on the sixth 
day of supplementation in STRONG compared with CON. We note that the design of 
our study does not permit us to distinguish between the effects of mouthwashes on acute 
compared to more chronic BR supplementation, per se; rather, our study investigated 
acute supplementation on the final day of a 6 day supplementation period.   
 
Plasma and Salivary [NO3
-] and [NO2
-] 
BR supplementation increased plasma [NO3
-] to a similar extent in the CON, WEAK 
and STRONG conditions. Similar [NO3
-] kinetics were reported by Govoni and 
colleagues [17] when comparing chlorhexidine containing mouthwash with the control 
condition after acute supplementation with sodium NO3
-. In the current study, plasma 
[NO3
-] rose by ~ 1900 % relative to baseline at 2 h and remained elevated by ~ 1500 % 
at 4 h post final BR ingestion. The slight reduction in plasma [NO3
-] between 2 and 4 h 
follows a pattern similar to that reported by Wylie et al. [47] after acute ingestion of a 
similar dose of NO3
--rich BR. Previous studies using oral supplementation with NO3
- 
salts have also reported increases in plasma [NO3
-], but of a lesser magnitude (~ 400-
600 %) [7, 30].  
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In the present study, BR supplementation resulted in a significant increase in plasma 
[NO2
-] at all time points, regardless of condition. The absence of antibacterial properties 
of the mouthwash in the CON condition resulted in an elevated plasma [NO2
-] by ~ 500 
% at 2 h and 4 h. Numerous other reports have also shown increases in plasma [NO2
-] 
after NO3
- supplementation; however, the size of these increases have typically been 
smaller (50-150 %) [2, 3, 7, 28, 30, 31, 41]. The larger elevations noted in the present 
study are likely due to the higher NO3
- dose (~12.4 mmol.day-1) compared to those 
reported in previous BR supplementation studies (5-6 mmol.day-1) [2, 3, 27, 41]. Wylie 
et al. [48] reported similar elevations in plasma [NO2
-] of ~ 400 % after ingestion of ~29 
mmol of NO3
- over a 36 h period. 
Consistent with our hypothesis, the increase in plasma [NO2
-] in STRONG was 
significantly lower than that observed in the WEAK and CON conditions. These results 
agree with those of others who noted an attenuation in the rise of plasma [NO2
-] after 
rinsing with chlorhexidine prior to acute NO3
- ingestion, in both humans [17] and rats 
[38]. The findings in the current study may be explained by the significantly higher 
salivary [NO3
-] and significantly lower salivary [NO2
-] in the STRONG condition 
compared with CON. This implies that mouth rinsing with chlorhexidine prior to a BR 
load attenuated the conversion of NO3
- to NO2
- by commensal anaerobes in the oral 
cavity [17]. A recent study reported that when subjects used a chlorhexidine containing 
mouthwash twice daily, for 7 days, in conjunction with a low NO3
- diet, salivary and 
plasma [NO3
-] were significantly elevated and salivary and plasma [NO2
-] were reduced 
by 90 and 25 %, respectively [24]. The results from the present study, and those of 
others, highlight the importance of the oral microflora in determining plasma [NO2
-] 
[24, 45]. 
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It is noteworthy that a blunting of the rise of plasma [NO2
-] (by ~ 29 %, when compared 
with CON) was also present at 2 h when a weak, non-chlorhexidine containing 
mouthwash (WEAK) was administered prior to BR ingestion. The change in salivary 
[NO3
-] from baseline in WEAK was similar to that in CON at both 2 h and 4 h. Salivary 
[NO2
-] decreased (~ 20 % from baseline) in WEAK, but this reduction was not 
significantly different when compared with CON. These findings follow a similar trend 
to the results of Govoni et al. [17]. The results for WEAK suggest that there may be 
another ingredient in this mouthwash that actively disrupts the conversion of salivary 
NO3
- to NO2
-. Previous research has suggested that rinsing with 10 % ethanol alone can 
influence the bacterial composition of the oral microflora [37]. It may be speculated 
therefore that the other active ingredient in the WEAK mouthwash was alcohol although 
we cannot rule out possible influences of other ingredients such as peppermint, clove or 
chamomile oils.  
 
Supine and Seated Blood Pressure 
Several studies have reported a significant reduction in both SBP and DBP after acute 
[25, 31, 40, 41, 45] and chronic [2, 30, 41] NO3
- supplementation. However, others have 
reported reductions in DBP [29] or SBP [28] only. The present study showed no 
significant reduction in resting supine BP across all conditions. These results are 
consistent with those of Larsen et al. [31] who also reported no significant change in 
SBP and DBP after 30 min of supine rest following NO3
- supplementation. The absence 
of a reduction in supine BP in the current study may be explained, at least in part, by the 
relatively low baseline BP (SBP: 111, DBP: 59, MAP: 76 mmHg) values in our 
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subjects. Kapil et al. [25] have previously reported a negative correlation between the 
baseline BP and the reduction in BP in response to NO3
- supplementation.  
BR supplementation in conjunction with WEAK resulted in a significant decrease in 
seated DBP, but not SBP or MAP at 2 h, when compared to baseline. In addition, the 
decrease in DBP with WEAK was significantly different from the small rise in DBP 
noted with STRONG. This may be explained by the difference in plasma [NO2
-] 
between the two conditions, with STRONG being significantly lower than WEAK. 
STRONG did not alter seated SBP, DBP or MAP. Petersson et al. [38] have reported 
significant reductions in DBP and MAP in rats after consuming NO3
- supplemented 
drinking water. However, such reductions were no longer present when rats were treated 
with chlorhexidine prior to NO3
- consumption. The results of the present study suggest 
that disrupting the oral commensal bacteria in the mouth, by regular use of STRONG 
mouthwash, attenuates the conversion of NO3
- to NO2
- and the potential for BR to lower 
BP [29, 45]. 
 
Exercising Blood Pressure and Heart Rate 
This is the first study to assess the effects of BR supplementation on BP during low-
intensity exercise, either with or without the use of antibacterial mouthwash. 
Ambulatory BP has been recognised as an important predictor of adverse cardiovascular 
events [43]. Monitoring BP over a 24 h period allows physicians and physiologists to 
determine BP during normal daily activities, such as walking and sleeping. However, 
with this approach, the activity taking place at the time at which BP measurements are 
recorded is dependent on participant recall. It has recently been reported that 
chlorhexidine use in the absence of NO3
- supplementation resulted in a small but 
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significant increase in ambulatory SBP (2-3.5 mmHg) [24]. In the present study, the 
CON condition did not significantly alter BP during low-intensity exercise relative to 
baseline. However, rinsing with STRONG prior to BR consumption resulted in 
significantly elevated SBP at 4 h during treadmill walking, compared to baseline. 
Additionally, SBP and MAP were higher in STRONG at 2 h and 4 h post final ingestion 
when compared with WEAK and CON. Typically, physical exertion tends to increase 
SBP due to the increase in cardiac output. The higher BP in STRONG, although 
relatively small, may be meaningful as it has been suggested that exaggerated increases 
in SBP and DBP during exercise are associated with a higher risk of developing 
hypertension, independent of other risk factors such as body mass index, fasting blood 
glucose and parental history of hypertension [13, 36]. 
There was a significant increase in HR during treadmill walking from pre to 4 h post 
BR ingestion when preceded by STRONG. Previous studies have reported no 
differences in HR following NO3
- compared to placebo ingestion during either rest or 
exercise [2, 3, 16, 30]. The explanation for these findings is not clear. However, it 
appears that STRONG increases the cardiovascular demand of low-intensity aerobic 
exercise by increasing both HR and MAP. 
 
Arterial Stiffness 
NO is known to contribute to the regulation of arterial elasticity in humans [26]. Arterial 
stiffness may be measured via PWV and carotid-femoral PWV is generally accepted as 
an appropriate, non-invasive and reproducible method of determining arterial stiffness 
[32]. Bahra and colleagues [1] found that acute inorganic NO3
- supplementation resulted 
in an improvement in arterial compliance (measured using an aortic PWV device). In 
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contrast, the results of the current study suggest that chronic supplementation with BR, 
a natural source of NO3
-, does not affect arterial stiffness. These equivocal findings may 
be due to the differences in techniques employed to determine arterial compliance. 
Previous research has suggested that inhibiting endogenous NO production with L-
NMMA results in a significant increase in PWV [26] which is associated with an 
increase in cardiovascular morbidity and mortality [4, 8, 46]. The results of the present 
study suggest that BR supplementation, preceded by different strength antibacterial 
mouthwashes, does not affect arterial compliance. Although plasma [NO2
-] was blunted 
in WEAK and STRONG conditions, indicating a potential reduction in the 
bioavailability of NO, it appears that the availability of NO was not altered sufficiently 
to significantly affect vascular tone.  
 
Implications 
The widespread use of antibacterial mouthwash in the prevention and treatment of 
plaque, gum disease [11] and malodor [6] may have a detrimental impact upon vascular 
health. The results from the present study suggest that chronic use of strong 
(chlorhexidine) and weak (no chlorhexidine) antibacterial mouth rinse prior to ingestion 
of NO3
--rich foodstuffs (BR) can disturb the oral microflora and attenuate the expected 
rise in plasma [NO2
-]. In the present study, chlorhexidine containing mouthwash 
resulted in a greater rise in BP during low-intensity exercise. An elevated BP during 
exercise is a significant risk factor for future hypertension and increases the likelihood 
of an adverse cardiovascular event [36]. An important novel observation in the current 
study is that alcohol (present in both rinses), or some other component of mouthwash, 
may potentially impact the physiological response to BR. Therefore, the use of 
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mouthwashes should be considered carefully when the goal is to derive putative 
cardiovascular or exercise-related benefits from the consumption of high NO3
- 
foodstuffs.  
 
Conclusion 
In summary, this study has shown that regular mouth rinsing with a chlorhexidine 
containing mouthwash and also a non-chlorhexidine containing mouthwash, attenuated 
the rise in plasma [NO2
-] following chronic supplementation with NO3
--rich beetroot 
juice. BR did not significantly reduce BP during seated and supine rest or during 
treadmill walking. However, prior rinsing with a chlorhexidine containing mouthwash 
led to a greater increase in BP during low-intensity exercise compared to the control 
condition. Our study adds to the growing body of literature [17, 24, 38] indicating that 
antibacterial mouthwashes have the potential to counteract the beneficial effects on 
cardiovascular health afforded by the consumption of NO3
- in the diet. 
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Figure Legends 
Figure 1:  Change (Δ) relative to presupplementation baseline in plasma [NO3-] (A) and 
[NO2
-] (C) and salivary [NO3
-] (B) and [NO2
-] (D) following oral rinsing with deionised 
water (CON; black filled bars), non-chlorhexidine containing mouthwash (WEAK; light 
grey filled bars) and chlorhexidine containing mouthwash (STRONG; dark grey filled 
bars) at 2 and 4 h post ingestion of the final BR dose. Data are presented as group mean 
± SE. Significant main effect by time shown as * for 2-way ANOVA (P < 0.05). 
Significant main effect by condition shown as ¥ for 2-way ANOVA (P < 0.05). 
Significant interaction effect (condition x time) shown as § for 2-way ANOVA (P < 
0.05). $ Significantly different from baseline; a significant difference from 2 h WEAK; b 
significant difference from 2 h STRONG; c significant difference from 4 h CON; d 
significant difference from 4 h WEAK; e significant difference from 4 h STRONG (P < 
0.05).    
 
Figure 2:  Change (Δ) relative to presupplementation baseline during supine rest for 
systolic blood pressure (SBP; A), diastolic blood pressure (DBP; B) and mean arterial 
pressure (MAP; C) and seated rest, SBP (D), DBP (E) and MAP (F) following rinsing 
with deionised water (CON; black filled bars), non-chlorhexidine containing 
mouthwash (WEAK; light grey filled bars) and chlorhexidine containing mouthwash 
(STRONG; dark grey filled bars) at 2 and 4 h post ingestion of the final BR dose. Data 
are presented as group mean ± SE. Significant main effect by time shown as * for 2-way 
ANOVA (P < 0.05). $ Significantly different from baseline; b significant difference 
from 2 h STRONG; c significant difference from 4 h CON; d significant difference from 
4 h WEAK; e significant difference from 4 h STRONG (P < 0.05).    
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Figure 3:  Change (Δ) relative to presupplementation baseline in exercising systolic 
blood pressure (SBP; A, D), diastolic blood pressure (DBP; B, E) and mean arterial 
pressure (MAP; C, F) measured during 4-6 min and 8-10 min of treadmill walking 
following rinsing with deionised water (CON; black filled bars), non-chlorhexidine 
containing mouthwash (WEAK; light grey filled bars) and chlorhexidine containing 
mouthwash (STRONG; dark grey filled bars) at 2 and 4 h post ingestion of the final BR 
dose.  Data are presented as group mean ± SE. Significant main effect by time shown as 
* for 2-way ANOVA (P < 0.05). Significant main effect by condition shown as ¥ for 2-
way ANOVA (P < 0.05). $ Significantly different from baseline; a significantly different 
from 2 h WEAK; d significantly different from 4 h WEAK; e significantly different from 
4 h STRONG (P < 0.05).    
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Table 1. Change (Δ) relative to presupplementation baseline in heart rate 
during rest and low-intensity exercise and absolute pulse wave velocity 
responses during supine rest following nitrate supplementation in combination 
with pre-rinsing with water (control), a chlorhexidine containing mouthwash, or a 
non-chlorhexidine containing mouthwash 
 
Values are means ± SD. PWV, pulse wave velocity; CON, deionised water; WEAK, 
non-chlorhexidine containing mouthwash; STRONG, chlorhexidine containing 
mouthwash. Significantly different from baseline, P < 0.05. $ Significantly different 
from STRONG, P < 0.05. 
                 CON WEAK STRONG 
   Heart Rate (b.min-1) 
   Seated 
   
   2 h  -1 ± 15 6 ± 8* 1± 8 
   4 h  -3 ± 15 0 ± 5 -3 ± 7 
   Supine    
   2 h  1 ± 11 4 ± 4* -1 ± 7 
   4 h -3 ± 13 0 ± 4$ -4 ± 6 
Low-intensity Exercise    
  2 h 0 ± 5 0 ± 5 4 ± 9 
  4 h  4 ± 10 2 ± 5   6 ± 7* 
PWV (m.s-1) 
  Carotid: Radial 
  Baseline 
  2 h 
  4 h 
  Carotid: Femoral 
  Baseline 
  2 h 
  4 h 
 
 
 
8.2 ± 1.6 
8.1 ± 1.1 
8.1 ± 1.1 
 
6.7 ± 1.3 
6.3 ± 0.8 
6.5 ± 1.0 
 
 
8.1 ± 1.8 
8.1 ± 1.5 
8.4 ± 1.6 
 
6.6 ± 0.7 
6.5 ± 1.0 
6.7 ± 0.8 
 
 
8.1 ± 1.6 
7.7 ± 1.1 
8.1 ± 1.2 
 
6.5 ± 1.1 
6.3 ± 1.1 
6.7 ± 1.4 
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Figure 1. 
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Figure 2.  
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Figure 3. 
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Abstract 
We tested the hypothesis that dietary nitrate-rich beetroot juice (BR) supplementation 
could partially offset deteriorations in O2 transport and utilization, and exercise 
tolerance, after blood donation. Twenty-two healthy volunteers performed moderate-
intensity and ramp incremental cycle exercise tests prior to and following the 
withdrawal of ~450 mL of whole blood. Before donation, all subjects consumed 7 x 70 
mL of nitrate-depleted beetroot juice shots (PL) in the 48 h preceding the exercise tests. 
During the 48 h after blood donation, subjects consumed 7 shots of either BR (each 
containing 6.2 mmol nitrate; n = 11) or PL (n = 11) before repeating the exercise tests. 
[Hemoglobin] and hematocrit were reduced by ~ 8-9 % following blood donation (P < 
0.05), with no difference between the BR and PL groups. When compared with pre-
donation, steady-state V̇O2 during moderate-intensity exercise was ~ 4 % lower post-
donation in BR (P < 0.05) but was unchanged in PL. The ramp test peak power 
decreased from pre-donation (PL: 341 ± 70 vs. BR: 331 ± 68 W) to post-donation (PL: 
324 ± 69 vs. BR: 322 ± 66 W) in both groups (P < 0.05). However, the decrement in 
performance was significantly less in BR (2.7 %) compared with PL (5.0 %; P < 0.05). 
Nitrate supplementation reduced the O2 cost of moderate-intensity exercise and 
attenuated the decline in ramp incremental exercise performance following blood 
donation. These results have implications for improving functional capacity following 
blood loss. 
New and Noteworthy: Dietary nitrate supplementation with beetroot juice lowered the 
O2 cost of moderate-intensity exercise, better preserved muscle oxygenation and 
attenuated the decline in incremental exercise test performance following donation of  
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450 mL whole blood. These results have implications for improving functional capacity 
following blood loss. 
Key words: blood withdrawal; beetroot juice; O2 transport; O2 uptake; exercise 
performance; nitric oxide 
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Introduction 
The peak rate of pulmonary oxygen uptake (V̇O2peak) is an important determinant of 
exercise capacity and is influenced by the interaction of several central and peripheral 
factors (6, 53, 64). V̇O2peak and exercise performance can be altered by manipulating the 
capability of the cardiovascular system to transport O2 to contracting skeletal muscles 
during exercise (5, 11, 18, 51, 57, 67). For example, interventions involving the infusion 
of erythrocytes (18, 19) or the stimulation of erythropoiesis (57, 67) to enhance 
hemoglobin concentration ([Hb]), increase V̇O2peak during maximal exercise. 
Conversely, limiting O2 transport to working muscle by reducing [Hb] via whole blood 
withdrawal consistently results in a lowered V̇O2peak (11, 18, 47, 54). During sub-
maximal exercise, however, Panebianco et al. (47) reported no change in V̇O2 at two 
and seven days post 450 mL blood donation, despite significant reductions in [Hb]. 
Compensatory adjustments in cardiovascular control, such as increases in heart rate 
(HR) and cardiac output (Q̇), offset the lower [Hb] and enable muscle O2 delivery to be 
maintained during low-intensity exercise after blood donation (19, 27, 51).  
The gaseous physiological signaling molecule, nitric oxide (NO), plays a key role in the 
regulation of vascular tone. NO can be synthesised via the oxidation of L-arginine in a 
reaction catalysed by the NO synthases (NOS; 32) or it can be produced via the 
reduction of nitrate (NO3
-) to nitrite (NO2
-) and subsequently NO (8). Recently, dietary 
NO3
- supplementation has been employed to augment plasma [NO2
-] and the potential 
for O2-independent NO synthesis (4, 38, 65). This NO3
--NO2
--NO pathway may be 
particularly important when NOS activity is compromised (20, 42), O2 availability is 
limited (14, 25, 34, 35) and pH is low (44). Limitations in systemic O2 transport can 
result in tissue hypoxia and greater metabolic perturbation (41, 60), which can  
 Chapter 5: Dietary nitrate supplementation attenuates the reduction in exercise tolerance 
following blood donation  
80 
 
 
contribute to reduced exercise tolerance (1), as is commonly observed at altitude (2) and 
in a number of disease states (35, 68). There is evidence to suggest that NO and NO2- 
can combat an insufficient muscle O2 supply by increasing muscle blood flow via 
hypoxia-induced vasodilatation (13, 61). Therefore, it is possible that dietary NO3
- 
supplementation could ameliorate deteriorations in exercise performance when ‘normal’ 
O2 availability is reduced, during for example, high-intensity exercise, in hypobaric 
hypoxia or after blood donation.    
We and others have reported that, in healthy subjects, dietary NO3
- supplementation can 
significantly impact the physiological responses to exercise (4, 15, 38, 59). Specifically, 
a reduction in the O2 cost of moderate-intensity exercise has been reported after 
supplementation with both sodium NO3
- (38, 39, 40) and NO3
--rich beetroot juice (BR; 
3, 4, 15, 59, 69). In addition, a significantly increased time to task failure (TTF), 
indicating improved exercise tolerance, has been reported following BR ingestion when 
recreationally-active, but not highly trained, subjects completed severe-intensity (3, 4, 
37) and ramp incremental exercise (59). These alterations may be due to a NO2
- or NO-
related reduction in the ATP cost of muscle contraction (3), greater mitochondrial 
efficiency (40), changes in muscle redox status (66), and/or enhanced muscle blood 
flow, particularly to type II fibres (21, 22). Such changes could be particularly 
advantageous after whole blood withdrawal when [Hb] is reduced and O2 transport is 
challenged (11, 18, 54). Indeed, BR supplementation has been shown to reduce muscle 
metabolic perturbation during exercise in normobaric hypoxia and to restore exercise 
tolerance and oxidative function to the values observed in normoxia (60, 61). In 
addition, it has been reported that, when the fraction of inspired O2 is lowered to 11-
13%, BR supplementation can improve muscle oxygenation status (43), reduce V̇O2  
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during sub-maximal exercise (34, 46), and enhance TTF during incremental exercise 
(43). BR supplementation has also been reported to increase arterial O2 saturation 
following dynamic apnea (i.e., breath-hold diving), which supports an O2 sparing effect 
of NO3
- ingestion (48). Collectively, these studies suggest that NO3
- ingestion may 
enhance the physiological response to exercise when O2 availability is limited, by 
sparing muscle O2 demand and/or better preserving muscle O2 supply. However, it is 
not known whether the reductions in O2 carrying capacity and exercise performance 
subsequent to the withdrawal of whole blood can be offset by BR supplementation. If 
so, this may have important implications for clinical conditions in which [Hb] is 
lowered, for example in anemia, following surgery or involuntary blood loss, or in 
athletes wishing to donate blood without compromising training.   
The purpose of the present study was to determine whether 48 h of BR supplementation 
following 450 mL of whole blood withdrawal alters the physiological responses to sub-
maximal and maximal intensity cycle exercise. It was hypothesized that BR 
supplementation would lower the O2 cost of moderate-intensity exercise, improve 
muscle oxygenation status, and attenuate the expected reduction in TTF during ramp 
incremental exercise following blood donation. 
 
Methods 
Subjects 
Twenty-two recreationally active and pre-registered National Health Service (NHS) 
blood donors (males, n = 14; females, n = 8) volunteered to participate in this study,  
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which was approved by the Institutional Research Ethics Committee and conformed to 
the ethical principles of the Declaration of Helsinki. None of the subjects were tobacco 
smokers or habitual users of dietary supplements. All subjects provided written 
informed consent prior to the commencement of the study, after the experimental 
procedures, associated risks and potential benefits of participation had been explained.  
Subjects were instructed to arrive at the laboratory in a rested and fully hydrated state, at 
least 3 h postprandial, and to avoid strenuous exercise in the 24 h preceding each visit. 
In addition, subjects were asked to avoid alcohol consumption, chewing gum and 
antibacterial mouthwash throughout each supplementation period and to avoid caffeine 
intake in the 3 h preceding each laboratory visit. Each subject recorded habitual diet and 
exercise undertaken during the first supplementation period and were asked to replicate 
these habits during the second supplementation period. Prior to data collection, subjects 
were fully familiarized with the exercise testing procedures. This minimized any 
possible learning effects during the study. Exclusion criteria were the presence of 
known cardiovascular disease, hypertension and anemia, the use of antihypertensive 
medication and antibiotics, and having major surgery or giving blood within 6 months 
of the study commencing. 
 
Experimental Overview 
 
Subjects were asked to report to the laboratory on three separate occasions over a ten 
day period. The first visit included a 5 min bout of moderate-intensity cycle exercise at 
80 W, followed by a ramp incremental test to task failure with no dietary 
supplementation. This served as the pre-intervention familiarization test. Hematocrit  
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(Hct), [Hb], plasma [NO3
-] and [NO2
-], pulmonary V̇O2 dynamics, muscle oxygenation 
status, HR, blood lactate concentration ([lactate]), blood glucose concentration 
([glucose]) and TTF during ramp incremental exercise were measured during the first 
visit and repeated during each visit to the laboratory. Prior to visit 2, subjects consumed 
7 shots of NO3
--depleted beetroot juice (PL) over ~ 48 h. On the final day of 
supplementation, subjects completed the same moderate-intensity exercise bout and 
ramp incremental test on a cycle ergometer as was performed at pre-intervention. Two 
days before the final visit to the lab, subjects attended a National Health Service (NHS) 
blood donation clinic. Each subject lay supine on a bed before ~ 450 mL of whole blood 
was drawn from an antecubital vein over a 15 min period. The blood withdrawal was 
performed by the NHS as part of the national blood donation service. Following blood 
donation, each subject was randomly assigned, in a double-blind, placebo controlled 
fashion to consume 7 shots of either NO3
--rich beetroot juice (BR; n = 11; mean ± SD; 
females, n = 4:  age 23 ± 3 years, body mass 67 ± 4 kg, height 1.76 ± 0.05 m; males, n = 
7: age 26 ± 5 years, body mass 81 ± 12 kg, height 1.80 ± 0.10 m) or NO3
--depleted 
beetroot juice as a placebo (PL; n = 11; mean ± SD; females, n = 4: age 22 ± 3 years, 
body mass 77 ± 11 kg, height 1.75 ± 0.10 m; males, n = 7: age 28 ± 7 years, body mass 
77 ± 8 kg, height 1.79 ± 0.10 m) over the next ~ 48 h. Visit 3 occurred on the final day 
of supplementation with the exercise tests conducted 2 h following final supplement 
ingestion. All tests were performed at the same time of day (± 2 h) to minimise diurnal 
variation on the physiological variables under investigation.   
 
Exercise tests 
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During the first visit to the laboratory subjects performed a short bout of low-intensity 
exercise at 80 W, followed by a ramp incremental exercise test to task failure on an 
electrically-braked cycle ergometer (Lode Excalibur Sport, Gronigen, The Netherlands) 
for determination of V̇O2peak and gas exchange threshold (GET). The protocol began 
with 3 min of ‘unloaded’ baseline cycling at 20 W, followed by 5 min at 80 W and 10 
min of passive rest. Subsequently, 3 min of baseline cycling at 20 W was performed and 
then the power output was increased linearly by 30 W.min-1 until the subject was unable 
to continue. The subjects cycled at a self selected cadence (~80 rpm), and this cadence, 
along with saddle and handle bar configuration, was recorded and replicated for 
subsequent tests. Pulmonary gas exchange was measured breath-by-breath and averaged 
into 10-s bins. V̇O2peak was taken as the highest 30-s mean value attained during the test. 
The GET was determined as described previously (59). The work rate that would 
require 80% of the GET (moderate-intensity exercise) was calculated, taking into 
account the mean response time for V̇O2 during ramp exercise (59).  
Subjects returned to the laboratory on two further occasions. The second visit was 
preceded by PL supplementation (n = 22) and the third visit, ~ 48 h post blood donation, 
was preceded by 2 days of either BR (n = 11) or PL (n = 11) supplementation. The final 
visit was conducted 48 h post donation to allow restoration of total blood volume (23) 
and to minimize the risk of a syncopal episode occurring during maximal exercise. On 
each of these two laboratory visits, subjects completed a single 5-min bout of moderate-
intensity exercise (at 80 % of the GET) and a ramp incremental test to task failure, 
separated by 10 min of passive rest. The incremental test was terminated when cadence 
fell more than 10 rpm below the chosen cadence, despite strong verbal encouragement.  
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TTF was recorded to the nearest second and the power output achieved at the point of 
test termination was recorded as the peak power output (PPO). Feedback on 
performance was only provided once all experimentation for the entire study had been 
completed. 
 
Measurements 
During each visit to the laboratory, a venous blood sample (~ 4 mL) was drawn from an 
antecubital vein into lithium-heparin tubes (Vacutainer, Becton-Dickinson, NJ, USA) 
and centrifuged for 10 min at 3000 g and 4 ˚C, within 2 min of collection. Subsequently, 
the plasma was extracted and frozen at -80 ˚C for later determination of [NO3-] and 
[NO2
-] using a modified chemiluminescence technique (7) as previously described (69). 
Blood samples from a pre-warmed fingertip were collected into four 30 μL heparinized 
microhematocrit tubes (Hawksley and Sons Ltd, Lancing, Sussex, England) which 
underwent microcentrifugation for 1 min for the determination of Hct (1560 Micro-
haematocrit reader, Hawksley and Sons Ltd, Lancing, Sussex, England). In addition, 
blood from the same fingertip was collected into four microcuvettes for determination 
of [Hb] (HemoCue AB, Ängelholm, Sweden).  
Pulmonary gas exchange and ventilation were measured breath-by-breath throughout all 
exercise tests. Subjects wore a nose clip and breathed through a mouthpiece and 
impeller turbine assembly (Jaeger Triple V). The inspired and expired gas volume and 
gas concentration signals were sampled continuously at 100 Hz, with the latter using 
paramagnetic (O2) and infrared (carbon dioxide; CO2) analyzers (Oxycon Pro, Jaeger, 
Hoechberg, Germany) via a capillary line connected to the mouthpiece. These analyzers 
were calibrated before each test with gases of known concentration, and the turbine  
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volume transducer was calibrated using a 3-litre syringe (Hans Rudolph, Kansas City, 
MO, USA). The volume and concentration signals were time-aligned by accounting for 
the delay in capillary gas transit and analyzer rise time relative to the volume signal. 
Pulmonary O2 uptake (V̇O2), CO2 output (V̇CO2), minute ventilation (V̇E) and 
respiratory exchange ratio (RER) were calculated and displayed breath-by-breath. HR 
was measured at rest and during all cycle tests using short-range radiotelemetry (Polar 
S610, Polar Electro Oy, Kempele, Finland). A fingertip blood sample was collected into 
a capillary tube over the 20 s preceding the step transition in work rate to moderate-
intensity exercise and the incremental test. Capillary samples were also collected during 
the final 20 s of the moderate-intensity exercise bout and following exhaustion in the 
ramp test. These samples were analyzed within 60 s of collection to determine blood 
[lactate] (YSI 2300, Yellow Springs Instruments, Yellow Springs, OH, USA). 
The oxygenation status of the m. vastus lateralis of the right leg was monitored using 
near-infrared spectroscopy (NIRS; model NIRO 300, Hamamatsu Photonics KK, 
Hiugashi-ku, Japan). Four different wavelength laser diodes provided the light source 
(776, 826, 845 and 905 nm) and a photomultiplier tube in the spectrometer was used to 
detect the light returning from the tissue. The intensity of incident and transmitted light 
was recorded continuously throughout exercise at 2 Hz and used to estimate the change 
in concentration from baseline for oxygenated, deoxygenated, and total tissue Hb and 
myoglobin. The NIRS data therefore represent a relative change based on the optical 
density measured in the first data point collected. The deoxyhemoglobin concentration 
([HHb]) was assumed to represent the balance between local O2 supply and utilization 
and therefore to provide an estimate of changes in O2 extraction within the field of 
interrogation (28, 36). Prior to the cycling exercise, the right leg was cleaned and  
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shaved around the belly of the muscle, the probes were placed in the holder and attached 
to the skin with an adhesive 20 cm above the fibular head. An elastic bandage was 
wrapped around the subject’s leg to secure the holder and wires in place and to 
minimize the possibility of extraneous light influencing the signal. Pen marks were 
made around the probe holder to allow for precise reproduction of the position of the 
probe in subsequent tests. The probe gain was set at rest with the subject in a seated 
position and the leg extended at down stroke on the cycle ergometer. NIRS data were 
collected continuously throughout the moderate-intensity and incremental exercise tests.  
 
Supplementation 
After completion of the familiarization test, subjects consumed 7 shots of NO3
--depleted 
beetroot juice (PL; beetroot juice containing ~ 0.04 mmol NO3
- per 70 mL; Beet It Sport 
Stamina Shot, James White Drinks, Ltd., Ipswich, UK) over ~ 48 h before completing 
the pre-donation control trial (PL-Pre and BR-Pre for the PL and BR groups, 
respectively). This was done in order to control for the antioxidants and polyphenols 
that exist in both the NO3
--rich and NO3
--depleted beverages. The PL was created by 
passing NO3
--rich BR through a Purolite A520E ion-exchange resin which selectively 
removes NO3
- (37). After blood donation, subjects were randomly assigned, in a double-
blind, placebo-controlled fashion, to consume 7 shots of either NO3
--rich (BR; beetroot 
juice containing ~ 6.2 mmol NO3
- per 70 mL; Beet It Sport Stamina Shot, James White 
Drinks, Ltd., Ipswich, UK; n = 11) or NO3
--depleted beetroot juice (PL; beetroot juice 
containing ~ 0.04 mmol NO3
- per 70 mL; Beet It, James White Drinks, Ltd., Ipswich, 
UK; n = 11) over ~ 48 h (PL-Post and BR-Post for the PL and BR groups, respectively).  
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During both supplementation periods subjects were instructed to consume 2 x 70 mL of 
the beverage in the evening (~7 p.m.) two days prior to testing, and 1 x 70 mL in the 
morning (~10 a.m.) and 1 x 70 mL in the evening (~7 p.m.) one day prior to testing. On 
each experimental day, subjects consumed a further 2 x 70 mL, 2 h prior to testing and 1 
x 70 mL on arrival at the laboratory. The supplementation periods were separated by a 
mean of 8 days (BR: 7 ± 5 days, PL: 9 ± 5 days).  
 
Data Analyses 
The breath-by-breath V̇O2 data collected during the exercise tests were initially 
examined to exclude errant breaths caused by, for example, coughing, swallowing and 
sighing, and those values lying more than four standard deviations (SDs) from the local 
mean were removed. V̇O2baseline was defined as the mean V̇O2 measured over the last 60 
s of baseline cycling and end-exercise V̇O2 was defined as the mean V̇O2 measured over 
the last 30 s of exercise. The baseline and end-exercise V̇CO2, RER, V̇E and HR values 
were calculated in the same manner.  
To provide information on muscle oxygenation, the changes in [HHb] and the tissue 
oxygenation index (TOI; calculated as the fraction of oxygenated [Hb] compared to 
total [Hb]) during moderate-intensity exercise were assessed at baseline (60 s preceding 
the transition to moderate-intensity exercise), in 10 s time bins surrounding 60 s, 120 s, 
240 s, and at end-exercise (mean response over the final 30 s of exercise). During ramp 
incremental exercise, the changes in [HHb] and TOI were assessed at baseline, in 10 s 
time bins surrounding 120 s, 240 s, 360 s and at task failure. 
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Blood lactate accumulation (Δ blood [lactate]) was calculated as the difference between 
blood [lactate] at end-exercise and blood [lactate] at baseline. Similarly, the change in 
blood glucose concentration (Δ blood [glucose]) was calculated as the difference 
between blood [glucose] at end-exercise and blood [glucose] at baseline. 
 
Statistical Analyses  
Differences in Hct, [Hb], plasma [NO3
-] and [NO2
-], pulmonary V̇O2 dynamics, HR, 
blood [lactate], NIRS-derived variables and TTF were assessed using a mixed model 
ANOVA. Significant main and interaction effects were further explored using Fisher’s 
LSD. Independent t-tests were used to assess the relative change between the BR and 
PL treatment groups. Pearson’s product moment correlation coefficient was used to 
explore relationships between changes in [Hb] and Hct and changes in TTF. Statistical 
analyses were performed using SPSS version 19.0 (Chicago, IL, USA). Data are 
presented as mean ± SD, unless otherwise stated. Statistical significance was accepted at 
P < 0.05.  
 
Results 
Subjects’ self-reported adherence to the supplementation regimen prior to and post 
blood donation was 100 %. All subjects reported that their physical activity and dietary 
patterns were similar throughout each of the supplementation periods. The ingestion of 
BR and PL supplements were well tolerated and no negative side effects were reported. 
Subjects did, however, report beeturia (red-stained urine). 
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[Hb] and Hct 
The group mean [Hb] and Hct data prior to and following blood donation and BR or PL 
ingestion are displayed in Table 1. There was a significant main effect by time for both 
[Hb] and Hct (P < 0.01) but no main effect by group and no interaction effect (P > 
0.05). Prior to donation, [Hb] and Hct were not different between the BR and PL 
treatment groups. [Hb] and Hct were both significantly reduced from pre to post 
donation (P < 0.05), with no differences between PL and BR groups (P > 0.05). 
 
Plasma [NO3
-] and [NO2
-] 
The group mean plasma [NO3
-] and [NO2
-] pre and post blood donation in the BR and 
PL groups are shown in Table 1. There was a significant main effect by time and group 
and an interaction effect on plasma [NO3
-] and [NO2
-] (P < 0.01). Prior to blood 
donation, neither plasma [NO3
-] nor [NO2
-] were different between groups (P > 0.05). 
Following blood donation, there was a substantial increase in plasma [NO3
-] and [NO2
-] 
in the BR group (P < 0.05). A small (~ 11 %) rise in plasma [NO3
-] (P < 0.05) was also 
observed in the PL group but there was no change in plasma [NO2
-] (P > 0.05).  
 
V̇O2 response to moderate-intensity and incremental exercise 
Moderate-intensity exercise  
The pulmonary gas exchange and ventilatory responses to moderate-intensity exercise 
pre and post blood donation in PL and BR groups are reported in Table 2 and the group 
mean V̇O2 response profiles in BR and PL groups pre and post blood donation are  
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shown in Figure 1. There was a significant main effect by time (P < 0.01) but no main 
effect by condition and no interaction effect (P > 0.05) for the V̇O2 measured during the 
baseline cycling period and at end-exercise. Prior to donation, there were no differences 
in baseline or end-exercise V̇O2 between BR and PL groups (P > 0.05). Follow-up tests 
revealed that both baseline V̇O2 (P < 0.01) and end-exercise V̇O2 (P < 0.05) were 
reduced in the BR group post-donation compared with pre-donation.  
The V̇CO2, V̇E, RER, blood [lactate] and blood [glucose] data during moderate-
intensity exercise are reported in Table 2. Prior to donation, there were no differences in 
these variables at baseline or at end-exercise between the BR and PL groups (P > 0.05) 
and there were no significant main effects by condition or time and no interaction 
effects (P > 0.05).  
 
Ramp incremental exercise 
The effects of blood donation and BR and PL supplementation on the ramp incremental 
test parameters are reported in Table 3 and illustrated in Figures 2 and 3.  
There was a significant main effect by time on V̇O2peak (P < 0.05), but no main effect by 
condition or an interaction effect (P > 0.05). There were no differences between the 
groups at baseline (P > 0.05). Follow-up tests indicated that, from pre to post donation, 
there was a significant reduction (0.19 L·min-1; ~ 5 %) in V̇O2peak in the PL group (P < 
0.05) but not in the BR group (0.12 L·min-1; ~ 3 %; P > 0.05). There was a significant 
main effect by time and an interaction effect (P < 0.05) but no main effect by condition 
(P > 0.05) for PPO and TTF. Post hoc tests revealed a significant reduction in PPO and  
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TTF in both PL and BR groups from pre to post donation (P < 0.01). There were no 
differences in PPO or TTF between the groups prior to blood donation (P > 0.05). 
However, the reduction in PPO and TTF following blood donation was more 
pronounced in PL compared with BR (5 % vs. 3 %; P < 0.05). The change in [Hb] and 
Hct from pre to post donation was correlated with the change in TTF during ramp 
incremental exercise in PL (r = 0.58; P = 0.06, and r = 0.70; P < 0.05, respectively) but 
not BR (r = -0.10; P > 0.05 and r = -0.41; P > 0.05, respectively).  
There was a significant interaction effect, but no main effects by time or group, for peak 
V̇CO2. Specifically, peak V̇CO2 was reduced in the PL group (P < 0.05), but was 
unaffected in the BR group (P > 0.05). There was no main effect by time or condition 
nor an interaction effect for peak V̇E (P > 0.05). There was a significant main effect by 
time and an interaction effect for peak RER (P < 0.05). Despite no difference at 
baseline, post hoc tests revealed an increase in peak RER in the BR group from pre to 
post donation (P < 0.01).  
 
NIRS measurements 
Moderate-intensity exercise 
There were no differences for total Hb (THb) between or within conditions during 
the moderate-intensity exercise bout. The [HHb] and TOI values measured during 
moderate-intensity exercise are reported in Table 4. There were no main effects by 
condition or time and no interaction effect for baseline [HHb] (P > 0.05). There was a 
significant main effect by time for [HHb] from pre to post donation at 60 s, 120 s, 240 s 
and end-exercise (P < 0.05), but no main effect by condition or an interaction effect at  
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any time point (P > 0.05). Post hoc tests revealed a trend toward an increase in [HHb] in 
the PL group, but not the BR group, from pre to post donation at 120 s and 240 s of 
moderate exercise (P < 0.10). There were no main effects by time or interaction effects 
for TOI at 60 s, 120 s, 240 s and end-exercise (P > 0.05). However, there was a trend 
toward a main effect by condition for all time points (P < 0.10). Follow-up tests 
revealed that blood donation resulted in reductions in TOI in the PL group at 60 s, 120 s 
and 240 s during moderate exercise, respectively (P < 0.05; Table 4).  
 
Ramp incremental exercise 
There were no differences for THb between or within conditions during ramp 
incremental exercise. The [HHb] and TOI values measured during ramp incremental 
exercise are reported in Table 4 and the [HHb] profile is shown in Figure 4. There was a 
significant main effect by time (P < 0.05) but no main effect by condition or an 
interaction effect (P > 0.05) for [HHb] at 120 s and 240 s during ramp incremental 
exercise. Post hoc tests showed that [HHb] increased from pre to post donation at 240 s 
in PL (P < 0.05) but not BR (P > 0.05; Table 4). There was a significant main effect by 
time (P < 0.05) and a trend for an interaction effect for [HHb] at 360 s (P < 0.10) and at 
end-exercise (P < 0.05) during the incremental exercise test. Post hoc tests revealed that 
[HHb] increased significantly from pre to post donation in the PL group at both 360 s 
and end-exercise (P < 0.05; Table 4). The change in [HHb] from pre to post donation 
was higher in PL versus BR at end-exercise (P < 0.05) and tended to be higher at 360 s 
(P<0.10).  
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Discussion 
The principal original findings in this study, consistent with our hypotheses, were that 
NO3
--rich beetroot juice ingestion lowered the O2 cost of moderate-intensity exercise, 
better preserved muscle oxygenation during moderate and ramp incremental exercise 
and attenuated the reduction in ramp incremental exercise test performance and V̇O2peak 
following blood donation. These results indicate that dietary NO3
- supplementation can 
ameliorate decrements in exercise performance in a situation (i.e. reduction in blood O2-
carrying capacity) which would be expected to compromise physiological function 
during exercise. 
 
Effects of blood donation on [Hb] and Hct 
The standard NHS blood bank donation (~ 450 mL) reduced [Hb] and Hct by a similar 
magnitude in the PL and BR groups. These results concur with previous studies that 
have investigated the influence of whole blood withdrawal on [Hb]. For example, 
Gordon et al. (27) and Mora-Rodriguez et al. (45) reported ~ 8 % and ~ 7 % reductions 
in [Hb], 24 and 48 h post blood donation, respectively. The ~ 8 % reduction in Hct in 
the present study is also similar to the values reported by Burnley et al. (11) and Gordon 
et al. (27) who reported a ~ 7-8 % decrease in Hct one day after 450 mL blood donation. 
The reduction in blood O2 carrying capacity, secondary to the lower [Hb] and Hct, can 
result in a reduction in muscle O2 delivery and muscle O2 diffusing capacity during 
maximal exercise, with significant implications for exercise performance (5, 11, 18, 47, 
54).  
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Effects of nitrate supplementation on plasma [NO3
-] and [NO2
-] 
The ingestion of NO3
--rich BR significantly elevated plasma [NO3
-] and [NO2
-] when 
compared with baseline values. These findings are in agreement with earlier studies 
which also examined the influence of BR supplementation in young, healthy subjects 
(4, 34, 69). A small but significant rise in plasma [NO3
-] was also noted in the PL group 
post donation. This may be explained by a slight hemoconcentration or an upregulation 
in NOS activity consequent to the reduction in whole body iron concentration after 
donating blood (62). Plasma [NO2
-] rose by ~ 800 % in the BR group from pre to post 
donation, suggesting appreciably enhanced NO bioavailability. Numerous other studies 
have also reported increases in plasma [NO2
-] after BR supplementation, but the 
percentage increases attained were approximately half of those reported in this study 
(56, 69). This finding is likely a result of the higher dose of NO3
- ingested (~ 43 mmol 
over 48 h) when compared with previous short-term BR supplementation studies. 
Interestingly, unlike in some earlier studies (4, 38, 59, 69), BR supplementation did not 
reduce resting blood pressure (BP) despite the elevated plasma [NO2
-] (mean arterial 
pressure, pre- vs. post-donation: 81 ± 7 vs. 80 ± 7 mmHg). Similar BP values pre- vs. 
post-donation in the PL group indicates that total blood volume was restored 48 h 
following blood donation. The lack of effect of BR on BP in the present study may be 
related to the relatively low baseline BP values of the study participants (115/64 mmHg) 
and the relatively large number of female participants. It has been reported that females 
are less sensitive than males to the influence of NO3
- supplementation on BP and that 
the extent of BP reduction with NO3
- supplementation is correlated with the baseline BP 
(33).      
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Effects of blood donation and nitrate supplementation on the physiological responses to 
moderate-intensity exercise 
The V̇O2 during both the unloaded baseline period and in the steady state of moderate-
intensity exercise was significantly reduced (by ~ 4 %) in the BR group, but not the PL 
group, after blood donation. A similar reduction in the O2 cost of moderate-intensity 
exercise has been reported by Bailey et al. (4) after six days of non-concentrated NO3
--
rich BR ingestion and by Larsen et al. (38) after three days of NaNO3 supplementation. 
The present findings are consistent with those of Kelly et al. (34) who observed that, in 
hypoxia, BR supplementation resulted in a decrease in both baseline and steady-state 
V̇O2 when compared with placebo. It has also been reported that acute (46) and 6 days 
(43) BR ingestion resulted in significant reductions in V̇O2 during submaximal cycling 
exercise in hypoxia (15 % and 11 % O2, respectively). Acute BR supplementation has 
also been reported to better preserve arterial O2 saturation following dynamic apnea 
(48).   
The lowering of the O2 cost of submaximal exercise after NO3
- supplementation may be 
due to a number of mechanisms, including a reduction in the ATP cost of muscle force 
production (4) and/or an improvement in mitochondrial efficiency (40) and/or changes 
in redox signalling (66). In addition to changes in muscle contractile or metabolic 
efficiency, muscle O2 delivery or its intramuscular distribution may be altered following 
NO3
- supplementation (21, 22). Exercise, particularly in hypoxia or under conditions 
that may limit O2 carrying capacity, such as blood donation, acts as a potent stimulus for 
vasodilatation and delivery of O2 to working muscle (12, 13). Both NO and O2 compete 
for the binding site at cytochrome-c oxidase (COX) in the mitochondrial electron 
transport chain (9). An elevation in NO availability via NO3
- supplementation, perhaps  
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especially in conditions limiting O2 delivery, increases the likelihood of NO binding to 
COX and therefore inhibiting O2 consumption at the mitochondrion (10). As a result, 
NO may modify the intramuscular distribution of O2 and improve the oxygenation status 
of muscle fibres that are situated further away from the capillaries (29, 55, 63). 
Compared to placebo, BR supplementation has been reported to enable a greater 
maximal rate of mitochondrial ATP resynthesis (Qmax) and result in faster muscle 
phosphocreatine recovery kinetics following exercise in hypoxia (60, 61), indicating 
improved muscle O2 availability at least in the immediate post-exercise period (61).    
In the present study, TOI was significantly reduced and [HHb] tended to be higher 
during moderate-intensity exercise post- compared to pre-donation in the PL group, 
suggesting that muscle O2 availability was lower and a greater muscle fractional O2 
extraction was necessary to achieve the required V̇O2 (24, 36). These changes were 
attenuated in the BR group, consistent with our hypothesis that BR supplementation 
would better preserve muscle oxygenation during moderate-intensity exercise when 
compared with PL. These results are consistent with Masschelein et al. (43) who 
reported that BR resulted in a greater muscle TOI and lower [HHb] during submaximal 
exercise in normobaric hypoxia. Collectively, these studies indicate that under 
conditions which may impair blood O2 carrying capacity, such as following blood 
donation (present study) or in normobaric hypoxia (43), BR ingestion promotes a better 
matching between muscle O2 delivery and O2 demand, i.e. less O2 extraction is required 
for the same moderate-intensity work rate, perhaps due to the lower exercise V̇O2 (34) 
or to preferential alterations in muscle perfusion (21, 22, 61). An increased ratio of O2 
delivery to O2 consumption at a given work rate would be expected to retard the rate of 
fatigue development and to improve exercise performance.   
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Effects of blood donation and nitrate supplementation on the physiological responses to 
incremental exercise 
As expected, blood donation and the associated reduction in O2 carrying capacity 
resulted in a significant reduction in PPO and TTF during ramp incremental exercise. 
Panebianco et al. (47) also reported a significant reduction in PPO during incremental 
exercise, 2 days post blood donation. An important original finding in the present study 
was that ingestion of BR in the 48 hours post blood donation partly negated the 
decrement in performance when compared with PL. Specifically, the reduction in PPO 
and TTF following blood donation was significantly more pronounced in the PL group 
compared with BR. Interestingly, the reduction in TTF in the PL group was quite well 
correlated with the reduction in [Hb] (r = 0.58, P = 0.06) and Hct (r = 0.70, P < 0.05) 
following blood donation, whereas in the BR group, the correlations were weaker and 
non-significant ([Hb]: r = -0.10; Hct: r = -0.41; both P > 0.05), implying that BR 
supplementation compensated for the lower [Hb] and Hct. These findings are consistent 
with those of Masschelein et al. (43) who reported that, compared to PL, BR ingestion 
significantly attenuated the reduction in TTF when incremental exercise was performed 
in hypoxia.  
V̇O2peak was reduced by 5 % from pre to 48 h post donation in the PL group. Similarly, 
Burnley et al. (11) reported a 4 % decrease in V̇O2peak during severe-intensity exercise 
24 h following blood donation. This reduction was proportional to the reduced [Hb] and 
thus the ability to deliver O2 to the working skeletal muscle during maximal exercise. In 
the present study, the reduced V̇O2peak in the PL group following blood donation 
occurred in conjunction with an increased muscle [HHb], which may be interpreted as 
an increase in muscle fractional O2 extraction in an (ultimately unsuccessful) attempt to  
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offset the effects of a reduced [Hb] and lower muscle O2 delivery (51, 54). In contrast, 
V̇O2peak and [HHb] during the incremental test were not significantly altered by blood 
donation in the BR group. These results may indicate that the O2 sparing effect of BR 
ingestion (Figure 2B), coupled perhaps with altered perfusion distribution (21, 22, 61), 
enabled muscle oxygenation to be better preserved during incremental exercise, such 
that an increased muscle fractional O2 extraction was not mandated to achieve a given 
V̇O2peak. Ferguson et al. (21, 22) have reported that, in rats, BR supplementation can 
enhance vascular conductance and blood flow to working muscle and elevate the 
microvascular partial pressure of O2 (PO2mv), particularly in type II fibres. If similar 
effects occur in humans, this may enhance the blood-myocyte O2 exchange gradient 
during higher intensity exercise, better preserving muscle oxygenation status, 
homeostasis and performance. It is also possible that a portion of the preserved ramp 
incremental test performance following blood donation with BR compared to PL may 
be attributable to effects of NO3
- on muscle contractile function (50), perhaps 
particularly in type II fibers (31).   
The mechanistic bases for the positive effects of BR ingestion on vascular and 
metabolic function in this and other situations warrants further investigation. In 
particular, while it is widely believed that the effects may be attributed to greater NO 
bioavailability or bioactivity, it is presently unclear precisely how this NO pool is stored 
and transported. NO is a highly reactive molecule with a short-half life in vivo and its 
rapid reaction with, for example, O2 or heme proteins (30) suggests that the free 
transport of NO may be limited in plasma and within cells. It has been proposed that 
NO2
- itself represents a principal means of ‘NO’ storage and transport, with the one 
electron reduction of NO2
- to NO in blood and other tissues being facilitated, amongst  
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many other factors including xanthine oxidoreductase, by deoxyhemoglobin and 
deoxymyoglobin, which will naturally be present in greater abundance in contracting 
skeletal muscle (16, 42). However, BR ingestion likely also increases the production 
and storage of other reactive nitrogen species. In particular, low molecular weight thiol 
groups may react with nitrogen oxides to yield s-nitrosothiol species (SNOs) which can 
be transported in the blood as s-nitrosohemoglobin (HbSNO) (17). It has recently been 
reported that the reduction in blood pressure following NO3
- or NO2
- ingestion in a rat 
model of hypertension was more closely related to plasma [s-nitrosothiol] than to 
plasma [NO2
-] (49) and that s-nitrosothiol bioactivity derived through βCys93 may be 
essential for hypoxic vasodilation by erythrocytes (70). In contrast, in humans, Gladwin 
et al. (26) reported a significant arterial-venous NO2
- gradient during forearm exercise 
and concluded that SNOs and HbSNO do not play a significant role in the regulation of 
vascular tone. The role of SNOs and HbSNO in the physiological effects of nitrate 
ingestion in humans remains to be clarified. Equally, the precise mechanisms by which 
an elevation of tissue [NO2
-] following NO3
- ingestion influences metabolic and 
vascular control at rest and during exercise remains unclear. While it is possible that 
NO2
- itself is bioactive (58), unresolved questions include the triggers and time course 
for the possible reduction of NO2
- to NO, and the nature of both NO transport to, and 
storage within, biological targets. Resolution of these issues will likely require synthesis 
of experimental data deriving from ‘competing’ hypotheses.     
  
Perspectives 
This study has shown for the first time that despite a significant reduction in [Hb] post 
blood withdrawal, BR supplementation lowered the O2 cost of moderate-intensity  
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exercise, better preserved muscle oxygenation during moderate-intensity and ramp 
incremental exercise, and attenuated the reduction in V̇O2peak and incremental exercise 
test performance. These results may have significant implications for athletes who wish 
to give blood without significant detriment to training, individuals with clinical 
conditions which reduce blood O2 carrying capacity, such as anemia, and in conditions 
resulting in acute blood loss such as surgery or military combat. In this context, it is of 
interest that transfusion of stored blood may impair vasodilatory capacity, an effect that 
might be linked to the loss of NO bioavailability that occurs during blood storage (17, 
52). Treating banked blood to better maintain NO stores might lead to improved 
functional outcomes following transfusion. In conclusion, BR supplementation 
attenuates the decline in functional capacity arising from blood donation.   
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Figure Legends 
Figure 1: Pulmonary oxygen uptake (V̇O2) response following BR and PL 
supplementation prior to and following blood donation during a step increment to a 
moderate-intensity work rate. Responses prior to blood donation are shown as solid, 
filled circles, while responses post blood donation are shown as open, unfilled circles. 
The dotted vertical line represents the abrupt imposition of the moderate work rate from 
a baseline of ‘unloaded’ cycling. A: Group mean V̇O2 response to moderate-intensity 
exercise following PL ingestion. B: Group mean V̇O2 response to moderate-intensity 
exercise following BR ingestion. C: Steady state V̇O2 following PL and BR 
supplementation relative to pre blood donation baseline. The O2 cost of moderate-
intensity exercise was reduced following BR supplementation and blood donation 
compared with pre donation values, *P < 0.05.   
 
Figure 2: Group mean pulmonary V̇O2 response to incremental exercise prior to blood 
donation and following BR and PL supplementation after blood donation. Responses 
prior to blood donation are shown as solid, filled circles, while responses post blood 
donation are shown as open, unfilled circles. The dotted vertical line represents the 
onset of the ramp incremental test from a baseline of ‘unloaded’ cycling. The V̇O2peak 
was reduced in the PL group (*= P < 0.05), but not the BR group, after blood donation. 
TTF was reduced in both groups post donation (# = P < 0.05), however, the reduction in 
TTF was greater in the PL group when compared with the BR group ($ = P < 0.05). 
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Figure 3. Group mean time to task failure (TTF) in the ramp incremental test prior to 
and post blood donation, following BR and PL supplementation. Responses prior to 
blood donation are shown as solid, filled bars, while responses post donation are shown 
as open, unfilled bars. The TTF was reduced in both groups post donation (*= P < 
0.05); however, the reduction in TTF was greater in the PL group when compared with 
the BR group (#=P < 0.05). 
 
Figure 4. Group mean changes in deoxyhaemoglobin ([HHb]) prior to and post blood 
donation, following BR and PL ingestion. Responses prior to blood donation are shown 
as solid, filled circles, while responses post blood donation are shown as open, unfilled 
circles. The dotted vertical line represents the onset of the ramp incremental test from a 
baseline of ‘unloaded’ cycling. [HHb] increased significantly from pre to post donation 
in the PL group at 360 s and end-exercise (*=P < 0.05). [HHb] was not altered from pre 
to post donation in the BR group. TTF was reduced in both groups post donation (# = P 
< 0.05), however, the reduction in TTF was greater in the PL group when compared 
with the BR group ($ = P < 0.05). 
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Table 1: Blood pressure, resting heart rate, plasma nitrate and nitrite concentrations, 
hemoglobin concentration and hematocrit prior to and following blood donation in the 
PL and BR groups. 
 
          
Values are mean ± SD. PL, Placebo group; BR, Nitrate group; Pre, pre-donation; Post, 
post-donation ; HR, heart rate; [NO2
-], nitrite concentration; [NO3
-], nitrate 
concentration; [Hb], hemoglobin concentration; Hct, hematocrit. *Significantly different 
from pre in the same condition (P < 0.05). $Significantly different from post 
supplementation value in the PL group (P < 0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
PL 
 
BR 
 
Pre Post Pre Post 
Blood pressure (mmHg)   
        Systolic 119 ± 7 118 ± 9 115 ± 11 113 ± 11* 
     Diastolic 69 ± 7 67 ± 7 64 ± 7 63 ± 7 
     Mean Arterial 86 ± 6 84 ± 8 81 ± 7 80 ± 7 
     Resting HR (b.min-1) 62 ± 9 66 ± 9 66 ± 11 71 ± 10* 
     
     Plasma [NO3-] (µM) 45 ± 11 50 ± 14* 47 ± 17 845 ± 350*$ 
Plasma [NO2-] (nM) 73 ± 18 72 ± 21 81 ± 29 619 ± 363*$ 
     
[Hb] (g.L-1) 149 ± 12 132 ± 18* 148 ± 15 137 ± 19* 
     Hct (%) 45 ± 2 41 ± 4* 45 ± 3 42 ± 5* 
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Table 2: Ventilatory and gas exchange dynamics, and blood lactate and glucose 
concentrations during moderate-intensity exercise prior to and following blood donation 
in the PL and BR groups 
 PL 
 
BR 
 Pre Post Pre Post 
 
    VO2 (L.min-1)     
Baseline  1.01 ± 0.17 0.97 ± 0.20 0.96 ± 0.20 0.87 ± 0.21# 
End exercise  1.72 ± 0.50 1.69 ± 0.53 1.65 ± 0.32 1.59 ± 0.34# 
 
    VCO2 (L.min-1) 
    Baseline 0.88 ± 0.19 0.86 ± 0.19 0.89 ± 0.19 0.81 ± 0.19# 
End exercise 1.60 ± 0.52 1.56 ± 0.50 1.53 ± 0.29 1.54 ± 0.29 
     RER 
    Baseline 0.88 ± 0.08 0.90 ± 0.06 0.89 ± 0.05 0.92 ± 0.09 
End exercise 0.94 ± 0.06 0.93 ± 0.06 0.93 ± 0.04 0.96 ± 0.06# 
 
    VE (L.min-1) 
    Baseline 25 ± 5 24 ± 5 24 ± 5 22 ± 5# 
End exercise 42  ± 11 40 ± 11 38 ± 6 38 ± 6 
     ∆ Blood [lactate] (mM) 0.0 ± 0.3 0.1 ± 0.4 0.1 ± 0.3 0.1 ± 0.4 
     ∆Blood [glucose] (mM) 0.1 ± 0.7 - 0.2 ± 0.7 0.00 ± 0.3 0.1 ± 0.5 
                
Values are mean ± SD. PL, Placebo group; BR, Nitrate group; Pre, pre-donation; Post, 
post-donation; [Bla], blood lactate concentration; [glu], blood glucose concentration; 
HR, heart rate. #Significantly different from pre in the same condition (P < 0.05). 
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Table 3: Physiological responses to ramp incremental exercise prior to and following 
blood donation in the PL and BR groups.  
 
PL 
 
BR 
 
 
Pre Post Pre Post 
     
V̇O2peak (L.min-1) 3.84 ± 0.91 3.65 ± 0.85* 3.52 ± 0.65 3.40 ± 0.73 
     
V̇O2peak (mL.kg-1.min-1) 49.9 ± 11.0 47.4 ± 10.0* 46.6 ± 6.0 44.9 ± 6.0 
     Peak power (W) 341 ± 70 324 ± 69* 331 ± 68 322 ± 66* 
     GET (L.min-1) 1.76 ± 0.40 1.68 ± 0.43 1.64 ± 0.44 1.63 ± 0.44 
     GET (W) 117 ± 29 109 ± 27 116 ± 35 112 ± 24 
     V̇CO2peak (L.min-1) 4.69 ± 1.12 4.44 ± 0.97* 4.26 ± 0.68 4.36 ± 0.77 
     RER peak 1.22 ± 0.06 1.22 ± 0.05 1.22 ± 0.06 1.29 ± 0.06* 
     V̇Epeak (L.min-1) 156 ± 44 150 ± 43* 134 ± 28 137 ± 32 
     HRpeak (b.min-1) 177 ± 16 181 ± 9 178 ± 12 179 ± 10 
     ∆ Blood [lactate] (mM) 6.1 ± 1.4 5.5 ± 1.2 6.1 ± 1.9 6.8 ± 2.5 
     ∆ Blood [glucose] (mM) -0.2 ± 0.7 0.0 ± 1.1 -0.2 ± 0.4 0.0 ± 1.1 
     
Values are mean ± SD. PL, Placebo group; BR, Nitrate group; Pre, pre-donation; Post, 
post-donation; GET, Gas exchange threshold; [Bla], blood lactate concentration; [glu], 
blood glucose concentration; HR, heart rate. *Significantly different from pre in the 
same condition (P < 0.05).  
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Table 4: Near-infrared spectroscopy-derived [HHb] and TOI dynamics during 
moderate-intensity and ramp incremental exercise prior to and following blood donation 
in the PL and BR groups. 
 
 
PL BR 
 
Pre Post Pre Post 
 
 
Moderate-intensity exercise 
[HHb] 
    
Baseline (AU) -4.4 ± 3.0 -2.3 ± 3.1 -3.1 ± 3.7 -1.9 ± 2.5 
60 s (AU) -1.2 ± 2.3 2.3 ± 5.0 -0.1 ± 5.0 0.6 ± 3.9 
120 s (AU) -0.9 ± 3.0 3.5 ± 6.2 -0.1 ± 4.9 1.0 ± 3.7 
240 s (AU) -0.7 ± 3.9 2.3 ± 5.2 0.1 ± 4.9 1.1 ± 3.6 
End (AU) 0.0 ± 4.4 2.5 ± 4.9 0.0 ± 4.9 1.0 ± 3.4 
 
    
TOI 
    Baseline (%) 65.3 ± 3.4 63.4 ± 3.3* 68.2 ± 4.3 70.1 ± 5.8 
60 s (%) 61.9 ± 4.9 57.7 ± 5.0* 64.6 ± 6.5 65.6 ± 8.5 
120 s (%) 61.9 ± 4.8 57.1 ± 5.7* 64.8 ± 6.1 65.6 ± 8.8 
240 s (%) 60.7 ± 6.6 58.1 ± 4.8* 64.8 ± 6.5 65.8 ± 8.9 
End (%) 61.4 ± 6.4 57.8 ± 5.0 65.3 ± 6.3 65.8 ± 8.9 
     
 
Ramp incremental exercise 
[HHb] 
    Baseline (AU) -6.2 ± 4.1 -3.4 ± 3.6 -5.1 ± 4.1 -2.6 ± 2.5 
120 s (AU) -3.3 ± 5.4 -0.1 ± 5.0 -2.7 ± 5.0 -0.7 ± 3.3 
240 s (AU) -0.8 ± 6.2 3.3 ± 5.8* -0.6 ± 5.8 1.4 ± 4.4 
360 s (AU) 2.0 ± 9.4 7.3 ± 9.1* 1.5 ± 6.6 3.4 ± 5.8 
End (AU) 6.2 ± 11.3 12.8 ± 10.1* 3.8 ± 7.6 5.3 ± 7.2 
     TOI 
    Baseline (%) 66.5 ± 3.9 67.3 ± 7.1 71.5 ± 3.9 72.5 ± 4.7 
120 s (%) 63.3 ± 5.1 64.6 ± 8.6 68.6 ± 5.5 69.5 ± 6.9 
240 s (%) 60.8 ± 6.5 60.7 ± 9.2 65.8 ± 7.5 65.9 ± 9.7 
360 s (%) 57.3 ± 11.5 55.4 ± 12.3 61.9 ± 8.6 61.7 ± 11.4 
End (%) 49.5 ± 12.6 47.6 ± 14.9 57.1 ± 7.0 57.2 ± 10.9 
 
Values are mean ± SD. PL, Placebo group; BR, Nitrate group; Pre, pre-donation; Post, 
post-donation; [HHb], deoxygenated haemoglobin concentration; TOI, tissue 
oxygenation index; AU, arbitrary units. *Significantly different from pre in the same 
condition (P < 0.05).  
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Figure 1. 
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Figure 2. 
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Figure 3. 
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Figure 4. 
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ABSTRACT 
Inorganic nitrate (NO3
-) supplementation has been shown to improve cardiovascular 
health indices in healthy adults. The purpose of this study was to investigate how the 
vehicle of NO3
- administration can influence NO3
- metabolism and the subsequent blood 
pressure response. Ten healthy males consumed an acute equimolar dose of NO3
- (~ 
5.76 mmol) in the form of a concentrated beetroot juice drink (BR; 55 mL), a non-
concentrated beetroot juice drink (BL; 456 mL) and a solid beetroot flapjack (BF; 60 g). 
A drink containing soluble beetroot crystals (BC; ~ 1.40 mmol NO3
-) and a control 
drink (CON; 70 mL deionised water) were also ingested. BP and salivary, plasma and 
urinary [NO3
-] and [NO2
-] were determined before and up to 24 h after ingestion. All 
NO3
--rich vehicles elevated salivary, plasma and urinary nitric oxide metabolites 
compared with baseline and CON (P < 0.05). The peak increases in plasma [NO2
-] were 
greater in BF (371 ± 136 nM) and BR (369 ± 167 nM) compared to BL (283 ± 93 nM; 
all P < 0.05) and BC (232 ± 51 nM). BR, but not BF, BL and BC, reduced systolic (~ 5 
mmHg) and mean arterial pressure (~ 3-4 mmHg; P < 0.05), whereas BF reduced 
diastolic BP (~ 4 mmHg; P < 0.05). Although plasma [NO2
-] was elevated in all 
conditions, the consumption of a small, concentrated NO3
--rich fluid (BR) was the most 
effective means of reducing BP. These findings have implications for the use of dietary 
NO3
- supplements when the main objective is to maintain or improve parameters of 
cardiovascular health. 
Word count: 247 
Key words: dietary nitrate, nitrite, blood pressure, pharmacokinetics, cardiovascular 
health 
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1.1 INTRODUCTION 
Nitric oxide (NO), an important signalling molecule, plays an essential role in the 
regulation of physiological processes, such as blood flow distribution (Shen et al., 
1994), blood pressure (BP) control (Webb et al., 2008), muscle contractility, 
mitochondrial respiration, and glucose and calcium homeostasis (Stamler & Meissner, 
2001). NO was previously thought to be generated exclusively via oxidation of the 
amino acid, L-arginine, in a reaction catalysed by a family of NO synthase (NOS) 
enzymes (Stuehr et al., 1991). However, it was later found that nitrate (NO3
-) and nitrite 
(NO2
-), originally known as inert end products of endogenous NO production (Moncada 
& Higgs, 1993), can be recycled in vivo to form NO, particularly in hypoxic and acidic 
environments (van Faassen et al., 2009; Modin et al., 2001).  
NO3
- can also be obtained through the diet, in the form of green leafy vegetables, 
beetroot juice and salts (Bryan & Hord, 2010) and can be serially reduced to form NO2
- 
and NO in a manner that does not depend on NOS activity (Benjamin et al., 1994). 
Once ingested, NO3
- is rapidly absorbed in the upper gastrointestinal tract (van Velzen 
et al., 2008) and approximately one quarter passes into the entero-salivary circulation 
and is concentrated in the saliva (Lundberg & Govoni, 2004; Spiegelhalder et al., 1976). 
Facultative anaerobes in the oral cavity reduce NO3
- to NO2
- (Duncan et al., 1995) and 
when swallowed, this NO2
- can be further reduced to NO and other reactive nitrogen 
intermediates in the acidic environment of the stomach (Benjamin et al., 1994). It is also 
clear that a small portion of the NO2
- can be absorbed into the systemic circulation 
where it can either directly (Dejam et al., 2004) or indirectly, via its reduction to NO 
(van Velzen et al., 2008), mediate physiological effects, such as the lowering of BP (e.g.  
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Ashworth et al., 2015; Bailey et al., 2009; Larsen et al., 2006; Vanhatalo et al., 2010; 
Webb et al., 2008). With hypertension [systolic blood pressure (SBP) / diastolic blood 
pressure (DBP); > 140/90 mmHg] being the leading cause of cardiovascular morbidity 
and mortality and affecting over one billion people worldwide (Chobanian et al., 2003; 
Wang et al., 2006), dietary NO3
- consumption has emerged as a potential prophylactic 
means for reducing the risk of high BP, stroke and coronary heart disease (Joshipura et 
al., 2001). Studies have reported that both acute and chronic ingestion of NO3
- can 
reduce BP (Ashworth et al., 2015; Bailey et al., 2009; Larsen et al., 2006; Vanhatalo et 
al., 2010; Webb et al., 2008), an effect that is closely related to the rise in plasma NO2
- 
concentration ([NO2
-]). While it has been reported that the increase in plasma [NO2
-] 
and reductions in BP after NO3
- ingestion follow a dose-response relationship (Kapil et 
al., 2010; Wylie et al., 2013), little is known about other factors that may also influence 
the increase in NO bioavailability and cardiovascular health benefits of NO3
- 
consumption.  
NO3
- can be administered in many different forms. Studies have previously reported an 
increase in NO metabolites and a reduction in BP after the consumption of NO3
- via 
non-concentrated beetroot juice (250-500 mL; e.g. Webb et al., 2008; Vanhatalo et al., 
2010), concentrated beetroot juice (70-140 mL; e.g. Wylie et al., 2013), beetroot bread 
(Hobbs et al., 2012), NO3
--rich whole green vegetables (Ashworth et al., 2015) and their 
juices (Jonvik et al., 2016), Swiss chard and rhubarb extract gels (Muggeridge et al., 
2014) and capsulated NO3
- salts (Kapil et al., 2010). The dietary NO3
- vehicle may 
potentially influence NO3
- metabolism and the subsequent lowering of BP, by, for 
example, altering the uptake of NO3
- and/or NO2
- into the systemic circulation. 
However, while the aforementioned studies demonstrate that different dietary NO3
-  
 Chapter 6: Influence of dietary nitrate food forms on nitrate metabolism and blood 
pressure in healthy normotensive adults  
125 
 
 
vehicles are effective at increasing NO bioavailability and lowering BP, inter-study 
differences in the baseline BP of the participants and the dose of NO3
- administered 
does not allow for the influence of the NO3
- vehicle, per se, to be elucidated. Recently, 
McIlvenna et al. (2017) reported that the plasma pharmacokinetic profile for plasma 
[NO3
-] and [NO2
-] and changes in BP were similar over a 6 h period following the 
ingestion of equimolar doses of a NO3
--rich chard gel and a concentrated beetroot juice. 
In addition, Flueck et al. (2016) reported that reductions in resting BP and O2 
consumption during moderate-intensity exercise were somewhat greater when an 
equimolar dose of NO3
- was administered as concentrated beetroot juice compared to 
NaNO3. Similarly, Jonvik et al. (2016) found that beverages made from beetroot, 
spinach and rocket raised plasma [NO3
-] and [NO2
-] to a similar extent but reduced SBP 
to a greater extent than a beverage containing NaNO3. However, no study to date 
assessed the plasma [NO3
-] and [NO2
-] and BP responses to the consumption of a range 
of different, commercially-available NO3
--rich products, including those in solid and 
liquid forms over a 24 h period. Establishing if there are differences in the physiological 
response to the various available dietary NO3
- food forms is important for informing the 
optimal supplementation strategy for beneficial effects.  
Therefore, the purpose of this study was to determine the pharmacodynamic and 
pharmacokinetic response to an equimolar dose of NO3
- administered in three different 
NO3
- vehicles using the same subject population. Specifically, we examined plasma, 
salivary and urinary [NO3
-] and [NO2
-] and the BP response to the acute consumption of 
an equimolar dose of NO3
-
 (~ 5.76 mmol) administered in the form of a low-volume 
NO3
--rich beetroot juice concentrate (BR; 55 mL), a high volume non-concentrated 
beetroot juice drink (BL; 456 mL), and a solid beetroot flapjack (BF; 60 g; all Beet It,  
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James White Drinks Ltd, Ipswich, UK). We also examined the same variables after the 
consumption of diluted beetroot crystals (BC; 114 mL) SuperBeets, Neogenis, now 
known as HumanN, Texas, US) which, at the dose recommended by the manufacturer, 
contains a lower NO3
- (1.40 mmol) content than the other products but also a small 
amount of NO2
- (~ 0.07 mmol). We also took the opportunity to assess the validity of a 
commonly used non-invasive test for estimating NO availability (NO Test Strips, 
Berkeley Test®, CA, USA), by comparing its results with determinations of salivary 
and plasma [NO3
-] and [NO2
-] derived via the gold standard chemiluminescence 
technique. It was hypothesised that relative to pre-supplementation baseline and a water 
control (CON), BR, BL, BF and BC would result in significant elevations in plasma, 
salivary and urinary [NO3
-] and [NO2
-] and reductions in systemic BP, but that such 
changes may vary between the different vehicles. 
 
1.2 METHODS 
1.2.1 Subjects 
Ten healthy, normotensive (mean ± SD; resting systolic BP (SBP) 112 ± 9 mmHg, 
diastolic  BP (DBP) 66 ± 6 mmHg, mean arterial pressure (MAP) 81 ± 6 mmHg) males 
(age 24 ± 5 years, body mass 74  ± 8 kg, height 1.77 ± 0.10 m) volunteered to 
participate in this study. None of the subjects habitually smoked tobacco, consumed 
dietary supplements or used antibacterial mouthwash. The study was approved by the 
University of Exeter Research Ethics Committee. Prior to testing and after the 
requirements of the study and potential risks and benefits of participation were 
explained, written informed consent was obtained.  
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Subjects were instructed to arrive at the laboratory in a fully rested and hydrated state, at 
least 8 h post prandial. Subjects were asked to avoid caffeine consumption and 
participation in strenuous exercise in the 24 h period prior to each laboratory visit. All 
subjects were also asked to refrain from alcohol consumption and the use of 
antibacterial mouthwash and chewing gum for the duration of the study. Each subject 
recorded diet and exercise undertaken during the 24 h period post ingestion of the first 
supplement and were asked to replicate these during the remaining four 
supplementation periods. Subjects were asked to abstain from high NO3
- foods 
throughout each 24 h supplementation period. Exclusion criteria were the presence of 
known cardiovascular disease and hypertension and the use of antihypertensive 
medication and antibiotics.  
 
1.2.2 Experimental Overview 
Subjects were asked to attend the laboratory on ten separate occasions over a three week 
period. Prior to the first visit to the laboratory, each subject was randomly assigned, in a 
single-blind, crossover fashion to consume an acute dose of ~ 5.76 mmol dietary NO3
- 
in the form of a concentrated beetroot drink (55 mL of Beet It Sport Stamina Shot, 
James White Drinks, Ltd., Ipswich, UK), a non-concentrated beetroot drink (456 mL of 
Beet It Organic Beetroot Juice, James White Drinks, Ltd., Ipswich, UK) and a beetroot 
flapjack (60 g of Beet It Pro Elite Sport Flapjack, James White Drinks, Ltd., Ipswich, 
UK). In addition, subjects consumed the recommended dose (5 g dissolved in 114 mL 
of water; 1.40 mmol NO3
- and ~ 0.07 mmol NO2
-) of Concentrated Organic Beetroot 
Crystals (SuperBeets Canister; Neogenis, now known as HumanN, Texas, US), and a  
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control drink (70 mL deionised water) which contained negligible NO3
- and NO2
- 
content.  
Owing to the NO2
- content of the SuperBeets product, we did not attempt to match the 
NO3
- content of this product with the other products tested in this study but rather 
provided the supplement as per the manufacturer’s instructions. All 10 subjects 
completed BR, BL, BF, BC and CON conditions, with each acute supplementation 
being separated by a minimum of a 48 h wash-out period. All supplements were 
presented to the subjects at room temperature. On the day of supplementation BR, BC 
and CON were consumed immediately after instruction, whereas BL and BF were 
ingested at regular intervals over a 5 and 10 min period, respectively. During each visit, 
saliva, blood and urine samples were collected and BP and indirect measures of NO 
availability (Berkeley Test®, CA, USA) were recorded prior to and over the 24 h period 
post NO3
- ingestion.  All tests began at the same time of day, typically at 9 am (± 1 h), 
to minimise diurnal variation on the physiological variables under investigation. The 
personnel performing the physiological measurements were not aware of the type of 
supplement being consumed by the subjects.  
 
1.2.3 Experimental Protocol 
Throughout each 24 h experimental period, a low NO3
- diet was provided, water 
consumption was standardised and subjects were asked to remain seated in the 
laboratory during the first 6 h to avoid influencing the physiological variables under 
investigation. During each visit to the laboratory, BP of the brachial artery and heart rate 
(HR) were measured using an automated sphygmomanometer (Dinamap Pro; GE 
medical Systems, Tampa, FL, USA) prior to NO3
- supplementation and at 1, 2, 3, 4, 5, 6  
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and 24 h post NO3
- supplementation. Five BP and HR measurements were recorded 
following each 10 min period of seated rest in a quiet room and the mean of the final 
four measurements were used for data analysis.  
Blood samples were obtained prior to ingestion of NO3
- and at 15 min, 30 min, 1, 2, 3, 
4, 5 and 6 h post ingestion. All samples (~ 6 mL) were drawn from a cannula (Insyte-
WTM, Becton-Dickinson, Madrid, Spain) inserted into the subject’s antecubital vein. At 
24 h, a single, resting venous blood sample (~ 6 mL) was drawn from an antecubital 
vein. All samples were drawn into lithium-heparin tubes (Vacutainer, Becton-
Dickinson, NJ, USA) and centrifuged for 10 min at 3000 g and 4 ºC within 2 min of 
collection and the plasma was then extracted. Saliva samples (~ 1 mL) were collected 
by expectoration, without stimulation, over a period of 5 min before NO3
- consumption 
and at 1, 2, 3, 4, 5, 6 and 24 h post consumption. Indirect measures of NO 
bioavailability were measured at the same time points using NO Test Strips (Berkeley 
Test®, CA, USA), as per the manufacturer’s guidelines. Specifically, the saliva 
collection pad on the NO Test Strip was used to swab the tongue and oral cavity over a 
5 s period. The two ends of the strip were then folded in half and the saliva collection 
pad was pressed firmly against the NO test pad (on the opposite end of the strip) for 10 
s. The NO test pad was then monitored for changes in colour and after 45 s, the intensity 
of the colour displayed on the NO test pad was compared with the associated colour 
chart on the packaging (Berkeley Test®, CA, USA) and recorded. The NO Test Strips 
are based on a modified Griess reagent reaction, which identifies the presence of NO2
- 
in the saliva. The changes in colour are, in theory, directly proportional to increases in 
salivary NO2
- (i.e. the darker the pink colour displayed on the Test Strip, the more 
salivary NO2
- present) and categorised as depleted, low, threshold, target and high levels  
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of NO bioavailability. In addition, midstream urine samples were collected at baseline 
and at 3, 6 and 24 h post NO3
- ingestion.  
Plasma, saliva and urine samples were frozen at -80 ºC for later determination of [NO3
-] 
and [NO2
-] using a modified chemiluminescence technique, as previously described 
(Wylie et al., 2013a). Briefly, [NO2
-] was determined by its reduction to NO in the 
presence of acetic acid and sodium iodide. [NO3
-] was determined by the reduction of 
NO metabolites ([NOx] = [NO3
-] + [NO2
-]) to NO in the presence of vanadium (III) 
chloride and hydrochloric acid and the subsequent subtraction of [NO2
-]. Immediately 
prior to analysis of saliva (for [NO3
-] and [NO2
-]) and urine (for [NO3
-] only) samples 
were centrifuged for 10 min at 18,600 g. The supernatants were then removed and 
diluted by a factor of 100 with NO3
- and NO2
- free deionised water. The same data 
collection protocol was repeated during each visit to the laboratory. 
 
1.2.4 Statistical Analyses 
Differences in BP, HR, NO indicator strip results and plasma, salivary and urinary 
[NO3
-] and [NO2
-] were assessed using a 2-way (condition x time) repeated-measures 
ANOVA. Significant main and interaction effects were further explored using Fisher’s 
LSD. Relationships between variables were assessed via Pearson’s product-moment 
correlation coefficient. Statistical analyses were performed using SPSS version 19.0 
(Chicago, IL, USA). Plasma [NO3
-] and [NO2
-] incremental area under the curve 
(iAUC) from baseline until 6 h (0 – 6 h) was calculated for BR, BL, BF and BC using 
the trapezium model (GraphPad Prism, GraphPad, San Diego, CA). Differences in 
iAUC between conditions were assessed using a 1-way ANOVA with significant main  
 Chapter 6: Influence of dietary nitrate food forms on nitrate metabolism and blood 
pressure in healthy normotensive adults  
131 
 
 
effects further explored using Fisher’s LSD. Data are presented as mean ± SD, unless 
otherwise stated. Statistical significance was accepted at P<0.05. 
 
1.3 RESULTS 
All subjects reported that they adhered to the prescribed dietary regime and abstained 
from physical activity during each of the 24 h experimental periods. The ingestion of 
the four NO3
- vehicles were well tolerated with no negative side effects. Subjects did, 
however, report beeturia (red urine) after BL consumption only.  
The plasma, salivary and urinary [NO3
-] and [NO2
-] prior to and post ingestion of all 
supplements is presented in Fig. 1. 
 
1.3.1 Salivary [NO3
-] and [NO2
-]  
There were significant main effects for time and condition and interaction effects for 
salivary [NO3
-] and [NO2
-] (P < 0.05). At baseline, there were no differences in salivary 
[NO3
-] and [NO2
-] between the conditions (P > 0.05). The elevations in salivary [NO3
-] 
in BR, BL, BF and BC were significantly higher than CON 1 h post ingestion and  
remained elevated above CON until 6 h post ingestion (P < 0.05). Salivary [NO3
-] was 
also higher in BR and BL 24 h after consumption when compared with CON (P < 
0.05). The peak elevation above baseline in salivary [NO3
-] occurred at 1 h (5.52 ± 1.23 
mM) post administration of BR and this rise in salivary [NO3
-] was significantly higher 
than BF (3.61 ± 1.30 mM) and BC (1.21 ± 0.36 mM) at the same time point (P < 0.05). 
Salivary [NO3
-] remained higher in BR compared to BF and BC at 2, 3, 4 and 6 h post 
ingestion (P < 0.05) Salivary [NO3
-] was also lower in BC compared with all other  
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NO3
--rich conditions at 1, 2, 3, 4, and 5 h post consumption and at 6 h when compared 
with BL (P < 0.05). The peak elevation above baseline in salivary [NO3
-] occurred at 2 
h in BL (4.53 ± 1.59 mM), BF (3.73 ± 1.49 mM) and BC (1.65 ± 0.99 mM). At 4 h, the 
rise in salivary [NO3
-] was significantly higher in BR (4.19 ± 1.92 mM) when compared 
with BL (3.36 ± 1.52 mM; P < 0.05).  
The increases in salivary [NO2
-] in BR, BL, BF and BC were significantly higher than 
CON at 2 h and remained elevated above CON until 6 h post ingestion (P < 0.05). The 
peak elevation above baseline in salivary [NO2
-] occurred at 2 h in BR (0.63 ± 0.53 
mM), BL (0.49 ± 0.38 mM), BF (0.34 ± 0.22 mM) and BC (0.14 ± 0.08 mM). The rise 
in salivary [NO2
-] was significantly higher in BR versus BF at 1, 3, 4 and 6 h post 
ingestion (P < 0.05). In addition, the rise in salivary [NO2
-] was higher in BL (0.40 ± 
0.26 mM) versus BF (0.29 ± 0.20 mM) at 1 h, and BR was higher than BL at 5 h (0.47 ± 
0.36 vs. 0.25 ± 0.18 mM) and 6 h (0.49 ± 0.27 vs. 0.27 ± 0.23 mM) post NO3
- 
consumption (P < 0.05). Salivary [NO2
-] was lower in BC when compared with all 
other NO3
--rich conditions from 1-6 h post ingestion (P < 0.05). 
 
1.3.2 Plasma [NO3
-] and [NO2
-]  
There were significant main effects for time and condition and interaction effects for 
plasma [NO3
-] and [NO2
-] (P < 0.05). At baseline, there were no differences in plasma 
[NO3
-] and [NO2
-] between the conditions (P > 0.05). Plasma [NO3
-] was significantly 
elevated in BR, BL and BF when compared with CON from 15 min to 24 h post NO3
- 
ingestion (P < 0.05). Plasma [NO3
-] was also significantly higher in BC when compared 
with CON from 30 min – 6 h post ingestion (P < 0.05). The peak elevation above  
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baseline in plasma [NO3
-] occurred at 2 h in BR (270 ± 40 µM), BL (228 ± 32 µM), BF 
(211 ± 28 µM) and BC (99 ± 20 µM). Plasma [NO3
-] in BR was higher than in BL (15 
min – 5 h; P < 0.05), BF (15 min – 6 h; P < 0.05) and BC (15 min - 24 h; P < 0.05).  In 
addition, plasma [NO3
-] was significantly higher in BL compared to BF at 15 min (98 ± 
30 µM vs. 57 ± 22 µM) and 1 h (200 ± 44 µM vs. 167 ± 30 µM) post NO3
- consumption 
(P < 0.05). Plasma [NO3
-] was lower in BC when compared with all other NO3
--rich 
conditions from 15 min-24 h post ingestion (P < 0.05). Plasma [NO3
-] iAUC 0-6 h was 
significantly greater in BR (67.6 ± 10.3 µM • min), BL (52.3 ± 7.5 µM • min) and BF 
(48.9 ± 7.2 µM • min) compared to BC (11.7 ± 3.9 µM • min; all P < 0.05). 
Furthermore, plasma [NO3
-] iAUC 0-6 h was greater in BR compared to BF and BL 
(both P < 0.05), and tended to be greater in BL compared to BF (P = 0.053). 
Plasma [NO2
-] was significantly elevated in BL (125 ± 44 nM) compared with CON (76 
± 16 nM) and BR (98 ± 43 nM) at 15 min post ingestion (P < 0.05). In addition, plasma 
[NO2
-] was higher in BC versus all conditions at 15 min and versus BL and BR at 30 
min post ingestion (P < 0.05). Plasma [NO2
-] was also higher in BR, BL and BF when 
compared with CON from 30 min until 6 h post supplement ingestion (P < 0.05). The 
peak elevation above baseline in plasma [NO2
-] occurred at 15 min in BC (232 ± 51 
nM), at 2 h in BF (371 ± 136 nM) and at 3 h in BR (369 ± 167 nM) and BL (283 ± 93 
nM). The rise in plasma [NO2
-] was significantly lower in BL when compared with BF 
at 1 and 2 h post ingestion and when compared with BR at 4 h post ingestion (P < 0.05). 
In addition, plasma [NO2
-] was lower in BC when compared with all other NO3
--rich 
conditions from 2 - 5 h post ingestion and lower at 1 and 6 h compared with BR and BF 
and BR and BL, respectively (P < 0.05). Plasma [NO2
-] iAUC 0-6 h was significantly 
greater in BR (72.2 ± 49.7 µM • min), BL (54.4 ± 28.9 µM • min) and BF (70.9 ± 46.3  
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µM • min) compared to BC (28.4 ± 17.8 µM • min; all P < 0.05). There was no 
difference in plasma [NO2
-] iAUC 0-6 h between BR and BF, but plasma [NO2
-] iAUC 
tended to be greater in BR and BF compared to BL (both P = 0.08).  
 
1.3.3 Urinary [NO3
-] and [NO2
-]  
There were significant main effects for time and condition and interaction effects for 
urinary [NO3
-] and [NO2
-] (P < 0.05). Urinary [NO3
-] was significantly elevated in BR, 
BL, BF and BC compared with CON at 3 and 6 h post ingestion (P < 0.05). Peak 
increases above baseline in urinary [NO3
-] occurred at 6 h in BR (5.63 ± 2.18 mM), BL 
(4.43 ± 1.81 mM), BF (4.23 ± 1.66 mM) and BC (1.63 ± 0.37 mM). Urinary [NO3
-] was 
lower in BC when compared with all other NO3
--rich conditions at 3 and 6 h post 
ingestion and at 24 h when compared with BR (P < 0.05). 
Urinary [NO2
-] was significantly elevated in BR, BL, BF and BC when compared with 
CON at 3 and 6 h post NO3
- ingestion (P < 0.05). Urinary [NO2
-] was also elevated in 
BR at 24 h post ingestion when compared with CON (P < 0.05). Peak elevations above 
baseline in urinary [NO2
-] occurred at 3 h in BR (7.54 ± 4.76 µM), BL (10.1 ± 6.15 
µM), BF (2.98 ± 1.26 µM) and BC (3.68 ± 10.5 µM). However, the peak rise in urinary 
[NO2
-] was significantly lower in BF when compared with BR and BL (P < 0.05) and 
BC was lower than BR and BL (P < 0.05). In addition, at 6 h post ingestion the rise in 
urinary [NO2
-] in BL (6.14 ± 2.65 µM) was significantly higher than BR (2.72 ± 1.00 
µM), BF (2.91 ± 2.31 µM) and BC (1.38 ± 0.48 µM), (P < 0.05). BR consumption also 
resulted in a significant elevation in urinary [NO3
-] and [NO2
-] at 24 h when compared 
with CON and BL (P < 0.05). 
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1.3.4 Nitric Oxide Indicator Strips 
The NO indicator strip results in response to acute ingestion of BR, BL, BF and BC are 
presented in Fig. 2. There were significant main effects for time and condition and an 
interaction effect for the NO indicator strips (P < 0.05). At baseline, there were no 
differences in NO indicator strip results between the conditions (P > 0.05). 
Consumption of BR, BL, BF and BC resulted in a significant elevation in NO indicator 
strip results from 1 – 6 h post ingestion when compared with baseline (P < 0.05). Peak 
increases above pre-supplementation baseline in the NO indicator strips occurred at 1 h 
in BR (Target) and at 2 h in BL (Threshold), BF (Threshold) and BC (Low). The NO 
strip results were higher at 1, 2, 3, 4, 5 and 6 h post BR, BL, BF and BC when 
compared with CON. At 24 h, NO indicator results were also higher in BL than CON (P 
< 0.05). In addition, at 1 h, the rise in NO indicator strip result was higher in BR 
(Target) when compared with BL (Threshold). NO strip results were lower in BC when 
compared with all other NO3
--rich conditions at 2 and 4 h post ingestion and when 
compared with BR and BL at 1, 3 and 5 h post ingestion (P < 0.05). There was a 
significant correlation between the change in plasma [NO2
-] and the change in NO 
indicator strip result across all conditions (r = 0.48, P < 0.05). There was also a 
significant correlation between salivary [NO2
-] and the NO indicator strip result across 
all conditions (r = 0.57, P < 0.05). 
 
1.3.5 Blood Pressure and Heart Rate  
The change in SBP and MAP following the acute ingestion of the four NO3
- vehicles are 
displayed in Fig. 3. There was a significant main effect for time and condition and an  
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interaction effect for SBP (P < 0.05). In the BR condition, SBP was significantly 
reduced from baseline (115 ± 10 mmHg) to 3 h post ingestion (110 ± 9 mmHg; P < 
0.01). The change in SBP in the BR condition was significantly greater when compared 
with CON from 1 h until 5 h post NO3
- ingestion (P < 0.05). In addition, the reduction 
in SBP in the BR condition was significantly greater when compared with BF, BL and 
BC at 3 h post ingestion (P < 0.05). BR also resulted in a greater reduction in SBP 
when compared with BL and BC at 1 and 2 h post ingestion, respectively (P < 0.05). 
There was a significant correlation between the change in SBP and the change in plasma 
[NO2
-] in BR (r = -0.29, P < 0.05). There was a significant main effect for time (P < 
0.05), but no main effect for condition (P > 0.05) or an interaction effect for DBP (P > 
0.05). Follow up analyses revealed that at 1 h, DBP in BR (63 ± 5 mmHg) and BF (62 ± 
6 mmHg) was significantly lower than pre-supplementation baseline (BR: 66 ± 5 
mmHg; BF 66 ± 7 mmHg) and CON (65 ± 8 mmHg; all P < 0.05). An interaction effect 
was noted for MAP (P<0.05). Follow up analyses revealed a significant reduction in 
MAP in the BR condition at 1 h (80 ± 6 mmHg) and 3 h (79 ± 6 mmHg) when 
compared with baseline (83 ± 6 mmHg; P < 0.05) and CON (1 h; 81 ± 8 mmHg, 3 h; 82 
± 9 mmHg; P < 0.05). In addition, MAP was lower 1 h after BF ingestion and 4 h after 
BR ingestion when compared with CON (P < 0.05).   
There was a significant main effect for time (P < 0.05) and an interaction effect for HR 
(P < 0.05). There were no differences in HR between conditions at baseline (P > 0.05). 
However, HR was elevated in CON (65 ± 8 b.min-1), BR (68 ± 9 b.min-1) and BF (65 ± 
5 b.min-1) at 1 h post ingestion when compared with baseline (CON: 61 ± 7; BR: 62 ± 8; 
BF: 62 ± 7 b.min-1; all P < 0.05). BR and BF ingestion also resulted in an elevated HR 
at 5 h (67 ± 8 b.min-1; P < 0.05) and 6 h (65 ± 7 b.min-1; P < 0.05) post consumption,  
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respectively. In contrast, HR was reduced at a number of time points across the 24 h 
period in the CON, BL and BC conditions (P < 0.05).  
 
1.4 DISCUSSION 
This study is the first to compare the pharmacodynamic and pharmacokinetic response 
to an equimolar dose of NO3
- administered in several different forms over 24 h as well 
as the ingestion of a small dose of NO2
--containing crystals in another commercially-
available supplement. We investigated the influence of an acute dose of dietary NO3
- (~ 
5.76 mmol NO3
-) in the form of a small concentrated volume of fluid (BR), a large non-
concentrated volume of fluid (BL), a solid (BF; flapjack) and dissolvable crystals (BC; 
1.40 mmol NO3
-) on plasma, salivary and urinary [NO3
-] and [NO2
-] and on resting BP 
over a 24 h period. The principal finding in this study was that the ingestion of 
concentrated beetroot juice was the most effective means of increasing markers of NO 
bioavailability and reducing systemic BP when compared with non-concentrated 
beetroot juice, beetroot flapjack and beetroot crystals. 
 
1.4.1 Salivary [NO3
-] and [NO2
-] 
The NO3
- supplements were successful in elevating salivary [NO3
-] and [NO2
-] over a 
24 h period. The largest elevation in salivary [NO3
-] occurred 1 h after concentrated 
beetroot juice ingestion, with there being a ~ 700 % increase above baseline. The peak 
elevation in non-concentrated beetroot juice, beetroot flapjack and beetroot crystals 
occurred at 2 h post ingestion, increasing by ~ 670, ~ 270 and ~ 130 % above baseline 
values, respectively. The kinetic profiles for salivary [NO3
-] were similar to those for  
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plasma [NO3
-], with concentrated beetroot juice providing the greatest increase in 
plasma [NO3
-], followed by non-concentrated beetroot juice, beetroot flapjack and then 
beetroot crystals. This similarity suggests that the differences in salivary [NO3
-] may 
have been mediated by between-vehicle differences in absorption of NO3
- into the 
systemic circulation. Specifically, these data imply that the absorption of NO3
- into the 
systemic circulation was greater when NO3
- was ingested in a fluid, compared to a solid, 
food form and that this difference subsequently altered the concentration of NO3
- in 
saliva. It is possible that the differences in NO3
- absorption may be explained, in part, 
by the different rates of gastric emptying between liquids and solids (Jian et al., 1979). 
However, if gastric emptying were to play an important role in salivary NO 
bioavailability, it may have been expected that the larger, non-concentrated volume of 
fluid would have increased the rate of gastric emptying and resulted in a faster time to 
peak salivary [NO3
-] compared to that of the concentrated fluid (Noakes et al., 1991), 
which was not the case in the present study. It is important to note here that the smaller 
salivary [NO3
-] elevation in the beetroot crystal condition was likely due to the smaller 
dose of NO3
- administered when compared with the other NO3
--rich vehicles (1.40 vs. 
5.76 mmol NO3
-). 
Consistent with earlier reports that there is a direct relationship between dietary NO3
- 
consumption and salivary [NO2
-] (Spiegelhalder et al., 1976), concentrated beetroot 
juice, non-concentrated beetroot juice and beetroot flapjack increased salivary [NO2
-] to 
a similar extent in the present study, peaking at 2 h post consumption and following a 
similar kinetic pattern to salivary [NO3
-] over the time course of the experiment. In 
contrast, the smaller dose of NO3
-administered in the beetroot crystal condition resulted 
in a smaller rise in salivary [NO2
-] when compared with the other vehicles. McDonagh  
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et al. (2015) have also shown increases in salivary [NO3
-] and [NO2
-] after chronic 
ingestion of the same concentrated beetroot juice shot but the magnitude of increase was 
much greater than in the present study, which may be linked to the longer 
supplementation period. 
The peak rise in salivary [NO2
-] was lower with the beetroot flapjack compared to 
concentrated beetroot juice and non-concentrated beetroot juice, but no difference in 
salivary [NO2
-] was found between non-concentrated beetroot juice and concentrated 
beetroot juice. These salivary [NO2
-] responses mirror those of salivary [NO3
-], 
suggesting that the increase in salivary [NO2
-] following the consumption of each 
supplement is proportional to the amount of NO3
- available for bacterial reduction to 
NO2
- in the oral cavity. However, it is important that other factors that may contribute to 
the differences in salivary [NO2
-] response between conditions are not disregarded. 
Indeed, salivary flow-rate, oral pH and temperature and the activity of bacterial NO3
- 
reductases (Djekoun-Bensoltane et al., 2007) have the potential to alter the salivary 
[NO2
-] response following NO3
- ingestion, and it is possible that some of these may 
have been altered by the ingestion of the different NO3
- vehicles.  
 
1.4.2 Plasma [NO3
-] and [NO2
-] 
The acute consumption of concentrated beetroot juice, non-concentrated beetroot juice, 
beetroot flapjack and beetroot crystals elevated plasma [NO3
-] and [NO2
-] above 
baseline values across the 24 h period. Peak plasma [NO3
-] occurred at 2 h post 
ingestion, rising by ~ 680, 530, 500 and 150 % in concentrated beetroot juice, beetroot 
flapjack, non-concentrated beetroot juice and beetroot crystals, respectively. Previous  
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studies have reported similar increases (~ 400 – 600 %) in plasma [NO3-] after 
supplementation with NO3
- salts (Bescós et al., 2012; Larsen et al., 2007). In fact, the 
overall pharmacokinetic profile of plasma [NO3
-] after ingestion of the three James 
White beetroot supplements (~ 5.76 mmol NO3
-) in this study is similar to previous 
work by Webb et al. (2008) and Wylie et al. (2013). Specifically, there was a rapid 
increase in plasma [NO3
-] within 30 min, attainment of peak values at 2 h (Larsen et al., 
2010), and then a steady decline beyond 4 h post NO3
- consumption.  
Peak plasma [NO2
-] was ~ 490, 520, 240 and 210 % above baseline in the concentrated 
beetroot juice, beetroot flapjack, non-concentrated beetroot juice and beetroot crystal 
conditions, respectively. These values are higher than those typically reported (~ 50 – 
140 %) after beetroot juice supplementation, despite a similar dose (5 - 6 mmol) of NO3
- 
being administered (Lansley et al., 2011; Vanhatalo et al., 2010). These differences may 
be explained by variations in the presence and/or activity of NO3
- reductases between 
the subject populations (Govoni et al. 2008; Webb et al. 2008) and/or differences in 
dietary control between studies (Vanhatalo et al., 2010). It is important to note, 
however, that the rise in plasma [NO2
-] in the non-concentrated beetroot juice condition 
was similar to those values previously reported after ingestion of 0.5 L of the same non-
concentrated NO3
--rich beetroot juice drink (Lansley et al., 2011; Vanhatalo et al., 
2010). Interestingly, the iAUC and the peak increase in plasma [NO2
-] were similar in 
the concentrated beetroot juice and beetroot flapjack conditions, despite the rise in 
salivary [NO2
-] being lower with the beetroot flapjack. This may be explained by a 
greater exposure time of the more solid supplement to the NO3
- reducing bacteria found 
in the oral cavity (via swallowing and chewing), particularly during the initial stages of  
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digestion, although we cannot rule out possible effects in the stomach and upper 
gastrointestinal tract.  
The peak rise in plasma [NO2
-] has been consistently reported to occur between 2 and 3 
h following dietary NO3
- intake (Webb et al., 2008; Wylie et al., 2013). In the current 
study, peak plasma [NO2
-] occurred at 2 h in beetroot flapjack and at 3 h in concentrated 
beetroot juice and non-concentrated beetroot juice. In contrast, peak plasma [NO2
-] 
occurred 15 min post ingestion of beetroot crystals owing to the small dose of NO2
- that 
was present in this supplement. Plasma [NO2
-] has been reported previously to peak 
between 15 and 30 minutes post consumption of an acute NO2
- bolus (Kevil et al., 
2011).  
The time lag between the appearance of peak [NO3
-] and [NO2
-] in plasma emphasises 
the importance of the entero-salivary circulation and the role of the oral bacteria in 
reducing NO3
- to NO2
- (Kapil et al., 2012; Webb et al., 2008). It is important to note 
here that although plasma [NO2
-] peaked within the typical time frame in the beetroot 
flapjack condition, there was a rapid elevation from 30 min – 1 h, suggesting that the 
kinetic response to the solid supplement was somewhat faster than either of the liquid 
supplements containing the same NO3
- and NO2
- content (concentrated beetroot juice 
and non-concentrated beetroot juice) used in this study. Muggeridge and colleagues 
(2014) also found that using a more solid NO3
- vehicle than a typical vegetable juice, 
such as a Swiss chard and rhubarb extract gel (Science in Sport GO + Nitrates, 
Lancashire, U.K.) resulted in a faster pharmacokinetic response for plasma [NO2
-]. In 
contrast, McIlvenna et al. (2017) reported similar plasma [NO3
-] and [NO2
-] after 
ingestion of concentrated beetroot juice and the chard gel. Interestingly, these authors  
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reported that the concentrated beetroot juice elevated total plasma nitroso species 
([RXNO]) to a greater extent than the chard gel (McIlvenna et al., 2017).  
Investigating the influence of a more diverse range of NO3
- vehicles on plasma [RXNO] 
in addition to [NO3
-] and [NO2
-] may be useful in future work. Consistent with the 
proposed explanation for the peak plasma [NO2
-] response (see above), this relatively 
faster time-to-peak in the beetroot flapjack condition, may also be explained by the solid 
food form spending more time in the oral cavity, or effects in the stomach and upper 
gastrointestinal tract.  
Overall, differences in dietary administration may play a key role in the 
pharmacokinetic response to NO3
- supplementation. Specifically, the different NO3
- 
food stuffs, particularly the more compact or dense products, may modify exposure time 
to oral bacteria, alter the uptake of NO3
- into the systemic circulation, change salivary 
flow rate and/or possibly alter the oral and gastric pH, resulting in different 
pharmacokinetic responses when compared to those values typically reported after 
consumption of NO3
--rich beetroot juice and salts (Kapil et al., 2010; Webb et al., 2008; 
Wylie et al., 2013). 
 
1.4.3 NO Indicator Strips 
This is the first study to validate the Berkeley Test® nitric oxide indicator strips as a 
means for estimating changes in NO bioavailability, via salivary [NO2
-], following the 
consumption of different NO3
- supplements. Modi et al. (2016) have previously reported 
that the test strips were significantly correlated with salivary [NO2
-] in non-
supplemented subjects. Overall, the strips identified elevations and subsequent falls in  
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NO biomarkers over the 24 h experimental period after NO3
- ingestion. The strips were 
able to identify the dose-response differences between the higher NO3
- products (5.76 
mmol NO3
-) and the beetroot crystal product (1.40 mmol NO3
-), but not the more subtle 
changes in NO bioavailability after the equimolar doses of NO3
-
. The NO strip test 
results were positively correlated with an increase in both salivary and plasma [NO2
-]. 
Therefore, Berkeley Test® nitric oxide indicator strips may provide a practical way of 
estimating salivary [NO2
-] following NO3
- ingestion, for example, in field studies or 
when more direct approaches, such as chemiluminescence, are not available. 
 
1.4.4 Urinary [NO3
-] and [NO2
-] 
In this study, the four NO3
- vehicles resulted in an increase in urinary [NO3
-] and [NO2
-] 
when compared with pre-supplementation baseline and CON. The pharmacokinetic 
profile revealed that the peak urinary [NO3
-] occurred at 6 h in all NO3
- loaded 
conditions, with concentrated beetroot juice resulting in the highest [NO3
-] when 
compared with non-concentrated beetroot juice, beetroot flapjack and beetroot crystals, 
increasing by 6-fold, versus 3-, 3.5- and 2- fold, respectively. Several studies have 
previously shown increases in urinary NO3
- excretion after ingestion of 
pharmaceutically (Bartholomew & Hill, 1984; Bescós et al., 2012) and naturally (Hobbs 
et al., 2012; Oldreive et al., 2001) derived NO3
-. Pannala et al. (2003) reported similar 
urinary NO3
- kinetics to this study after ingestion of a high-nitrate meal (containing ~ 
3.9 mmol NO3
-). These authors reported that urinary NO3
- increased by 4-fold and this 
peak excretion occurred between 4 and 6 h post ingestion of the NO3
--rich meal, with 
basal concentrations reached by 24 h.  
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Peak urinary [NO2
-] occurred at 3 h post ingestion of concentrated beetroot juice, non-
concentrated beetroot juice, beetroot flapjack and beetroot crystal conditions, with 26-, 
25-, 6- and 12-fold increases noted above baseline, respectively. The results in the 
present study seemed to be higher than those previously reported (2-fold increase in 
urinary NO2
- output) after ingestion of a high NO3
- meal (Pannala et al., 2003). At 24 h, 
urinary [NO3
-] and [NO2
-] had returned to baseline values in the beetroot flapjack, non-
concentrated beetroot juice and beetroot crystal conditions. However, urinary [NO3
-] in 
the concentrated beetroot juice condition remained elevated above pre-supplementation 
values and the beetroot crystal condition 24 h post ingestion. The majority (60-75 %) of 
endogenously and exogenously derived NO3
- is ultimately excreted in the urine (Hobbs, 
2013; Wagner et al., 1983). Differences in the concentration of both urinary [NO3
-] and 
[NO2
-] were noted between the conditions and this is likely explained by the consistency 
of the vehicle and its absorption rate within the body, with the fluid conditions, 
particularly the concentrated fluid, resulting in higher excretion than the solid condition.  
However, it is important to note that total urine output was not measured in the present 
study, and therefore total NO3
- and NO2
- excretion is not known. 
 
1.4.5 Blood Pressure and Heart Rate 
Acute dietary NO3
- supplementation reduced systemic BP at several time points when 
compared with the pre-supplementation baseline and CON. Specifically, concentrated 
beetroot juice resulted in a reduction in SBP (- 5 mmHg) at 3 h post ingestion when 
compared with baseline; however, there was no decrease in SBP in beetroot flapjack, 
non-concentrated beetroot juice and beetroot crystals when compared with pre-
supplementation values. It is important to note, however, that the change in SBP across  
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all conditions was negatively correlated with the increase in plasma [NO2
-]. Wylie et al. 
(2013) also reported a 5 mmHg reduction in SBP after ingestion of a single bolus of a 
similar beetroot concentrate (containing 4.2 mmol NO3
-). In contrast to our findings, 
Kapil et al. (2010) found that 3 h after the consumption of 250 mL of a non-
concentrated beetroot juice (Beet It, James White Drinks, Ltd., Ipswich, UK, containing 
5.5 mmol NO3
-) SBP was reduced by ~ 5 mmHg. At 1 h post ingestion of concentrated 
beetroot juice and beetroot flapjack, DBP was reduced by 3 and 4 mmHg when 
compared with baseline, respectively. The magnitude of the reduction in DBP in both 
the concentrated beetroot juice and beetroot flapjack conditions are in line with the 
associated elevations in plasma [NO2
-] at the same time point. Wylie et al. (2013) also 
reported that consumption of 2 (8.4 mmol NO3
-) and 4 (16.8 mmol NO3
-) concentrated 
beetroot shots reduced DBP by 3 and 4 mmHg at 4 h and 2 h, respectively, whereas 
consumption of 1 shot (4.2 mmol NO3
-) did not alter DBP.  
MAP was reduced in the concentrated beetroot juice condition only when compared 
with both the pre-supplementation baseline (1 h: 3 mmHg, 3 h: 4 mmHg) and CON (1 
h: 1 mmHg, 3 h: 2 mmHg). Other studies have also reported similar reductions in MAP 
following consumption of a concentrated beetroot shot (Wylie et al., 2013). In contrast 
to our study, Webb et al. (2008) reported a reduction in MAP (3 h: 8 mmHg) when a 
larger volume of a non-concentrated NO3
--rich beetroot juice was consumed. The 
discrepancy in results between the studies is likely due to the increased [NO3
-] (22.5 
mmol) consumed in the latter study (Webb et al., 2008) compared to the current study 
(5.76 mmol). In the present study, non-concentrated beetroot juice did not affect DBP 
across the 24 h time frame, findings that are consistent with Kapil et al. (2010). It may 
be suggested that despite the same NO3
- dose being ingested, the larger volume of fluid  
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consumed in the non-concentrated beetroot juice condition versus beetroot flapjack and 
concentrated beetroot juice, may have helped to sustain a relatively stable BP over the 
24 h experimental period in this study (Jormeus et al., 2010). The beetroot crystal 
product did not reduce BP at any time point. This may be explained by the low dose of 
NO3
- administered and consequently the smaller rise in markers of NO bioavailability 
and also by the fact that the earliest measurement of BP at 1 h did not coincide with the 
peak plasma [NO2
-] in this condition. Another important consideration in the 
interpretation of the BP results in this study is that the subjects were normotensive 
(112/66 mmHg) such that large changes in BP following NO3
- ingestion would not be 
expected. For a given NO3
- dose, the reduction in BP is significantly correlated with the 
baseline BP (Ashworth et al., 2015). 
Several studies have found no change in HR during rest and exercise following NO3
- 
supplementation (Bailey et al., 2009; Ferguson et al., 2013a; 2013b). However, in the 
present study, there was a rise in HR across a number of conditions with the most 
noteworthy being the elevation in HR at 1 h post concentrated beetroot juice ingestion. 
This small rise in HR may be a compensatory mechanism to maintain cardiac output in 
the face of the reduced MAP (Klein, 2013). 
 
1.4.6 Clinical Significance 
Overall, concentrated beetroot juice was more effective in reducing BP when compared 
to beetroot flapjack, non-concentrated beetroot juice and beetroot crystals. It is 
noteworthy that a 5 mmHg reduction in SBP (as seen in this study), if maintained, may 
be estimated to decrease the risk of mortality by 7 % and, more specifically, reduce the  
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risk of mortality by stroke and coronary heart disease by 14 and 9 %, respectively 
(Stamler, 1991). Even a sustained 2 mmHg reduction in SBP could result in a 10 and 7 
% reduction in stroke mortality and cardiovascular disease mortality, respectively, 
(Lewington et al., 2002). The rise in the bioavailability of NO following NO3
- ingestion 
is believed to be responsible for the reductions in systemic BP. Although NO2
- itself 
may produce direct vasodilatory effects (Alzawahra et al., 2008), elevated levels of NO 
can encourage the binding of NO with guanylate cyclase (Ignarro, Harbison, Wood & 
Kadowitz, 1986) stimulating the release of cyclic guanosine monophosphate (cGMP). 
The consequent activation of several protein kinases by cGMP can reduce intracellular 
calcium concentration and consequently lead to smooth muscle relaxation (Lohmann et 
al., 1997). Therefore, it may be suggested that dietary NO3
- supplementation, 
particularly in the form of a small, concentrated beetroot drink, may be useful 
therapeutically or prophylactically for maintaining a healthy BP. 
 
1.4.7 Conclusion 
In summary, dietary supplementation with NO3
--rich concentrated beetroot juice, non-
concentrated beetroot juice, beetroot flapjack and beetroot crystals successfully elevated 
NO-related metabolites when compared with pre-supplementation values and a water 
control. Beetroot flapjack and concentrated beetroot juice were the most effective 
vehicles for increasing plasma [NO2
-] and reducing systemic BP, results which may be 
especially important for clinical populations. However, concentrated beetroot juice was 
the supplement that resulted in the greatest and most consistent reductions in both SBP 
and MAP. Based on these results, it may be suggested that the consumption of a small, 
concentrated volume of NO3
--rich fluid, such as beetroot juice, may be recommended as  
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a practical approach for maintaining or perhaps improving markers of cardiovascular 
health in young, healthy individuals.  
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FIGURE LEGENDS 
Figure 1. Salivary nitrate (A), salivary nitrite (B), plasma nitrate (C), plasma nitrite (D), 
urinary nitrate (E) and urinary nitrite (F) following consumption of a water control        
(CON;●), 5.76 mmol of a nitrate-rich beetroot concentrate (BR; ■), beetroot flapjack       
(BF; ○) and a non-concentrated beetroot drink (BL; ▲) and 1.40 mmol of nitrate 
containing beetroot crystals (BC; □). Data are presented as group mean ± SE. 
aSignificantly different from pre-supplementation; *Significantly different from CON; 
$Significantly different from BL; #Significantly different from BR; bSignificantly 
different from BC (all P < 0.05). 
 
Figure 2. Nitric oxide indicator strip results following consumption of a water control 
(CON; ●), 5.76 mmol of a nitrate-rich beetroot concentrate (BR; ■), beetroot flapjack 
(BF; ○) and a non-concentrated beetroot drink (BL; ▲) and 1.40 mmol of nitrate 
containing beetroot crystals (BC; □). Data are presented as group mean ± SE. 
aSignificantly different from pre-supplementation; *Significantly different from CON; 
$Significantly different from BL; bSignificantly different from BC (all P < 0.05). 
 
Figure 3. Change (Δ) relative to pre-supplementation baseline in systolic blood pressure 
(SBP; A) and mean arterial pressure (MAP; B) following consumption of a water 
control (CON; ●), 5.76 mmol of a nitrate-rich beetroot concentrate (BR; ■), beetroot 
flapjack (BF; ○) and a non-concentrated beetroot drink (BL; ▲) and 1.40 mmol of 
nitrate containing beetroot crystals (BC; □). Data are presented as group mean ± SE. 
aSignificantly different from pre-supplementation; *Significantly different from CON;  
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$Significantly different from BL; #Significantly different from BR; bSignificantly 
different from BC (all P < 0.05). 
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Abstract 
Background: Ingestion of nitrate- (NO3
-) containing vegetables, alcohol and 
polyphenols, separately, can reduce blood pressure (BP). However, the pharmacokinetic 
response to the combined ingestion of NO3
- and polyphenol rich or low alcoholic 
beverages is unknown. Aim: To investigate how the consumption of low and high 
polyphenolic alcoholic beverages combined with a NO3
--rich meal can influence NO3
- 
metabolism and systemic BP. Methods: In a randomised, crossover trial, 12 
normotensive males (age 25 ± 5 years) ingested an acute dose of NO3
- (~ 6.05 mmol) in 
the form of a green leafy salad, in combination with either a polyphenol-rich red wine 
(NIT-RW), a low polyphenol alcoholic beverage (vodka; NIT-A) or water (NIT-CON). 
Participants also consumed a low NO3
- salad and water as a control (CON; ~ 0.69 mmol 
NO3
-). BP and plasma, salivary and urinary [NO3
-] and nitrite ([NO2
-]) were determined 
before and up to 5 h post-ingestion. Results: Each NO3
--rich condition elevated NO 
biomarkers when compared with CON (P < 0.05). The peak rise in plasma [NO2
-] 
occurred 1 h after NIT-RW (292 ± 210 nM) and 2 h after NIT-A (318 ± 186 nM) and 
NIT-CON (367 ± 179 nM). Systolic BP was reduced 2 h post consumption of NIT-RW 
(-4 mmHg), NIT-A (-3 mmHg) and NIT-CON (-2 mmHg) compared with CON (P < 
0.05). Diastolic BP and mean arterial pressure were also lower in NIT-RW and NIT-A 
compared with NIT-CON (P < 0.05). Conclusion: A NO3
--rich meal, consumed with or 
without an alcoholic beverage, increases plasma [NO2
-] and lowers systemic BP for 2-3 
h post ingestion. 
Keywords dietary nitrate, alcohol, red wine, blood pressure, pharmacokinetics, nitric 
oxide, Mediterranean diet 
 Chapter 7: A randomised controlled trial exploring the effects of different beverages 
consumed alongside a nitrate-rich meal on systemic blood pressure 
165 
 
 
Introduction 
Hypertension is one of the leading and most avertable causes of morbidity and 
mortality. Much scientific and medical research has therefore focused on interventions 
to lower blood pressure (BP) and improve cardiovascular health and longevity (Appel et 
al., 1997; Joshipura et al., 1999, 2001). A vegetable-rich diet can elicit favourable 
effects on BP and these effects have, in part, been attributed to the high polyphenolic 
and nitrate (NO3
-) content of these foods. Green leafy vegetables and beets are an 
important source of NO3
- and a precursor for the production of the vasodilator, nitric 
oxide (NO; Hord, Tang and Bryan, 2001). Following absorption through the upper 
gastrointestinal tract, 25 % of the consumed NO3
- passes into the enterosalivary 
circulation and accumulates in the oral cavity (Lundberg and Govoni, 2004). Here, 
commensal bacteria rapidly reduce NO3
- to nitrite (NO2
-; Duncan et al., 1995), 
ultimately leading to an increased systemic plasma NO2
- concentration ([NO2
-]; Dejam 
et al., 2004). NO and other nitrogen oxides, can be enzymatically and non-
enzymatically produced from NO2
- (Gladwin et al., 2005; Webb et al., 2004; Zweier et 
al., 1995). In environments with a low pH, like the stomach (Benjamin et al., 1994), 
swallowed salivary NO2
- interacts with the gastric acid and is converted to nitrous acid 
(HNO2) which can be further transformed into, for example, dinitrogen trioxide (N2O3), 
nitrogen dioxide (NO2) and NO (McKnight et al., 1997).
 In the presence of ascorbic 
acid (Vitamin C), thiocyanate and polyphenols (which are abundant in fruit and 
vegetables), the production of NO is favoured over that of other nitrogen species (Gago 
et al., 2007; Peri et al., 2005; Weitzberg and Lundberg, 1998). 
It is clear that the diet plays a fundamental role in the formation of NO and its 
derivatives, and the subsequent lowering of systemic BP (Gladwin, 2004). Indeed, the  
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acute and chronic ingestion of dietary NO3
- has been shown to increase plasma [NO2
-] 
and reduce BP in a range of different populations (Ashworth et al., 2015; Kenjale et al., 
2011; Vanhatalo et al., 2010; Webb et al., 2008). Wylie et al. (2013) reported a dose-
dependent increase in markers of NO and reductions in BP in young, healthy males after 
acute concentrated beetroot juice ingestion, with peak changes occurring 2-4 h post 
consumption. In another study, 7 days of high NO3
- vegetable consumption resulted in a 
4 mmHg decrease in systolic BP (SBP) in normotensive females (Ashworth et al., 
2015).  
The ingestion of red wine following sodium NO3
- consumption has also been reported 
to promote NO formation, as measured in air expelled from the human stomach (Gago 
et al., 2007). In addition, anthocyanin and catechol fractions found in red wine have 
been reported to dose- and pH-dependently promote NO formation when mixed with 
NO2
- in vitro (Gago et al., 2007). Moreover, a NO2
--ethanol blend, under gastric 
conditions, can generate ethyl NO2
-, a potent vasodilator, and relaxation of rat gastric 
fundus strips and femoral artery rings (Gago et al., 2008). It was recently reported that 
50 g of lettuce followed by either 300 mL of red wine or 60 mL of whisky increased 
ethyl NO2
- in the stomach, with higher concentrations noted in the whisky condition 
(Rocha et al., 2015). NO was also substantially elevated, but in the red wine condition 
only, which underlines the importance of polyphenols in the univalent reduction of NO2
- 
to NO (Rocha et al., 2015). It is important to note here that these studies administered 
NO3
- 15-45 min prior to ingestion of alcohol or polyphenols to increase their exposure 
to gastric NO2
-.  
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However, this approach to increasing NO metabolites for subsequent cardiovascular 
benefit is not likely to be adopted in real life; a more realistic approach, such as the 
consumption of a NO3
--rich meal alongside alcohol and/or polyphenols, as often occurs 
as part of the so-called Mediterranean diet (Giacosa et al., 2016; Shen et al., 2015), 
warrants investigation.  
Overall, the consumption of green leafy foods and moderate red wine intake (as a whole 
or in the form of its constituents) can reduce systemic BP and risk of mortality (Appel et 
al., 1997; de Lorgeril et al., 1995; Foppa et al., 2002). While NO3
- (Webb et al., 2008; 
Wylie et al., 2013) and polyphenol (Li, Xia and Fӧrstermann, 2012; Migliori et al., 
2015; Schroeter et al., 006) ingestion, both separately and in combination (Peri et al., 
2005; Rocha et al., 2009, 2015), can elevate NO bioavailability, NO3
- and NO2
- 
pharmacokinetics and BP responses to a typical NO3
--rich meal consumed alongside a 
low and high polyphenolic alcoholic beverage has not been determined in humans.  
The purpose of this study was to establish the plasma, salivary and urinary [NO3
-] and 
[NO2
-] pharmacokinetic profiles and BP response to three NO3
--rich salad meals in 
conjunction with either a polyphenol-rich red wine (NIT-RW), a low-polyphenol 
alcoholic beverage (NIT-A; vodka and lemonade) or a water control drink (NIT-CON) 
over a 5 h period. It was hypothesised that relative to pre-supplementation baseline and 
a low NO3
- meal with a water control condition (CON), NIT-RW, NIT-A and NIT-CON 
would result in significant increases in plasma, salivary and urinary [NO3
-] and [NO2
-] 
and reductions in systemic BP. It was also hypothesised that NIT-RW would have a 
more pronounced effect upon BP compared with NIT-A and NIT-CON due to the 
polyphenol content.  
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Methods 
Participants 
Twelve healthy, normotensive males volunteered to participate in this study (See Table 
1. for baseline characteristics). Subjects were recruited from the University student 
population from November 2016 until January 2017. None of the subjects smoked 
tobacco, consumed dietary supplements or used antibacterial mouthwash habitually. 
Prior to testing and after the requirements of the study and potential risks and benefits of 
participation were explained, written informed consent was obtained. The sample size 
was determined in G*Power by inputting previous data for changes in BP following red 
wine consumption and the calculation was approved by a statistician. This study was 
approved by the University of Exeter Research Ethics Committee and conformed to the 
ethical principles of the World Medical Association Declaration of Helsinki. 
Participants were instructed to arrive at the laboratory in a fully rested and hydrated 
state, at least 3 h post prandial. In addition, participants were asked to avoid caffeine 
consumption and participation in strenuous exercise in the 24 h period prior to each visit 
to the laboratory. All participants were also asked to refrain from alcohol consumption 
(other than that administered by the researcher) and the use of antibacterial mouthwash 
and chewing gum for the duration of the study. Each participant recorded their habitual 
diet and exercise undertaken during the 24 h period prior to consumption of the first 
experimental condition and were asked to replicate these during the remaining three 
experimental conditions. Exclusion criteria were the presence of known cardiovascular 
disease and hypertension, allergy to alcohol, and the use of antihypertensive medication 
and antibiotics. 
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Experimental Design 
Participants were asked to attend the laboratory on four separate occasions over a two 
week period. Prior to the first visit to the laboratory, each participant was randomly 
assigned, in a single-blind (i.e., the researcher was blinded to the order), simple 
crossover fashion to consume an acute dose of ~ 6.05 mmol of dietary NO3
- in the form 
of a green leafy salad (50 g rocket, 88 g spinach and 160 g cucumber), in combination 
with either a polyphenol-rich red wine [NIT-RW; 175 mL Montepulciano d’Abruzzo, 
Tesco Stores Ltd, Welwyn Garden City, U. K; 12.5 % alcohol by volume (ABV)], a low 
polyphenol alcoholic beverage (NIT-A; 58 mL Red Label Smirnoff  Vodka, The 
Smirnoff Co., London, U.K; 117 mL Tesco Sparkling Lemonade, Tesco Stores Ltd, 
Welwyn Garden City, U.K;  12.5 % ABV) or a control drink (NIT-CON; 175 mL 
deionised water). The NO3
- content of the salad was determined by analysing multiple, 
homogenised samples of each component via chemiluminescence. We did not measure 
the polyphenol content of the red wine but a phenolic profile is provided by Sagratini et 
al. (2012). We calculated and provided similar total polyphenol content in the high and 
low NO3
- salads based on previous data (Ashworth et al., 2015). The NIT-RW and NIT-
A conditions were matched by total alcohol ingested and this was achieved by diluting 
the vodka prior to administration to 12.5 % ABV. In addition, participants consumed a 
salad low in NO3
- (55 g cucumber, 68 g green beans and 200 g cherry tomatoes; 0.69 
mmol NO3
-) alongside the ingestion of a control drink (CON; 175 mL deionised water). 
Participants completed each of the four conditions in a random order (using a computer 
generated sequence), and consumed the allocated meal and drink within 25 min on each 
occasion. During each condition, saliva, blood and urine samples were collected and BP 
was recorded prior to and over a 5 h period following consumption of each meal. All  
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tests were performed at the same time of day, usually 9 am (± 1 h), to minimise diurnal 
variation on the physiological variables under investigation and each visit to the 
laboratory was separated by a minimum of 48 h. The researcher performing the 
physiological measurements was not aware of the meal and beverage that had been 
consumed by the participants on each visit or the randomisation sequence.  
 
Experimental Protocol 
During each visit to the laboratory, an automated sphygmomanometer (Dinamap Pro; 
GE medical Systems, Tampa, FL, USA) was used to measure BP of the brachial artery, 
prior to meal consumption and at 1, 2, 3, 4 and 5 h post consumption of each meal. 
Following 10 min of seated rest in a quiet room, five BP and heart rate (HR) 
measurements were recorded and the mean of the final four measurements was used for 
data analysis.  
Blood samples were obtained prior to ingestion of each meal and at 30 min, 1, 2, 3, 4 
and 5 h following meal consumption. All blood samples (~ 6 mL) were drawn from a 
cannula (Insyte-WTM, Becton-Dickinson, Madrid, Spain) inserted into the antecubital 
vein and collected in lithium-heparin tubes (Vacutainer, Becton-Dickinson, NJ, USA). 
Blood samples were centrifuged for 10 min at 3000 g and 4 ºC within 2 min of 
collection and the plasma was subsequently extracted. Saliva samples (~ 1 mL) were 
collected by expectoration, without stimulation, at baseline and at 1, 2, 3, 4 and 5 h post 
consumption of each meal. Midstream urine samples were also collected and then 
aliquoted into 3 x 1.5 mL Eppendorf tubes prior to and at 3 and 5 h post consumption of 
each meal.  
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Plasma, saliva and urine samples were frozen at -80 ºC for later determination of [NO3
-] 
and [NO2
-] using a modified chemiluminescence technique (Wylie et al., 2013a). 
Following thawing and prior to analysis, plasma, saliva and urine samples were 
centrifuged for 10 min at 18 600 g. The supernatants were removed and diluted using 
deionized water by a factor of 100 (for salivary [NO3
-] and [NO2
-] and urinary [NO2
-]) 
and 1000 (for urinary [NO3
-]). Plasma samples were deproteinised using a cold ethanol 
precipitation technique: 1000 µL of ethanol (at 0 ºC) was added to 500 µL of plasma 
and vortexed for 30 s before being left to stand on ice for 30 min. Samples were 
centrifuged at 18 600 g for 5 minutes and the supernatant was removed and used for 
analysis of [NO3
-] and [NO2
-].  
Throughout each 5-h laboratory visit, water consumption was standardised and 
participants remained seated between measurements to avoid influencing the 
physiological parameters or NO biomarkers under investigation (Liddle et al., 2018). 
All measurements (other than urine samples, which were provided in a private cubicle 
in close proximity to the laboratory) were collected in a seating position. The same 
protocol was repeated during each visit to the laboratory. 
  
Statistical Methods  
Differences in BP, HR and salivary, plasma, and urinary [NO3
-] and [NO2
-] were 
assessed using a 2-way (condition x time) repeated-measures ANOVA. Significant main 
effects and interaction effects were further explored using Fisher’s LSD. Relationships 
between variables were assessed via Pearson’s product-moment correlation coefficient. 
Plasma [NO3
-] and [NO2
-] incremental area under the curve (iAUC) from baseline until  
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5 h (0 – 5 h) was calculated for NIT-RW, NIT-A, NIT-CON and CON using the 
trapezium model (GraphPad Prism, GraphPad, San Diego, CA). Differences in iAUC 
between conditions were assessed using a 1-way ANOVA with significant main effects 
further explored using Fisher’s LSD. Statistical analyses were performed using SPSS 
version 23.0 (Chicago, IL, USA). Data are presented as mean ± SD, unless otherwise 
stated. Statistical significance was accepted at P < 0.05. 
 
Results 
All participants reported that they adhered to the dietary and exercise requirements and 
restrictions of the study during the 24-h period prior to each laboratory testing session. 
The ingestion of the high and low NO3
- meals and the beverages were well tolerated 
with no negative side effects. 
The salivary, plasma, and urinary [NO3
-] and [NO2
-] prior to and post ingestion of all 
meals and beverages are presented in Fig. 1.  
 
Salivary [NO3-] and [NO2-]  
There were significant main effects for time and condition and interaction effects for 
salivary [NO3
-] and [NO2
-] (P < 0.05). The elevations in salivary [NO3
-] and [NO2
-] in 
NIT-RW, NIT-A and NIT-CON were higher than CON and pre-supplementation 
baseline from 1 - 5 h post ingestion (P < 0.05). The peak rise in salivary [NO2
-] 
occurred at 2 h in NIT-A (0.75 ± 0.38 mM) and NIT-CON (1.00 ± 0.66 mM) and at 3 h 
in NIT-RW (1.18 ± 1.07 mM). The increase in salivary [NO2
-] was significantly higher  
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in NIT-CON compared to NIT-A at 2-4 h after meal consumption (P < 0.05). The peak 
increase in salivary [NO2
-] relative to the peak increase in salivary [NO3
-] (i.e. the 
Δ[NO2-]/Δ[NO3-]) ratio) was lower for NIT-A compared to NIT-CON (P < 0.05). 
 
Plasma [NO3-] and [NO2-]  
There were significant main effects for time and condition and interaction effects for 
plasma [NO3
-] and [NO2
-] (P < 0.05). Plasma [NO3
-] was significantly elevated 30 min 
after consumption of NIT-RW, NIT-A and NIT-CON when compared with CON and 
pre-supplementation baseline and remained elevated until 5 h post consumption (P < 
0.05). The peak rise in plasma [NO3
-] above baseline occurred at 2 h in NIT-RW (226 ± 
71 µM) and NIT-CON (220 ± 80 µM) and at 3 h in NIT-A (198 ± 38 µM). There were 
no differences in plasma [NO3
-] at any time point between the three NO3
--rich 
conditions (P > 0.05). Plasma [NO3
-] iAUC 0 - 5 h was significantly greater in NIT-RW 
(49.1 ± 11.8 mM•min), NIT-A (43.3 ± 11.2 mM•min) and NIT-CON (51.2 ± 21.3 
mM•min) compared to CON (2.5 ± 1.8 mM•min; all P < 0.05); however, there were no 
significant differences between the three NO3
--rich conditions (P > 0.05).  
Plasma [NO2
-] was significantly increased above baseline in all NO3
--rich conditions 
from 30 min until 5 h after ingestion of each meal and beverage (P < 0.05). The peak 
rise in plasma [NO2
-] above baseline was similar in all NO3
--rich conditions and 
occurred at 1 h in NIT-RW (292 ± 210 nM) and at 2 h in NIT-A (318 ± 186 nM) and 
NIT-CON (367 ± 179 nM). Plasma [NO2
-] was higher in NIT-CON and NIT-A when 
compared with CON at 30 min post ingestion (P < 0.05). In addition, plasma [NO2
-] 
was significantly increased in NIT-RW, NIT-A and NIT-CON compared with CON,  
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from 1-5 h post ingestion (P < 0.05). At 4 h, plasma [NO2
-] was higher in NIT-CON 
(294 ± 168 nM) when compared with NIT-A (205 ± 113 nM; P < 0.05). Plasma [NO2
-] 
iAUC 0-5 h was significantly greater in NIT-RW (47.5 ± 25.0 µM•min), NIT-A (52.5 ± 
40.3 µM•min) and NIT-CON (56.9 ± 43.9 µM•min) compared to CON (3.6 ± 3.3 
µM•min; all P < 0.05); however, there were no differences between the three NO3--rich 
conditions (P > 0.05). There were no main or interaction effects on Δ[NO2-]/Δ[NO3-] 
ratio between the three high NO3
- conditions (P > 0.05). 
 
Urinary [NO3-] and [NO2-]  
There were significant main effects for time and condition for both urinary [NO3
-] and 
[NO2
-] and a significant interaction effect for urinary [NO3
-] only (P < 0.05). Urinary 
[NO3
-] and [NO2
-] were elevated to a similar extent above baseline and CON at 3 and 5 
h after consumption of NIT-RW, NIT-A and NIT-CON (P < 0.05), with peak increases 
occurring  3 h post ingestion of each condition (See Fig. 1.).  
 
Blood Pressure and Heart Rate  
The BP responses to ingestion of all meals are displayed in Fig. 2. There was a 
significant main effect for time (P < 0.05) and condition (P < 0.05) for SBP. SBP was 
reduced 2 h after consumption of NIT-CON (-2 mmHg; P = 0.054) and NIT-A (-3 
mmHg; P < 0.05) when compared with baseline. At the same time point, SBP was 
lower in NIT-RW (111 ± 7 mmHg; P < 0.05), NIT-A (113 ± 5 mmHg; P = 0.056) and 
NIT-CON (112 ± 4 mmHg; P < 0.05) compared with CON (116 ± 6 mmHg). At 3 h, 
SBP was lower in NIT-RW by 4 mmHg compared with baseline (116 ± 7 mmHg;  
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P < 0.05). At 5 h, SBP was also significantly lower in NIT-RW (115 ± 8 mmHg; P < 
0.05) and NIT-CON (115 ± 5 mmHg; P < 0.05) compared to CON (119 ± 7 mmHg). 
There was a significant main effect for time for DBP (P < 0.05). Follow up analyses 
revealed that DBP was significantly reduced following consumption of NIT-RW (1 h: -
3 mmHg; 2 h: -4 mmHg) and NIT-A (1 and 2 h: -4 mmHg; all P < 0.05) compared with 
pre-supplementation baseline. DBP was lower after ingestion of NIT-RW (1 h: 59 ± 5, 2 
h: 58 ± 4 mmHg) and NIT-A (1 h: 59 ± 4, 2 h: 60 ± 4 mmHg) compared with CON (1 h: 
62 ± 5, 2 h: 61 ± 6 mmHg; all P < 0.05). DBP was also lower in NIT-RW at 1 and 3 h 
(3 h: 60 ± 7 mmHg) post ingestion compared with NIT-CON (1 h: 62 ± 5, 3 h: 64 ± 6 
mmHg; P < 0.05). 
There was a significant main effect for time for MAP. Follow up analyses revealed that 
MAP was lower 1 h after NIT-A (77 ± 4 mmHg) compared with CON (80 ± 4 mmHg) 
and NIT-CON (80 ± 5 mmHg; all P < 0.05). In addition, MAP was reduced at 2 h post 
ingestion of NIT-RW (76 ± 4 mmHg) compared with baseline (80 ± 6 mmHg) and CON 
(80 ± 6 mmHg; P < 0.05). At the same time point, MAP was also significantly lower 
after NIT-A (77 ± 3 mmHg) compared with CON (80 ± 6 mmHg; P < 0.05). At 3 h, 
MAP was reduced after NIT-RW (77 ± 6 mmHg) compared with CON (81 ± 7 mmHg) 
and NIT-CON (80 ± 6 mmHg; all P < 0.05). 
There was a significant main effect for time and condition and an interaction effect for 
HR (all P < 0.05). HR decreased from baseline (61 ± 10 b.min-1) to 4 h (54 ± 7 b.min-1) 
and 5 h (55 ± 8 b.min-1) post ingestion in CON (P < 0.05). HR was greater in NIT-RW 
(1 h: 69 ± 13 b.min-1) and NIT-A (1 h: 66 ± 13, 2 h: 68 ± 12 b.min-1) compared with pre-
supplementation baseline (NIT-RW, 62 ± 12; NIT-A, 62 ± 12 b.min-1; P < 0.05). HR  
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was higher in NIT-RW and NIT-A than CON at 1-3 h post ingestion (P < 0.05). In 
addition, HR was higher in NIT-RW compared with NIT-CON at 1-3 h post ingestion 
and higher than CON at 4 h post consumption (P < 0.05). 
 
Discussion 
This study is the first to investigate the pharmacodynamics and pharmacokinetics of 
salivary, plasma and urinary [NO3
-] and [NO2
-] and systemic BP to the ingestion of a 
NO3
--rich meal consumed alongside low and high polyphenolic alcoholic beverages in 
humans. We investigated the influence of an acute dose of dietary NO3
- (~ 6.05 mmol of 
NO3
-), ingested in the form of a rocket and spinach salad, in combination with either 
175 mL of red wine (NIT-RW), vodka and lemonade (NIT-A) or water (NIT-CON) on 
plasma, salivary and urinary [NO3
-] and [NO2
-] and on resting BP over a 5 h period. The 
key finding was that NIT-RW and NIT-A were effective in reducing BP over a 5 h 
period compared with baseline, CON and, at some time points, NIT-CON. Although the 
magnitude of SBP reduction was consistently more after consuming NIT-RW compared 
with NIT-A, there were no statistically significant differences between these conditions. 
This suggests that the alcohol content of the beverages may have modulated the changes 
in BP following ingestion of a high NO3
- meal.  
 
Salivary [NO3-] and [NO2-]  
The three NO3
--rich leafy salads in combination with red wine, vodka and lemonade, 
and water beverages elevated salivary [NO3
-] and [NO2
-] over a 5 h period compared 
with baseline and the low NO3
- salad condition (CON). The pharmacokinetic profile and  
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peak rise in salivary [NO3
-], which occurred at 1 h following meal consumption, was 
similar in the three NO3
--rich conditions. This may be due to the same, prolonged 
exposure time of the NO3
--rich foods to the oral cavity and subsequent uptake into the 
systemic circulation and enterosalivary system. 
It is well established that there is an association between the ingestion of dietary NO3
- 
and an increase in salivary [NO2
-] (Kapil et al., 2015; Pannala et al., 2003; 
Spiegelhalder, Eisenbrand and Preussman, 1976). In the present study, salivary [NO2
-] 
was increased across the 5 h period, with maximum elevations occurring between 2 h 
(NIT-A; NIT-CON) and 3 h (NIT-RW) following meal ingestion. Interestingly, there 
was a reduced conversion of salivary NO3
- to NO2
- in the NIT-A (3 h: 22 %, 4 h: 25 %) 
condition compared with NIT-CON (3 h: 28 %, 4 h: 34 %). Previous research has 
shown that rinsing the mouth with a solution of ethanol similar to that ingested in the 
present study, can alter the bacterial composition of the oral microflora (Muto et al., 
2000). McDonagh et al. (2015) reported that the rise in salivary [NO2
-] was blunted after 
rinsing with a weak mouthwash prior to beetroot juice ingestion and speculated that the 
component adversely impacting the conversion of NO3
- to NO2
- in the mouth might 
have been alcohol. 
In the present study, the rise in salivary [NO2
-] was attenuated in NIT-A compared with 
NIT-RW, despite the beverages having the same alcohol content and the increase in 
salivary [NO3
-] being similar between the two conditions. It may be speculated that the 
high polyphenol content in NIT-RW compared with NIT-A has a protective effect on 
the oral microflora upon exposure to alcohol or that it counteracts the negative effect of 
alcohol on NO3
- to NO2
- conversion in the oral cavity. Salivary [NO2
-] has been reported 
to be highly variable between and within individuals and, in addition to the number and  
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activity of bacterial nitrate reductases, appears to depend upon a number of factors, 
including salivary flow rate and mouth pH (Djekoun-Bensoltane et al., 2007; James et 
al., 2015). It is feasible that changes in these variables impacted upon the salivary [NO2
-
] measured in the present study. 
 
Plasma [NO3-] and [NO2-]  
To our knowledge, this study is the first to analyse NO3
- and NO2
- in plasma after 
consumption of a high NO3
- meal alongside an assortment of possible accompanying 
beverages. NIT-RW, NIT-A and NIT-CON all increased plasma [NO3
-] and [NO2
-] 
above baseline values over the 5 h period. The absolute peak plasma [NO3
-] was similar 
across all conditions, with peaks occurring at 2 h post ingestion in NIT-RW and NIT-
CON and at 3 h post ingestion in NIT-A.   
Similar increases in plasma [NO3
-] have been reported after consumption of high NO3
- 
foods (lettuce, rocket and spinach) without co-ingestion of alcohol (Jonvik et al., 2016; 
Pannala et al., 2003) and the overall pharmacokinetic response to NIT-RW, NIT-A and 
NIT-CON was similar to that reported previously after ingestion of beetroot juice 
(Webb et al., 2008; Wylie et al., 2013). It appears therefore that the ingestion of alcohol, 
either with or without polyphenols, alongside a NO3
--rich meal, does not appreciably 
influence either the initial increase in plasma [NO3
-] or the enterosalivary uptake of 
NO3
- and the elevation of salivary [NO3
-]. NIT-A, however, does result in a slightly 
delayed achievement of time to peak plasma [NO3
-] compared with NIT-RW and NIT-
CON (See Fig. 1). 
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Plasma [NO2
-] increased significantly after NIT-RW, NIT-A and NIT-CON compared 
with pre-supplementation baseline. Interestingly, the peak values (190-270 % above 
baseline) measured in this study were higher than those typically reported (~ 50-140 %) 
after ingestion of a similar dose of NO3
- (in the form of beetroot juice) without co-
ingestion of alcohol (Lansley et al., 2011; Vanhatalo et al., 2010). Although some 
studies have reported similar increases in plasma [NO2
-] (McMahon et al., 2017), the 
differences between some studies may be explained by the different routes of NO3
- 
administration, different methods of plasma sample preparation prior to analysis, the 
presence and activity of NO3
- reducing bacteria in the oral cavity and the exposure time 
of the NO3
- source to these bacteria (Govoni et al., 2008; McDonagh et al., 2018; Webb 
et al., 2008). 
Although there were no significant differences in the absolute rise in plasma [NO2
-], the 
iAUC for plasma [NO2
-] or the Δ[NO2-]/Δ[NO3-] ratio between the high NO3- 
conditions, the peak values tended to be lower in NIT-RW and NIT-A compared with 
NIT-CON. It may be speculated that the two alcoholic beverages promoted formation of 
other nitrogen oxides in the stomach (Gago et al., 2007, 2008; Rocha et al., 2015). The 
rise in plasma [NO2
-] was blunted in the NIT-RW condition across a number of time 
points, possibly due to the phenolic radicals in the red wine acting as gastric reducing 
agents and stimulating the formation of NO from the swallowed salivary NO2
- in the 
stomach (Gago et al., 2007; Peri et al., 2005). Similarly, plasma [NO2
-] was lower in 
NIT-A compared to NIT-CON and this was significant at 4 h post ingestion. The 
relatively lower plasma [NO2
-] in NIT-A and NIT-RW compared to NIT-CON may be 
explained by the generation of ethyl NO2
- as well as NO2
-, after the consumption of an 
alcoholic beverage with a high NO3
- meal (Gago et al., 2008; Rocha et al., 2015).  
 Chapter 7: A randomised controlled trial exploring the effects of different beverages 
consumed alongside a nitrate-rich meal on systemic blood pressure 
180 
 
 
Unfortunately, we did not measure the production of NO markers in the stomach and 
therefore cannot confirm the mechanistic basis for the observed changes. It is important 
to note here that participants consumed the high and low NO3
- meals at the same time as 
the allocated beverage in order to reflect the ingestion of a typical Mediterranean-style. 
We acknowledge, however, that this method may have reduced the likelihood of alcohol 
and/or the additional polyphenols from the red wine interacting with NO2
- in the 
stomach and forming NO. 
Overall, the kinetic response of plasma [NO2
-] to the NO3
--rich meals in combination 
with the three beverages was faster than that typically reported after ingestion of a 
vegetable juice in isolation (McDonagh et al., 2018). These findings may be due to the 
increased contact time of the NO3
- source to the oral bacteria through mastication of the 
foods over a sustained period. 
 
Urinary [NO3-] and [NO2-]  
Our results suggest that the additional polyphenol and/or alcohol content of the 
beverages had limited influence on urinary [NO3
-] and [NO2
-] in comparison to NIT-
CON (present study) and studies that have investigated both acute and chronic NO3
- 
supplementation in the absence of alcohol using either salts (Bartholomew and Hill, 
1984; Bescós et al., 2012) or food stuffs (Hobbs et al., 2012; Kapil et al., 2015; Oldreive 
et al., 2001; Radomski, Palmiri & Hearn, 1978).  
 
Blood Pressure and Heart Rate  
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It has been suggested that a diet high in NO3
- may represent a natural prophylactic for 
reducing the risk of hypertension (Gilchrist, Winyard and Benjamin, 2010; Joshipura et 
al., 2001 Webb et al., 2008). Consistent with our hypothesis and previous literature, the 
three NO3
--rich conditions reduced BP compared with pre-supplementation baseline and 
CON. SBP was lower in NIT-RW (2 h: -5 mmHg; 5 h: -4 mmHg), NIT-A (2 h: -3 
mmHg) and NIT-CON (2 and 5 h: -4 mmHg) compared with CON, with the largest 
reductions found in the NIT-RW condition. Similarly, NIT-RW consistently reduced 
DBP (by 2-4 mmHg) across a number of time points compared to NIT-CON, pre-
supplementation baseline and CON. NIT-A also decreased DBP compared with pre-
supplementation baseline and CON (by ~ 1-4 mmHg). 
A novel finding in the present study was that the consumption of NO3
- with an alcoholic 
beverage (NIT-RW and NIT-A) resulted in larger reductions in BP compared to NIT-
CON, despite the tendency for plasma [NO2
-] to be blunted in the former conditions 
compared to the latter. The more pronounced reduction in MAP in NIT-A compared to 
NIT-CON may be due to the production of another NO donor, ethyl NO2
-, from the mix 
of ethanol and NO2
- in the stomach (Rocha et al., 2015). The increased presence of 
dietary polyphenols consumed in NIT-RW can also contribute to reductions in BP 
through a greater reduction of some NO storage pools, such as NO2
- and ethyl NO2
-, but 
the results of the present study suggest that this is not likely to have occurred (Rocha et 
al., 2009, 2015). While plasma [NO2
-] represents a good biomarker of increased NO 
bioavailability, dietary NO3
- ingestion also increases the production of other reactive 
nitrogen intermediates including S-nitrosothiols (RSNO). Indeed, it has been reported in 
rats that the antihypertensive effect of oral NO2
- administration is closely associated 
with plasma [RSNO] and can be dissociated from plasma [NO2
-] (Pinheiro et al., 2016).  
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A limitation of the present study is that we did not measure plasma [RSNO] or exhaled 
NO as an indication of stomach NO production. Further examination of the effects of 
NO3
-, alcohol and their co-ingestion on changes in BP relative to changes in plasma 
[NO2
-] and other reactive nitrogen intermediates may be an important avenue for future 
work. 
In general, NIT-RW and NIT-A were the most effective combinations for inducing 
reductions in BP, with the former eliciting slightly greater decreases in systemic BP 
across the 5 h time frame compared to the other conditions. It may therefore be 
suggested that alcohol contributed to the alterations in BP we observed. We did not 
include control (low NO3
- meal) alcohol (vodka or red wine) or polyphenol (which 
could have been achieved through administration of alcohol-free red wine) conditions 
and so cannot confirm the isolated effects of red wine, ethanol or polyphenols on BP in 
this study. Although the changes in BP might appear to be relatively small, it is possible 
that such changes may be meaningful, if maintained, in terms of reducing stress on the 
endothelium. For example, a reduction of just 5 mmHg in SBP has been suggested to 
decrease the risk of death by cardiovascular related causes, such as a stroke and heart 
disease by 14 % and 9 %, respectively (Stamler, 1991). Even a sustained 2 mmHg 
reduction in SBP could result in a 10 % reduction in stroke mortality and a 7 % 
reduction in cardiovascular disease mortality (Lewington et al., 2002). Future work 
might usefully characterise longer-term BP responses to NO3
-, ethanol and polyphenols 
separately, and together, using an ambulatory BP monitor. 
The NO3
--rich dietary conditions employed in the present study resulted in reduced BP 
despite the participants being young and ostensibly normotensive. It has been reported 
that BP reduction is negatively correlated with baseline BP (Kapil et al., 2010) and it  
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may therefore be expected that hypertensive, or even pre-hypertensive, individuals may 
gain greater benefits from the ingestion of dietary NO3
- alone or in combination with 
moderate consumption of high and low polyphenolic alcoholic beverages, than their 
normotensive counterparts. It is important to emphasise that, following an initial 
vasodilatory response, there may be a subsequent rebound in BP following acute 
consumption of alcohol in isolation, at least at higher doses than that employed in this 
study, and that chronic or heavy alcohol consumption can predispose to the 
development of hypertension (Barden et al., 2013; Beilen, Puddey and Burke, 1996). 
We therefore do not advocate increasing alcohol consumption but instead note that the 
occasional glass of wine, as practiced in the ‘Mediterranean diet’, could be beneficial, or 
at least not obviously harmful, in some circumstances (Giacosa et al., 2016; Shen et al., 
2015). 
NO3
- supplementation has not typically been reported to alter resting HR (Bailey et al., 
2009; Ferguson et al., 2013, 2013a). However, in the current study, HR was increased in 
the high NO3
- conditions as systemic BP decreased. The most notable changes in HR 
were those present in the NIT-RW and NIT-A conditions compared with CON at 2 h 
post meal ingestion. These elevations in HR may be a means of maintaining cardiac 
output in the face of decreased MAP. 
 
Conclusion 
In summary, consumption of a NO3
--rich meal in combination with red wine (NIT-RW), 
vodka and lemonade (NIT-A) and water (NIT-CON) elevated salivary, plasma and 
urinary [NO3
-] and [NO2
-] both above baseline and compared to a low NO3
- condition  
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(CON). Although all three high NO3
- meals and the accompanying beverages reduced 
systemic BP, NIT-A and NIT-RW were the most effective means of reducing BP, with 
a tendency for greater and more frequent reductions occurring after NIT-RW 
consumption. The ingestion of a green leafy salad may be a simple means of acutely 
lowering BP in young normotensive individuals and this effect is not compromised by 
the ingestion of an accompanying moderate alcoholic beverage. 
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FIGURE LEGENDS 
Figure 1. Salivary nitrate (A), salivary nitrite (B), plasma nitrate (C), plasma nitrite (D), 
urinary nitrate (E) and urinary nitrite (F) following consumption of a low-nitrate meal 
with a water control (CON;    ), a nitrate-rich meal (6.05 mmol) with red wine (NIT-
RW;    ), vodka and lemonade (NIT-A;   ) and a water control (NIT-CON;    ). Data are 
presented as group mean ± SE. aSignificantly different from pre-supplementation; 
*significantly different from CON; $significantly different from NIT-CON (all P < 
0.05). 
 
Figure 2. Change (Δ) relative to pre-supplementation baseline in systolic blood pressure 
(SBP; A), diastolic blood pressure (DBP; B) and mean arterial pressure (MAP; C) 
following consumption of a low-nitrate meal with a water control (CON;   ), a nitrate-
rich meal (6.05 mmol) with red wine (NIT-RW;    ), vodka and lemonade (NIT-A;   ) 
and a water control (NIT-CON;  ). Data are presented as group mean ± SE. 
aSignificantly different from pre-supplementation; *significantly different from CON; 
$significantly different from NIT-CON (all P < 0.05). 
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Table 1. Baseline characteristics 
n     12  
Age, years    25 ± 5 
Male, n    12/12 
Body mass, kg   79 ± 11 
Height, m    1.78 ± 0.06 
Systolic blood pressure, mmHg 116 ± 5 
Diastolic blood pressure, mmHg 63 ± 6 
Mean arterial pressure, mmHg 81 ± 5 
    
Values are mean ± SD. 
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Figure 1. 
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Chapter 8: General Discussion 
Traditionally, NO was considered to be a notorious air pollutant but has since been 
identified as a major physiological signalling molecule involved in the regulation of a 
number of biological processes, including BP (Rees, Palmer & Moncada, 1989; Webb 
et al., 2008), blood flow (Shen et al., 1994), metabolic control (Larsen et al., 2014) and 
skeletal muscle contractility (Hart & Dulhunty, 2000; Viner et al., 2000), to name a few. 
NO is known to be synthesised endogenously by the NOS family which promotes the 
oxidation of L-arginine (Stamler & Meissener, 2001) and by the NO3
--NO2
--NO route 
(Benjamin et al., 1994). A current and popular new avenue of research involves the use 
of dietary NO3
- supplementation to increase NO bioavailability and to promote vascular 
health and exercise tolerance. However, recent reports indicate that many factors, some 
of which are related to daily lifestyle choices, can influence the physiological effects of 
dietary NO3
- ingestion.  
 
Research Questions Addressed  
The primary aims of this thesis were to establish the role of dietary NO3
- consumption 
in elevating markers of NO and improving systemic blood pressure in the presence of 
certain factors that might influence its effectiveness. Specifically, the questions posed 
included: 
1) What are the effects of the prolonged use of different strength antibacterial 
mouthwashes, in combination with NO3
- supplementation, on NO metabolites 
and resting and exercise BP? 
2) What are the effects of short-term NO3- ingestion on exercise tolerance 
following voluntary blood donation? 
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3) What are the pharmacokinetic responses of salivary, plasma and urinary [NO3-] 
and [NO2
-] and BP following consumption of different NO3
- food forms? 
4) What are the pharmacokinetic responses of salivary, plasma and urinary [NO3-] 
and [NO2
-] and BP following consumption of a NO3
--rich meal with an 
accompanying polyphenol-rich or -low alcoholic beverage? 
 
Summary of main findings 
NO3
- and mouthwash 
Chapter 4 investigated the influence of different strength mouthwashes on NO 
bioavailability and BP following chronic NO3
- supplementation. Specifically, we 
explored how strong and weak antibacterial mouthwashes and a water control in 
combination with regular concentrated beetroot juice ingestion (6.2 mmol of NO3
-, 
twice per day) over a 6 day period, impacted salivary and plasma [NO3
-] and [NO2
-] and 
resting and exercise BP. Despite a similar increase in plasma [NO3
-] across the 
conditions, there was a decrease in the formation of salivary NO2
- from NO3
- in the oral 
cavity after rinsing with the strong mouthwash compared with the weak and control 
mouthwashes. In addition, a stepwise attenuation in plasma [NO2
-] was noted with 
increasing strength of mouthwash used. Resting BP was not altered by any condition, 
possibly due to the low baseline BP in this cohort. However, SBP and MAP during low-
intensity treadmill exercise were higher after using the strong mouthwash compared to 
baseline and the water control. Together, these results highlight the role of the oral 
microflora in elevating NO bioavailability and regulating BP, particularly during low-
intensity exercise. These data provide important practical information for 
supplementation regimens. Specifically, limiting mouthwash use (unless it is  
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recommended by a health professional to enhance oral hygiene) during periods of NO3
- 
supplementation may help to maximise the increase in key NO markers and 
improvements in vascular health. 
 
NO3
- and blood donation 
Approximately 3 % of the population aged 17-70 years donate blood each year in 
England. Whilst this does not sound like a large percentage, it equates to almost 2 
million individuals (NHS Blood & Transplant, 2015). Chapter 5 explored the 
physiological response to exercise after short term supplementation with concentrated 
NO3
--rich beetroot juice, following whole blood donation. Results showed that despite a 
similar reduction in haemoglobin concentration ([Hb]) between the groups, NO3
--rich 
beetroot juice caused a 4 % reduction in V̇O2 during moderate-intensity exercise, and 
this improved efficiency, better preserved muscle oxygenation and attenuated the 
decrement in exercise tolerance to ramp incremental exercise, compared with the 
placebo condition.  
NO3
- supplementation may help to improve functional capacity and reduce fatigue in a 
typical person during recovery from a standard blood bank donation. These results have 
implications for offsetting the decline in exercise capacity in circumstances where [Hb] 
is lowered, such as in anaemia, following surgery or blood loss or in recreationally 
active members of the public wishing to donate blood without compromising exercise 
training or performance.  
 
NO3
- food forms 
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The remaining two experimental chapters of this thesis focused on the 
pharmacodynamic and pharmacokinetic response to acute NO3
- ingestion in different 
food forms and different meal combinations. 
Chapter 6 characterised the pharmacokinetic response to an equimolar (5.76 mmol of 
NO3
- for concentrated beetroot juice, beetroot flapjack and non-concentrated beetroot 
juice; beetroot crystals contained a lower dose of 1.04 mmol of NO3
- as per the 
manufacturer’s guidelines) dose of different NO3- vehicles. The solid, flapjack 
supplement resulted in a faster time (2 h) to reach peak plasma [NO2
-] versus the 
concentrated beetroot juice shot and non-concentrated beverage (3 h). Interestingly, 
peak plasma [NO2
-] occurred at 15 min in the beetroot crystal condition, which is likely 
due to the small dose of NO2
- present in this supplement. Although all NO3
-supplements 
used in this thesis elevated markers of NO bioavailability, the most effective food forms 
for increasing NO storage pools were the concentrated beetroot juice shot and the 
beetroot flapjack. In addition, the small, concentrated shot of beet juice, BR, was the 
most successful and consistent means of reducing SBP and MAP. However, it is 
noteworthy that the flapjack condition, BF, also reduced DBP. 
These results provide important practical information for optimising supplementation 
regimens (with regard to type and timing of ingestion) for maximal cardiovascular and 
potential performance benefits in a young, healthy population. Specifically, consuming 
a small, concentrated volume of NO3
--rich beetroot juice (BR) may be recommended as 
a way of elevating NO biomarkers and inducing reductions in systemic BP in 
normotensive individuals. 
 
NO3
- and alcohol 
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Chapter 7 established for the first time the [NO3
-] and [NO2
-] pharmacokinetics and BP 
response to a green leafy salad (containing 6.05 mmol of NO3
-) consumed alongside an 
alcoholic beverage rich in polyphenols (red wine) or low in polyphenols (vodka and 
lemonade) and a water control. BP and salivary, plasma and urinary [NO3
-] and [NO2
-] 
were measured prior to supplementation and at regular intervals over the 5 h period post 
consumption of each meal and beverage combination. Results revealed that all three 
high NO3
- conditions elevated salivary, plasma and urinary [NO3
-] and [NO2
-] above 
baseline and compared to a low NO3
- condition. In addition, systemic BP was reduced 
after consumption of all NO3
--rich meals and accompanying beverages. Although NIT-
A and NIT-RW were the most effective means of lowering BP, there was a tendency for 
greater and more frequent reductions to occur after NIT-RW ingestion. These findings 
show that, in moderation, ingestion of an alcoholic beverage does not compromise the 
improvements in vascular health indices, such as BP, in a young, healthy cohort after a 
meal rich in NO3
-. 
 
Evidence of increased nitric oxide bioavailability 
In all four Experimental Chapters, dietary NO3
-, despite being ingested alongside a 
number of factors that might impact its effectiveness, such as mouthwash (Govoni et al., 
2008), blood donation, the use of different food forms (Jonvik et al., 2016) and alcohol 
ingestion (Rocha et al., 2015), successfully elevated NO bioavailability as shown by 
increases in salivary, plasma and urinary [NO3
-] and [NO2
-]. These results are consistent 
with previous studies reporting elevations in markers of NO in a number of different 
bodily fluids following dietary NO3
- ingestion only (Kapil et al., 2010; Pannala et al., 
2003; Spiegelhalder et al., 1976; Wylie et al., 2013).  
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In Chapter 4, 6 days of concentrated beetroot juice supplementation elevated plasma 
[NO2
-] by ~ 500 %. In Chapter 5, ingestion of 7 concentrated beetroot juice shots over 
the 48 h period post blood donation increased plasma [NO2
-] by ~ 800 %. These values 
are higher than previously reported (50-150 %; Bailey et al., 2009; 2010; Bescós et al., 
2010; Lansley et al., 2011; Larsen et al., 2007; 2010; Vanhatalo et al., 2010), which is 
likely due to the higher dose of NO3
- (Chapter 4: 12.4 mmol per day; Chapter 5: ~ 43 
mmol over 48 h) administered over the experimental period.  
The pharmacokinetic response to the ingestion of an equimolar dose of NO3
- (5.76 
mmol) via three different food forms and the consumption of beetroot crystals 
(containing 1.4 mmol of NO3
- as per the manufacturer’s guidelines), on separate 
occasions, was determined in Chapter 6. The results of this study demonstrated that a 
small, acute dose of NO3
- can elevate salivary, plasma and urinary markers of NO 
bioavailability. Specifically, beetroot flapjack and concentrated beetroot juice were the 
most effective means of increasing plasma [NO2
-], and thus the potential for smooth 
muscle relaxation. Indeed, beetroot flapjack and concentrated beetroot juice resulted in 
reductions in systemic BP and these findings will be discussed in more detail in a later 
section. 
Chapter 7 was the first study to reveal the salivary, plasma and urinary [NO3
-] and 
[NO2
-] pharmacokinetic response to a green leafy salad (containing 6.05 mmol of NO3
-) 
in combination with an alcoholic beverage rich or low in polyphenol content, or a water 
control. All NO3
--rich conditions increased markers of NO, with peak increases in 
plasma [NO2
-] occurring 1 h after NO3
- and red wine (NIT-RW) ingestion and 2 h post 
consumption of NO3
- and vodka and lemonade (NIT-A) and NO3
- and a water control 
(NIT-CON). BP was reduced after all high NO3
- conditions; however, NIT-A and NIT- 
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RW were the most effective means of reducing systemic BP, with a tendency for larger 
magnitudes and more common reductions after NIT-RW ingestion. 
Overall, it is reasonable to suggest that dietary NO3
- ingestion, even when consumed in 
a single, acute bolus, particularly in the form of concentrated beetroot juice, non-
concentrated beetroot juice, beetroot flapjack, beetroot crystals and a green leafy salad, 
can increase NO bioavailability, inferred from measured increases in salivary, plasma 
and urinary [NO3
-] and [NO2
-]. Although such measurements are consistently used as 
practical and sensitive markers of NO status, it must be acknowledged that elevations in 
circulating [NO3
-] and [NO2
-] are not a direct indication of increases in NO formation 
per se and the additional measurement of cGMP would have offered more insight into 
systemic [NO]. It is also important to note that swallowed salivary NO2
- interacts with 
acid in the stomach and polyphenols, ascorbic acid and thiocyanate (to name a few) 
from the diet and can subsequently lead to the production of a number of different 
nitrogen species (other than NO3
- and NO2
-) that have not been measured in this thesis. 
Future work may include determination of an array of nitrogen species following NO3
- 
ingestion. It may also be beneficial to confirm the minimum rise in, for example, plasma 
[NO2
-] required to induce favourable physiological effects in healthy and diseased 
populations after consumption of inorganic NO3
-. 
 
Therapeutic effects of nitrate supplementation 
The results from the experimental chapters in this thesis may have a number of 
therapeutic implications for both healthy and clinical populations.  
 
Blood pressure 
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The lowering of systemic BP is one of the most valuable physiological benefits of 
dietary NO3
- ingestion due to its potential prophylactic effects against hypertension. It 
has been consistently demonstrated that NO3
- consumption can elevate NO  
 
 
Figure 8.1 Negative Pearson product moment correlation between baseline MAP and 
the change in MAP following nitrate supplementation and prior mouth rinsing with 
STRONG and WEAK mouthwash or a water control (CON); this demonstrates that 
individuals with higher resting baseline BP have a greater reduction in MAP in response 
to dietary nitrate ingestion, regardless of mouthwash use. 
 
bioavailability, as shown by increases in, for example, plasma [NO2
-]. An increase in 
intravascular NO stimulates cGMP and it is the subsequent cascade of events that leads 
to smooth muscle relaxation and a reduction in BP (Archer et al., 1994; Lohmann et al., 
1997).  
The results from the current thesis support the notion that dietary NO3
- is capable of 
reducing systemic BP. Data from Chapter 6 assessed resting, seated BP in a healthy  
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cohort, and, consistent with previous studies (Jonvik et al., 2016; Kelly et al., 2013a; 
Muggeridge et al., 2014; Thompson et al., 2016; Wylie et al., 2013), demonstrated 
decreases in SBP (-5 mmHg) and MAP (-4 mmHg) following concentrated beetroot 
juice ingestion. Novel findings from this chapter also include a peak reduction in DBP 
(-4 mmHg) following a beetroot flapjack. In addition, Chapter 7 reported a reduction in 
SBP following a green leafy salad (-2 mmHg). However, more noteworthy decreases 
were found after the addition of a polyphenol-rich (-4 mmHg) or -low (-3 mmHg) 
alcoholic beverage. It has previously been suggested that a 5 mmHg decrease in SBP, as 
observed frequently in this thesis, is likely to reduce the risk of death by 7 %, and the 
risk of death by stroke and coronary heart disease by 14 % and 9 %, respectively 
(Stamler, 1991). In addition, it has been proposed that a 2 mmHg reduction in an adult’s 
SBP could save > 14 000 lives in the United Kingdom each year (Critchley & Capewell, 
2003). Turnbull (2003) also demonstrated that even a 1-2 mmHg decrease in BP is 
associated with reducing the risk of stroke and major cardiovascular events. It may 
therefore be suggested that, at present, this is the minimum clinically relevant reduction 
in BP required to improve cardiovascular health and reduce risk. However, further 
work, including long-term follow up of those ingesting dietary NO3
- regularly, is needed 
to confirm this threshold, particularly in clinical populations. Overall, the findings in 
this thesis suggest that increased dietary NO3
- ingestion, through commercially available 
supplements or increased vegetable consumption can be beneficial for vascular health 
(Van der Avoort et al., 2018). 
However, resting BP was not always reduced following NO3
- consumption, as shown in 
Chapters 4 and 5 following prolonged concentrated beetroot juice ingestion. It is likely 
that this is a consequence of a low baseline BP within the study populations (See Figure  
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8.1). Kapil et al. (2010) have suggested that there is a negative correlation between 
baseline BP and the lowering of BP in response to dietary NO3
- ingestion, and our 
results support this notion (Figure 8.1). Overall, further work is required to determine 
the effects of different forms of NO3
- supplementation, if consumed over a more 
prolonged period than explored in this thesis, on lowering systemic BP. It is important 
to note that the findings from Chapter 4 show that the use of strong, and even weak, 
mouthwash should be used with caution during periods of dietary NO3
- 
supplementation, particularly when the aim is to maximise NO bioavailability and 
reduce systemic BP. However, the maintenance of good oral health is also important 
and daily routines to ensure this is achieved should not be overlooked. 
Overall, these results show encouraging signs that dietary NO3
-, consumed as a 
concentrated beetroot drink, beetroot flapjack or salad (with or without polyphenol rich 
or low alcoholic beverages - to be consumed in moderation) could contribute to future 
public health guidelines as an innovative, practical and potentially cost effective means 
of preventing and treating high BP and the associated risk of cardiovascular disease, 
reduced quality of life and mortality. However, further work is required to determine 
more prolonged effects of dietary NO3
- ingestion, through supplementation or by 
increased vegetable consumption in the habitual diet, on cardiovascular health and risk 
of mortality. 
 
Muscle oxygenation 
In Chapter 5, indirect measures of muscle oxygenation were determined using near-
infrared spectroscopy (NIRS) during moderate-intensity and ramp incremental exercise 
prior to and post blood donation. Following 7 shots of NO3
--depleted beetroot juice over  
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the 48 h after blood donation, tissue oxygenation index (TOI) was reduced and [HHb] 
tended to be higher when compared with pre donation values. This suggests that muscle 
O2 availability was lower and more O2 extraction at the muscle was required to attain 
the required V̇O2 during the submaximal exercise bout. In the NO3--rich condition, these 
changes were ameliorated, suggesting that muscle oxygenation was better preserved 
when compared with the placebo condition. Masschelein and colleagues (2012) reported 
similar responses to submaximal exercise in hypoxia after beetroot juice ingestion. In 
addition, Kelly et al. (2014) reported that the effect of NO3
- ingestion on exercise 
efficiency and tolerance was greater in hypoxia than normoxia. The reduced arterial O2 
concentration and intracellular partial pressure of O2 that results from breathing a 
hypoxic inspirate can lead to muscle tissue hypoxia and subsequently, increase muscle 
metabolic perturbation (Linnarsson et al., 1974). An increase in local blood flow, via 
hypoxia-induced vasodilation, can help to restore O2 availability, through NO mediated 
processes (Casey et al., 2010). Therefore, supplementing the diet with NO3
- increases 
the bioavailability of NO and may help to augment this process further, over and above 
that seen in normoxia. 
Overall, it may be suggested that the high NO3
- content of the aforementioned beverages 
helped to promote a better matching of muscle O2 delivery to O2 demand when O2 
availability is limited by reduced [Hb] or breathing a hypoxic inspirate.  
 
Exercise efficiency 
In Chapter 5, the O2 cost of submaximal exercise was assessed during CWR cycle tests 
performed by a young, healthy cohort. The results demonstrated that 7 shots of 
concentrated beetroot juice (each containing 6.2 mmol of NO3
-) over the 48 h period  
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post blood donation lowered V̇O2 during baseline and moderate-intensity exercise, by 4 
%. This study was the first to assess the effects of dietary NO3
- on exercise efficiency 
after inducing a reduction in blood O2-carrying capacity. The findings, however, are 
similar to previous studies that have reported that NO3
- invoked a 4-8 % reduction in the 
O2 cost of submaximal cycling exercise when O2 availability was limited through 
breathing a hypoxic inspirate (Kelly et al., 2014; Masschelein et al., 2012; Muggeridge 
et al., 2014).  
As stated in the literature review, the suggested mechanistic bases for a lower V̇O2 
during moderate-intensity exercise include a reduction in the ATP cost of muscle force 
production (Bailey et al., 2009) which might be facilitated by enhanced Ca2+-related 
contractility (Hernández et al., 2012), and/or an improvement in mitochondrial 
efficiency (Larsen et al., 2011; Vaughan et al., 2016). More recently, however, it has 
been suggested that an improvement in mitochondrial efficiency may not be present 
when NO3
- is administered as beetroot juice (Whitfield et al., 2016). Specifically, 7 days 
of beetroot juice (26 mmol of NO3
- per day) were shown to lower V̇O2 during 
submaximal exercise in the absence of changes in the P/O ratio and expression of ANT 
and UCP-3; therefore, it is likely that the reduced V̇O2 was due to a decrease in the ATP 
cost of muscle force production. 
As well as changes in metabolic or muscle contractile efficiency, alterations in muscle 
O2 delivery or intramuscular distribution may also occur after ingestion of dietary NO3
- 
(Ferguson et al., 2013; 2013a). It is important to note that NO has been directly 
implicated in the regulation of mitochondrial O2 consumption. Specifically, both NO 
and O2 have a strong affinity for COX and compete for its binding site in the 
mitochondrial electron transport chain (Brown, 2001). Whilst it is likely that a  
 Chapter 8: General Discussion 
213 
 
 
combination of the elevation in NO bioavailability from dietary NO3
- and a reduction in 
blood O2-carrying capacity after blood donation (as seen in Chapter 5) increased the 
binding of NO to COX and modified the intramuscular distribution of O2, resulting in 
impeded O2 consumption at the mitochondrion (Brown & Cooper, 1994; Cleeter et al., 
1994) and improved oxygenation of the muscle fibres situated further away from the 
capillaries (Hagen et al., 2003; Thomas et al., 2001; Victor et al., 2009), it may have 
also triggered a signalling cascade for a resultant downregulation in some mitochondrial 
proteins, such as ANT, and enhance respiratory chain efficiency (Larsen et al., 2011).  
 
Exercise tolerance 
Chapter 5 demonstrated that dietary NO3
-, in the form of concentrated beetroot juice can 
attenuate the deleterious effects of whole blood withdrawal on incremental exercise 
tolerance (-2.7 %) compared with the NO3
--depleted condition (-5.0 %). This finding is 
consistent with that of Masschelein et al. (2012), who reported that beetroot juice (0.07 
mmol of NO3
- per kg of body mass per day, for 6 days) partly negated (+ 5 %) the 
reduction in time to exhaustion achieved during incremental exercise in hypoxia when 
compared with the placebo condition. Others have also reported that NO3
- consumption 
can enhance tolerance to CWR exercise (Kelly et al., 2014; Vanhatalo et al., 2011) and 
improve time trial performance (Muggeridge et al., 2014) under hypoxic conditions.  
In Chapter 5, blood donation also decreased V̇O2peak during incremental exercise and 
this occurred alongside an increase in muscle [HHb]. This may be suggestive of an 
increase in muscle O2 extraction in an effort to counteract the reduced muscle O2 
delivery due to a lower [Hb] post blood donation (Roach et al., 1999; Schaffartzik et al., 
1993). However, in the NO3
- condition, V̇O2peak and [HHb] were not altered.  
 Chapter 8: General Discussion 
214 
 
 
Mechanisms for improvement in exercise tolerance following dietary NO3
- ingestion 
and blood donation may include a combination of O2 sparing as well as vasodilatory-
dependent increases in blood flow and/or possible altered intramuscular O2 distribution, 
which enables better preservation of muscle oxygenation (Ferguson et al., 2013; 2013a; 
Hernández et al., 2012; Vanhatalo et al., 2014).   
These data suggest that NO3
--rich BR may have therapeutic benefits for individuals with 
reduced O2-carrying capacity, such as those with anaemia or those recovering from 
blood loss through surgery or combat. The improvements in functional capacity noted in 
Chapter 5 may also be transferable to other pathological conditions where O2 
availability may be limited, such as COPD, PAD, diabetes and heart failure with both 
reduced and preserved ejection fraction. Some research has already been undertaken 
regarding the potential benefits of dietary NO3
- ingestion on exercise capacity in such 
populations, but mixed outcomes have been reported. No effect of beetroot juice 
ingestion has been reported for the distance covered in a six minute walk test in 
individuals with diabetes (Shepherd et al., 2015) and also those with COPD (Shepherd 
et al., 2015a). However, an extended time to exhaustion has been reported during 
different forms of exercise in individuals with COPD (Berry et al., 2015; Leong et al., 
2015), PAD (Kenjale et al., 2011) and heart failure with preserved ejection fraction 
(Zamani et al., 2015; 2017). In another study, concentrated beetroot juice did not 
improve exercise tolerance in patients with heart failure with reduced ejection fraction 
(Hirai et al., 2017). More work is required to determine the effects of dietary NO3
- on 
exercise capacity in clinical populations (McDonagh et al., 2018). 
 
Translation of findings 
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In this thesis, the consumption of NO3
- in a variety of different food forms resulted in 
beneficial effects on BP, muscle oxygenation and exercise efficiency and tolerance in 
young, healthy individuals. However, the use of mouthwash prior to NO3
- ingestion 
markedly reduced elevations in NO biomarkers and the potential for BP to be lowered 
and, therefore, its use should be considered carefully if one’s aim is to derive 
therapeutic or ergogenic benefits from NO3
-. Although these findings agree with 
previous work (Bondonno et al., 2014; Kapil et al., 2013; Petersson et al., 2009), many 
other factors regarding the impact of mouthwash on the oral microbiome, NO 
bioavailability and the subsequent BP response remain unknown. Further work may 
involve determination of the species of NO3
--reducing bacteria predominantly affected 
by mouth rinsing with strong and weak antibacterial agents, and whether such rinsing 
results in a reduction in NO3
- reductase activity or total population of the bacteria 
residing in the oral cavity. It may also be beneficial to establish the duration of 
disruption of the oral microbiome following mouthwash and how the timing of NO3
- 
ingestion (prior to or post mouthwash), number of mouth rinses per day and time 
between rinsing and NO3
- ingestion impacts NO markers and cardiovascular indices. 
In Chapter 5, concentrated beetroot juice shots were effective in lowering the O2 cost of 
moderate-intensity exercise and offsetting the deleterious effects of blood donation on 
exercise tolerance. However, the NO3
- dose administered over the 48 h period following 
blood withdrawal was high and unlikely to be achieved via typical vegetable intake. 
Future work should therefore attempt to characterise the physiological response to 
exercise in combination with a high NO3
- diet, achieved through increased fruit and 
vegetable consumption, following whole blood donation and in those living with 
anaemia. A more ecologically valid approach to supplementing the diet with NO3
- may  
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enhance exercise tolerance, ability to perform ADLs and improve the quality of life of 
those living with reduced O2 carrying capacity. 
Although the findings in this thesis are important, the implications of a NO3
--rich diet 
with or without polyphenol-rich or -low alcoholic beverages, may be much greater for 
older and clinical populations than young, healthy individuals. At present, the impact of 
dietary NO3
- among older individuals and those with chronic disease are equivocal. A 
recent systematic review revealed that NO3
- intake improved the physiological response 
to exercise, however, mixed findings were noted regarding benefits for cardiovascular 
and cerebrovascular health in persons over the age of 50 years (Stanaway et al., 2017). 
Similarly, NO3
- ingestion has resulted in varied responses regarding elevations in 
plasma [NO2
-], reductions in BP and improvements in exercise efficiency and tolerance 
in those with chronic conditions (McDonagh et al., 2018).  
Elucidating the optimal NO3
- dose and long-term effects of NO3
- on parameters of 
cardiovascular health, cognitive function, tolerance to exercise and vascular risk may be 
beneficial for healthy and diseased individuals. Encouraging the consumption of NO3
- 
via concentrated beetroot juice shots or flapjacks, or by devising a dietary strategy that 
may more acceptable to the general public, such as ingesting palatable fruit- and 
vegetable- rich meals, rather than potentially costly and often unpleasant tasting 
supplements, may improve uptake and subsequently, cardiovascular health and general 
well-being. Educating members of the public about the benefits of NO3
- consumption 
and factors that might affect its effectiveness should also be undertaken. In addition, 
dissemination of key research findings, particularly from Chapters 4-7, via peer-
reviewed publications, local newspapers, social media and charities, to target audiences,  
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such as patients, the public, key stakeholders and policy makers may lead to changes in 
future cardiovascular and WHO guidelines. 
 
Limitations 
General 
Overall, the experimental chapters in this thesis provide a novel insight into some 
factors that can affect the efficacy of dietary NO3
- ingestion. However, a number of 
limitations must be acknowledged.  
Although power calculations were performed, there were relatively small sample sizes 
in each study and this may have contributed to some of the non-significant main effects 
and interaction effects noted. In contrast to a more widely used statistical approach in 
which a non-significant interaction is not typically followed by comparisons of factor 
means, an alternative method was employed where post hoc tests were performed in the 
absence of significant interaction effects. Specifically, when main effects were noted for 
time and/or condition, follow-up tests were undertaken to determine which particular 
means differed (Wei et al., 2012). This approach was particularly useful in establishing 
whether dietary NO3
- increased NO biomarkers or reduced BP when compared with 
baseline or other high or low NO3
- conditions, and at which specific time point 
following ingestion such differences occurred. 
It is also important to mention that inclusion of only young, healthy individuals in 
Chapters 4-7 may have induced selection bias regarding the efficacy of dietary NO3
- on 
BP and exercise efficiency and performance. Future work may address the impact of  
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NO3
- ingestion on cardiovascular biomarkers and exercise performance in a more 
general population, including those who are older and living with chronic disease.  
 
Nitrate dose 
In Chapters 4-7, all subjects were required to ingest a set dose of dietary NO3
-, 
regardless of the size of the person, sex, baseline BP or baseline plasma [NO2
-], all of 
which may contribute to the efficacy of exogenous NO3
- ingestion (Kapil et al. 2010; 
Wilkerson et al., 2012). Although the fixed doses of NO3
- given in each study (Chapters 
4 and 5: 12.4 mmol per day for 6 days and 48 h, respectively; Chapter 6: 5.76 mmol, 
acutely; Chapter 7: 6.05 mmol, acutely) were based on previous research that had 
demonstrated beneficial effects on NO bioavailability, BP and exercise efficiency and 
performance after an acute dose of NO3
- (~ 5.2 mmol; Vanhatalo et al., 2010; ~ 6-16.8 
mmol; Wylie et al., 2013; 2016), it may be worth exploring the dose of natural NO3
- 
sources relative to body mass, baseline characteristics and health status in the future. 
This would allow clarification on the dose of NO3
- required to invoke changes in plasma 
[NO2
-] and improvements in cardiovascular health and performance in different 
populations. 
 
Safety, tolerance and efficacy of the interventions 
The WHO guidelines (2002) stipulate an ADI of 3.7 mg of NO3
- per kg of body mass. 
This guideline was introduced with the aim of reducing incidents of harmful side effects 
(such as methaemoglobinaemia and gastric cancer) previously thought to be associated 
with the consumption of NO3
-. However, WHO (2010) have recently acknowledged that 
NO3
- ingestion may be beneficial for health. In fact, a diet rich in vegetables is often  
 Chapter 8: General Discussion 
219 
 
 
promoted (e.g. the DASH diet) due to the subsequent improvements in cardiovascular 
indices, even though it exceeds the recommended NO3
- intake threshold. In Chapters 4-
7, the NO3
- dose administered exceeded the ADI, but frequently resulted in cardio-
protective (reductions in BP) and ergogenic (improvements in exercise tolerance and 
efficiency) effects. However, no measures of NO3
- or NO2
- toxicity were undertaken and 
therefore this is an avenue for future work. Specifically, it may be worth examining the 
effects of increasing NO3
- doses and the long term effects of such doses on 
cardiovascular health and markers of oxidative and nitrosative stress in bodily fluids. 
It is important to note that the concentrated beetroot juice (Chapters 4, 5 and 6), beetroot 
flapjack, non-concentrated beetroot juice, beetroot crystals (Chapter 6) and salad 
(Chapter 7) were well tolerated, with the latter two forms being the most popular choice 
of NO3
- vehicle based on taste. The concentrated beetroot juice and non-concentrated 
beetroot juice did, however, sometimes result in the appearance of red urine and stools 
but did not cause any gastrointestinal discomfort.   
 
Measurement of NO bioavailability restricted to [NO3
-] and [NO2
-] 
The sole purpose of administering dietary NO3
- was to encourage the potential for NO 
production. NO has a short half-life in vivo (0.1 s) and therefore is very difficult to 
quantify (Kelm & Schrader, 1990). However, NO-linked metabolites, such as NO3
- and 
NO2
-, which form large storage pools in the body (Cosby et al., 2003; Silver, 2011), are 
much more stable than NO and can be detected in a range of biological fluids. As a 
result, plasma (Lauer et al., 2001), salivary and urinary [NO3
-] and [NO2
-] were deemed 
as suitable and practical for determining NO bioavailability and therefore were 
measured in this thesis. Despite this, it must be acknowledged that additional NO  
 Chapter 8: General Discussion 
220 
 
 
storage forms or indicators of its presence could have been measured, including, S-
nitrosothiols and S-nitrosohaemoglobin (Doctor & Stamler, 2011; Pinheiro et al., 2015) 
and cGMP (Archer et al., 1994; Murad et al., 2003). It may also have been beneficial to 
have measured NO in the air expelled from the stomach, particularly in Chapter 7 where 
the presence of polyphenols in red wine may have increased the conversion of NO2
- to 
NO in the stomach (Gago et al., 2007). Future research may include the assessment of a 
combination of NO storage pools after NO3
- ingestion which could help clarify their 
contribution to NO-mediated processes. 
 
Exercise testing 
In Chapters 6 and 7 the pharmacokinetic responses to different commercially available 
NO3
- vehicles and a green leafy salad alongside an array of accompanying beverages 
was determined over a 24 and 5 h period, respectively. Due to the extensive nature of 
blood, saliva and urine sampling needed for the determination of the pharmacokinetic 
responses, there was insufficient time to include exercise protocols within the study 
designs and therefore the physiological responses were limited to BP measurements. A 
future line of work may be to determine exercise tolerance and the V̇O2 response to 
moderate-intensity exercise after consumption of different NO3
- vehicles. This 
information would help to inform future supplementation strategies. 
 
Future research questions 
The current thesis contributes to the growing body of evidence which supports the role 
of NO3
- supplementation as a therapeutic and ergogenic aid, particularly when certain 
factors that may influence its effectiveness are considered carefully prior to ingestion.  
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Overall, it may be suggested that dietary NO3
- is beneficial for cardiovascular health 
when administered as a concentrated beetroot juice, flapjack (Chapter 6) or green, leafy 
salad perhaps in combination with an alcoholic beverage (in moderation; Chapter 7). It 
is also noteworthy that NO3
- supplementation may improve exercise efficiency and 
tolerance post blood donation (Chapter 5). However, the cardio-protective effects of 
NO3
- may only be present if habitual use of antibacterial mouthwash is restricted during 
periods of supplementation (Chapter 4). Whilst this thesis highlights the role of some 
factors on the effectiveness of NO3
- ingestion as a natural aid for health and 
performance, further questions have come to light and may be worthy of future 
investigation. 
 
Oral microbiome and lifestyle factors 
It is well established that the oral microflora plays a crucial role in the NO3
--NO2
--NO 
pathway. The NO3
- reducing bacteria in the mouth are capable of altering NO 
homeostasis and vascular function, as previously shown by the deleterious effects of 
antibacterial mouthwash on BP after NO3
- ingestion (Chapter 4).  
Whilst the microbial communities in the adult mouth are relatively stable, biological 
changes, such as ageing, pregnancy and the development of disease (such as diabetes; 
Chapple & Genco, 2013) can affect the balance of bacterial species within such 
communities (Marsh, Head & Devine, 2015). In addition, lifestyle choices, such as 
smoking, dietary intake, poor oral hygiene or use of antibiotics can also result in a 
dysbiotic shift and altered diversity of bacteria in the oral cavity (Kilian et al., 2016; 
Marsh, Head & Devine, 2014; Wu et al., 2016). However, the influence of many daily 
choices with or without NO3
- ingestion on the oral microflora and subsequent BP  
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response is not yet known. Future studies could be directed at exploring the 
effectiveness of NO3
- ingestion on BP and cardiovascular disease risk, as well as the 
inter-individual differences in the oral flora, when consumed alongside chronic 
mouthwash use, smoking and dietary habits, particularly in clinical and athletic 
populations. 
 
Clinical populations 
The purpose of Chapter 5 was to identify the effects of concentrated NO3
--rich beetroot 
juice on exercise capacity after voluntary whole blood withdrawal, which can simulate 
clinical conditions where blood O2-carrying capacity and tissue O2 delivery may be 
limited. Over the past few years, the influence of dietary NO3
- in older persons (Kelly et 
al., 2013) and in individuals with diabetes (Gilchrist et al., 2014; Shepherd et al., 2015), 
COPD (Berry et al., 2015; Shepherd et al., 2015a), PAD (Kenjale et al., 2011) and heart 
failure with preserved (Zamani et al., 2015; 2017) and reduced (Coggan et al., 2018) 
ejection fraction has been investigated, but with varied outcomes. Future research could 
be directed toward the effects of NO3
- ingestion in other clinical populations where 
promotion of the NO3
--NO2
--NO pathway may be particularly useful, such as in 
anaemia. The use of dietary NO3
- as a therapeutic aid in the clinical domain may have 
larger implications than those seen in young, healthy persons and therefore, determining 
the timing and dosage of dietary NO3
- needed to positively influence parameters of 
cardiovascular health in such populations may be a future channel of research. 
 
Ascorbic acid and polyphenols 
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Chapter 7 highlights the potential role of alcohol, and more noticeably, although not 
significantly, the combination of alcohol and polyphenols (via red wine) in reducing 
systemic BP, alongside NO3
- ingestion. Polyphenols, including quercetin and resveratrol 
have been linked to mitochondrial biogenesis, associated increases in aerobic capacity 
(Davis et al., 2009; Ganio et al., 2010; Lagouge et al., 2006) and reductions in BP (Liu 
et al., 2015). It has also been suggested that NO formation is enhanced in the presence 
of vitamin C (ascorbic acid; Carlsson et al., 2001). However, the influence of 
polyphenols and ascorbic acid in isolation and in conjunction with NO3
- 
supplementation requires further research. The dose- and pharmacokinetic- response to 
NO3
- with ascorbic acid and an array of polyphenols has yet to be determined, so too is 
the subsequent impact on BP and the physiological response to exercise. 
 
Conclusion 
The physiological response to the consumption of dietary NO3
-, which is available in a 
multitude of different forms and ingested as part of a normal human existence and 
alongside a selection of factors that might impact its efficacy, is a fast-evolving area of 
research in exercise physiology and medicine today.   
This thesis has highlighted cardiovascular benefits of dietary NO3
- ingestion in young, 
healthy individuals. Overall, the results suggest that factors, such as the regular use of 
mouthwash, blood donation, choice of food form and beverage accompanying NO3
--rich 
foods, can impact the effectiveness of dietary NO3
- ingestion on cardiovascular 
parameters and therefore must be carefully considered when the aim is to derive 
physiological benefits. Specifically, dietary NO3
-, in many different forms, can elevate 
markers of NO bioavailability and reduce systemic BP. Therefore, NO3
- can be  
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recommended as a means for improving cardiovascular health, but a number of factors 
must be taken into account during periods of supplementation to ensure maximum 
benefit is achieved. 
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